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ABSTRACT
Changes of cellular glycosylation, such as the increased expression o f the 
oncofetal Thomsen-Freidenreich antigen (galactosel31-37V-acetylgalactosaminea-,TF), 
are common in cancer and pre-cancerous conditions. The glycosylation changes 
observed in colon cancer can be induced by prevention of the normal acidification of 
the Golgi in colonocytes probably through fragmentation o f the Golgi apparatus. This 
might in turn be triggered by bacterial-epithelial interactions or by consequential 
inflammation. It seems highly likely that the altered mucosal glycosylation seen in the 
inflamed, pre-malignant and malignant epithelium leads to recruitment o f ‘non- 
pathogenic’ bacteria. It would also result in increased recruitment o f dietary TF- 
binding lectins. The edible mushroom (Agaricus bisporus) lectin (ABL), that binds TF 
and sialyl-TF, has an anti-proliferative effect that relates to its internalisation and 
inhibition o f NLS-dependent nuclear protein import mediated via its interaction with 
an N-terminally truncated form of the stress glycoprotein Orpl50. This thesis sets out 
to characterise Orpl50 glycosylation and investigate further the role of Orpl50 in 
nuclear protein import, and to observe whether bacteria alter mucosal glycosylation by 
inducing a disorganisation of the Golgi apparatus.
In this study, immunoblotting of protein extracts from HT29 colon cancer cells 
showed the presence of two Orpl50 isoforms of which the lower molecular weight 
isoform is stress-inducible by glucose starvation; selective membrane permeabilisation 
with digitonin showed release of a constitutive Orpl50 isoform in the released 
cytoplasm. Lectin affinity purification of protein extracts from a glucose-starved cell 
preparation with Jacalin yielded selective extraction of the constitutive Orpl50 form 
suggesting differential glycosylation of the two Orpl50 isoforms. siRNAOrpl50 
treatment of HT29 cells resulted in 63±5% reduction of Orpl50 expression and 
subsequently 61% reduction (% nuclear fluorescence, without heat stress 46±4, after 
heat stress 58±3, siOrpl50 + heat stress 51±3, PO.OOOl) of the nuclear translocation 
o f Hsp70 in response to heat stress, thus confirming a role for Orpl50 in nuclear 
localisation sequence (NLS)-dependent nuclear protein import.
The functional importance of sialyl-TF on Orpl50 was investigated by utilising 
known O-glycosylation inhibitors: 5-CDP, benzyl-GalNAc, TNFa and bafilomycin or 
siRNAGalT treatments to alter TF expression. The consequent glycosylation 
alterations were not seen to alter NLS-dependent nuclear protein import. A number of 
other possible cytoplasmic proteins expressing sialyl TF were identified through ABL 
lectin affinity purification and mass spectrometry. Further investigation demonstrated 
the possibility o f Hsp90 also expressing sialyl-TF.
Bacterial supernatant from E.coli HM427 isolated from a Crohn’s disease 
patient was shown to cause fragmentation of the Golgi in HT-29 MTX goblet cells 
(differentiated colon cancer cells) after 10 days incubation, increasing the average 
number of Golgi fragments per nuclei from 2.7±0.5 to 4.5±0.6 (p<0.01), as observed 
by immunohistochemical staining with a cfr-Golgi structural protein Giantin. The 
supernatant also increased TF expression as measured by PNA binding density from 
1400±300 ADU in control to 2300±200 ADU (p<0.01) after 10 days incubation.
This is one of only 2 reports so far of a cytoplasmic protein expressing sialyl- 
TF and could be of significant importance in the understanding O-glycosylation 
pathways. The finding in this study of Golgi fragmentation in response to bacterial 
supernatant is an exciting phenomenon which could be an important component in the 
complex interactions between bacteria and the host epithelium and consequent aberrant 
glycosylation.
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CHAPTER 1
INTRODUCTION
Glycans are abundant in nature and the field o f glycobiology, which has grown 
rapidly in the past 20 years due to advances in technology has not only given insights 
into the vast number o f enzymes and proteins that are devoted to the mechanism of 
glycosylation, but also the emerging biological role of these glycans. It is now known 
that glycans are important in a large and diverse range o f functions and this is 
highlighted by the growing number o f human diseases that are the result of defective 
glycan assembly. Aberrant epithelial glycosylation is a common consequence of 
disease and this has been clearly demonstrated in colon cancer with the increased 
expression of certain truncated glycans.
This thesis examines the importance of glycosylation in human colon epithelial 
cells with particular attention to the oncofetal Thomsen-Freidenreich antigen. This 
antigen in its sialylated form has been demonstrated to be expressed on a cytoplasmic 
protein which has been implicated in protein transport into the nucleus. This thesis will 
investigate the function o f this antigen and investigate whether other proteins present 
in the cytoplasm also express the TF antigen. The Golgi apparatus is at the centre of 
the glycosylation process and this thesis will finally investigate relationship between 
the structure o f the Golgi and aberrant glycosylation.
1.1 Glycoproteins
Glycoproteins are proteins that have carbohydrate covalently attached to their 
peptide portion. They are widely distributed throughout animal, bacterial and plant 
kingdoms and are involved in a broad range of processes and functions. More than half 
o f all proteins are glycosylated in eukaryote biological systems (Van den Steen et al.
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1998). The predominant type of posttranslational modification which involves 
carbohydrates is the most heavily studied TV-glycosylation, followed by O- 
glycosylation.
1.2 iV-glycosylation
TV-glycans are initiated by a series of stepwise enzyme-catalysed reactions in 
various localised cellular compartments. This begins with the transfer of a lipid linked 
oligosaccharide precursor Glc3Man9GlcNAc2 -P-P-Dol to the endoplasmic reticulum 
(ER) (Komfeld et al. 1985). The formation of complex carbohydrate structures is 
initiated by the addition o f 2 core GlcNAc monosaccharides proceeded by 5 mannose 
residues for which the donors are UDP-GlcNAc and GDP-Man (Abeijon et al. 1992). 
The Man5GlcNAc2-Dol then flips across the lipid bilayer to become positioned in the 
ER lumen where a further 4 mannoses and 3 glucose residues are added to give rise to 
a complex oligosaccharide that can be transferred from the lipid precursor to the 
nascent polypeptide chain by oligosaccharyltransferase (OST), this process is 
described in figure 1.1.
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Figure 1.1: The A-glycosylation pathway (Adapted from www.icp.ucl.ac.be)
Attachment occurs at the site Asn-X-Thr/Ser, where X is any amino acid 
except proline. Modification of the attached oligosaccharide then occurs with 
glucosidases I and II acting first on the protein-linked oligosaccharide precursor to 
remove all three glucoses sequentially. These glycosidases are present in the lumen of 
the ER with glucosidase I acting specifically on the single al-2-linked terminal 
glucose. The three glucose residues are cleaved sequentially, in a process conserved in 
eukaryotes and now known to be cmcial in protein folding. The /V-glycans then 
become available to enzymes in the Golgi and ER which are responsible for the 
formation of three main oligosaccharide types, as shown in figure 1.2.
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High-Klatinose Hybrid Complex
Figure 1.2: Diversification of A-glycans
(Adapted from Essentials o f Glycobiology, Varki et al 1999)
The structures share the same pentasaccaride core but differ in the type and 
sequence o f sugars in the branches which are altered by the action of mannosidases or 
glycosyltransferases. The high mannose type has only mannose sugars on the 
branches, hybrid types have GlcNAc substituted on one branch with mannose on the 
other, while complex types have both branches substituted with GlcNAc. These 
differing core structures bestow specificity, allowing only certain enzymes to act upon 
them and thus leading to the enormous amount o f diversity in A-glycans. Protein may 
also be glycosylated differently at other sites, this is termed microheterogeneity.
1.3 O-glycosylation
1.3.1 Mucin type 0-glycosylation: addition of GalNAc
The initial step in O-glycosylation is simpler than that for A-glycosylation 
although the glycans produced probably have greater variation in linkage and
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substitution; it is a posttranslational modification in which the monosaccharide 
GalNAc is added from a nucleotide donor, UDP-GalNAc, to the serine or threonine 
residues o f the fully folded and assembled protein, catalysed by a polypeptide GalNAc 
transferase (GalNAcT) [Figure 1.3]. This distinguishes it from other types of 
glycosylation and also other forms of O-glycosylation such as O-GlcNAc (Hart 1997), 
O-mannose and O-fucose (Harris et al. 1993). A family o f GalNAcTs are responsible 
for the addition of GalNAc to the serine and threonine residues. Initially in 1993, 
Hagen and colleagues cloned the cDNA of bovine GalNAcT (Hagen et al. 1993), then 
it was shown that other GalNAcTs existed (Sorensen et al. 1995, White et al. 1995), 
GalNAcTs continue to be identified (Bennett et al. 1996, Clausen et al. 1996) and to 
date up to 20 members have been identified (Ten Hagen et al. 2003)
9
t
Figure 1.3: Initiation o f O-glycosylation by a family of GalNAcTs facilitating the 
addition o f GalNAc to serine and threonine residues of folded protein.
It has been shown that the various GalNAcTs are expressed in a tissue-specific manner 
which changes during development (Roth et al. 1994, Young et al. 2003). An 
understanding o f the reason for the large number and tissue specificities o f these 
GalNAcTs will give an insight in to the functions o f O-glycans.
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The transfer o f GalNAc is thought to occur in the Golgi apparatus (Rottger et 
al. 1998, Storrie et al. 1998), specific regions of the endoplasmic reticulum or an inter 
ER-Golgi compartment (ERGIC) (Bieberich et al. 2000, de Graffenried et al. 2004, 
Young 2004). Subsequently, the GalNAc residue is often acted upon by specific 
transferases in a stepwise fashion to yield several core structures; to date 8 core 
structures have been identified (Hounsell et al. 1996). The core structures can then be 
further modified by acetylation, fucosylation, sialylation, sulphation or 
polylactosamine-extension.
1.3.2 Core structures and T antigen
Core structures are formed after the action o f the GalNAcTs; many O-glycans 
contain the Core 1 structure by the addition of galactose in a 131-3 linkage to GalNAc, 
which is catalysed by the glycosyltransferase: Core 1 131-3 glycosyltransferase (Core 1 
GalT). Core 1 GalT has also been shown to be differentially expressed in tissue types. 
Core 2 O-glycans are formed by the addition of GlcNAc to the GalNAc in a 131-6 
linkage and may be elongated in a mono or biantennary form. A further 6 Core 
structures have been identified, these can be elongated further by competitive action of 
specific core GalNAcTs (Schachter et al. 1989) [Figure 1.4].
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Figure 1.4: Core structures and TF antigens.
O-glycans can also be modified and terminated by sialic acid. The 
sialyltransferases that are responsible can act after the transfer of GalNAc to the serine 
/threonine or on the Core 1 structure. The addition o f sialic acid restricts further 
elongation o f the structure. The GalNAca-Ser/Thr structure is called the Tn antigen 
and the Galfi 1 -3GalNAca-Ser/Thr disaccharide is called the T or Thomsen- 
Friedenreich (TF) antigen (Hanisch et al. 1997). These structures are rarely seen under 
normal circumstances, as they are the acceptors for the glycosyl and sialyl transferases 
located in the specific areas of the Golgi and ER. They act as oncofetal antigens, which 
are epitopes expressed only in embryonic tissues and tumour cells. They have been 
demonstrated to be expressed in a number of cancers including breast and colon 
(Campbell et al. 1995, Kumar et al. 2005). A list of blood group and related antigens
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on O-linked cores is presented in table 1.1 and mucin type O-glycans in cancer in table
1.2.
1.3.3 Mucins
Mucins are a family of heavily O-glycosylated proteins with apparent 
molecular weights of about 107Da. They have distinct peptide domains of functional 
importance that are Ser/Thr/Pro-rich and contain a variable number o f tandem repeat 
(VNTR) domains that are heavily O-glycosylated (Hollingsworth et al. 2004). Mucins 
form a physical barrier over surface epithelial cells conveying protection, lubrication 
and transport functions. Mucins are often resistant to proteases, especially in the 
heavily O-glycosylated regions. The most likely reason is that attached carbohydrate 
blocks access to the peptide core as the same sequences are susceptible in the absence 
o f the carbohydrate (Kozarsky et al. 1988). Currently there are 20 genes that encode 
mucin type proteins (Ali et al. 2007) that are expressed by epithelial cells in the 
gastrointestinal, tracheobronchial and reproductive tracts. Their biophysical properties 
are due to the extensive O-glycosylation of the serine- and threonine-rich tandem 
repeat domains and each mucin appears to have its own unique repeat sequence. The 
increased expression of MUC1 has been demonstrated in many carcinomas (Denda- 
Nagai et al. 2000). Salivary oral mucins have an important role in oral health by 
protecting the teeth by acting as protective barrier, but also have the ability to act as a 
microbial acceptor thus adding further protection (Moniaux et al. 2001). It has also 
been shown that MUC5B secreted in the saliva is a key molecule in the initial 
interaction between host and invading pathogens in the mouth (Thomsson et al. 2005).
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B lo o d  g r o u p  a n d  re la te d  a n tig e n s  o n  O -lin k e d  c o re s  |
TF(Thomsen Friedenreich 
antigen)
G a lp l -3 G a lN A c a l -S er/T h r
Disialyl TF N eu A ca2 -3  G al P 1-3 G a lN A c a l-S e r /T h r  
a 2 ,6  
N e u A c
Sialyl T n N e u A c a 2 -6 G a lN A c a l-S e r/T h r
Tn G a lN A c a  1-S e r /T h r
Type 1 backbone (G al/31  -3 G lc N A c p l -3 /6 )n (G a ip i -3 )G a lN A c a l -S er/T h r
Type 2 backbone (G a lp  1 -4 G lcN A cp l-3 /6 )n (G alp  1 -3 )G a lN A c a l-S e r/T h r
Blood group H F u c a l-2 G a ip i-
Blood group A
G a lN A c a  1-3
\
G a lp l
F u c a l-2  / / ^
Blood group B G a la  1-3
\  
G al p i
F u c a l- 2
CAD (SDa) G a lN A c p l-4
G a ip i
/
N e u A ca2 -6
Sialyl Lewis" N e u A c a 2 -3 G a ip i -3 G lc N A c p i-  
h 4
F u c a
Lewis" G aip  1 -3 G lcN A cP  1 -
M
F u c a
Lewis'* G a lp l-3 G lc N A c p l-  
| l , 2  |lj4 
F u c a  F u c a
X antigen (SSEA-1, Lex) G a lp l-4 G lc N A c p l-
M
F u c a
Y antigen (Ley) G a lp M G lc N A c p l-  
¡1,2 [,3  
F u c a  F u c a
Table 1.1: Blood group and related antigens on 0-1 inked cores (Hounsell et al. 1996)
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1.3.4 Intracellular/nuclear glycosylation: 0-GlcNAc
It was thought that N- and O-glycosylation mechanisms that take place in the 
Golgi and ER destined proteins for secretory pathways and that glycoproteins were all 
either restricted to the plasma membrane and extra cellular spaces or secreted 
(Haltiwanger et al. 1997). However, there is now a large amount of data to show that 
there are glycoproteins in the cytoplasm (Hart et al. 1989a, Hart et al. 1989b). The 
most studied cytoplasmic form of glycosylation is O-GlcNAc, which is P-N- 
acetylglucosamine O-linked to the hydroxyl groups of Ser/Thr (Torres et al. 1984). 
Over 50 proteins bearing this glycosylation have been identified and the vast majority 
are nuclear localised, but some reside in the cytoplasm. As for other O-glycans no 
consensus sequence has been identified, however most known OGalNAc Ser/Thr sites 
have a proline residue within a few amino acids o f the serine and threonine. The 
enzymes responsible for the addition of O-GlcNAc, O-GlcNAc transferase (OGT), 
and removal, P-N-acetylglucosaminidase (O-GlcNAcase) have been characterised 
(Iyer et al. 2003). The biological role o f O-GlcNAc is still being uncovered, but so far 
it has been shown to be involved in a regulatory mechanism, which shares similarities 
with phosphorylation in terms of its impact on dynamic cycling and the proteins that 
are modified (Comer and Hart. 2000). The sugar nucleotide UDP-GlcNAc is the 
donor for OGlcNAc addition and it is generated through the hexosamine biosynthetic 
pathway. An increased flux through this pathway has been shown to coincide with a 
resistance to insulin. A possible mechanism for this resistance lies with the O-GlcNAc 
modification, as it is dependent on the hexosamine biosynthetic pathway (Marshall et 
al. 1991).
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Further studies on O-GlcNAc have confirmed that O-GlcNAc modification has
a regulatory role:
• O-GlcNAc modification occurs at the same site as phosphorylation in c-myc. 
This modification has a role in protein stability (Chou et al. 1995)
• Insulin stimulates the biosynthesis o f Spl and also regulates both its O- 
glycosylation and phosphorylation (Majumdar et al. 2004)
• Transcription factors and RNA polymerase II can be modified by O-GlcNAc to 
promote gene silencing (Yang et al. 2002)
1.4 Altered glycosylation in disease
Glycosylation is one of the most common posttranslational modifications of 
proteins. It is therefore not surprising that a common phenotypic change seen in cancer 
cells is altered glycosylation (Kim et al. 1996) (Kobata et al. 2005). Early interest in 
the pathophysiological role o f glycosylation arose from experimental research showing 
the appearance o f certain oligosaccharides during tumour progression. These truncated 
glycan structures were also seen in embryonic tissues so were termed oncofetal 
antigens. Tumour cells undergo activation and rapid growth and have the ability to 
adhere to different cell types (Varki, A. et al. 1999). These features are accompanied 
by altered glycosylation, some of which can be recognised by various lectins and 
antibodies. Alterations in glycosylation can arise in various forms (Kim et al. 1997), 
most are truncated versions of normally occurring oligosaccharides such as TF, Tn or 
Lewis structures in native and sialylated forms. These can occur due to the up 
regulation or down regulation of competing glycosyltransferases or changes in the 
elongation of the core oligosaccharide structures that give rise to more favourable 
acceptors for later glycotransferases (Corfield et al. 1995). A common glycosylation
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change seen in cancer is the more frequent occurrence of highly branched heavily 
sialylated glycoproteins (Warren et al. 1978). This increase, often as (a2-6)-linked 
sialic acids, is frequently the reason for the increased binding of Wheat Germ lectin in 
tumour samples. The increased size of tumour cell glycopeptides has been shown to be 
due to the increased (31-6 branching of A-glycans which is the result of an increased 
expression of GlcNAc transferase V (Saito et al. 1995). Increased GlcNAc transferase 
V bestows cell lines an increased frequency o f metastasis, this was highlighted by an 
experiment where transfection of GlcNAcT-V cDNA into a cell line caused 
tumorigenic behaviour by previously nontumorrigennic cells. In Wiscott Aldrich 
syndrome (WAS), patients demonstrate abnormal glycosylation of CD43, due to 
increased pl-6GlcNAcT activity resulting in more branched core 2 glycan or lower 
molecular weight CD43. This may be the cause of the development of the autoimmune 
disorders and progressive lymphopenia observed in WAS patients (Khan et al. 2007). 
Hypogalactosylation of salivary and gingival fluid immunoglobulin G has been 
observed in patients with advanced periodontitis (Stefanovic et al. 2006). Reelin is a 
protein essential for the correct cytoarchitectonic organization of the developing CNS. 
In Alzheimer’s patients reelin was differently glycosylated depending on its 
localisation in the plasma or cerebrospinal fluid (Botella-Lopez et al. 2006). In cancer 
cells mucin type O-glycans are the major carriers of altered glycosylation and these 
alterations in cancer can have differing biological and pathological consequences.
1.4.1 Aberrant glycosylation in colonic disease
Glycosylation changes seen in colon cancer, adenomatous and metaplastic 
polyps and cases o f chronic inflammation such as UC and CD are similar, typically 
showing truncated O-linked oligosaccharides, reduced sulphation, increased sialylation
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and Lewis variants [Table 1.2]. The TF antigen has been demonstrated following its 
specific cleavage by O-glycanase from mucins extracted from colon cancer and UC 
mucosal samples (Campbell et al. 1995). In other studies the Tn antigen in its native 
and sialylated form (Brockhausen et al. 1998, Karlen et al. 1998) is seen in UC patients 
and in colonic adenomas (Itzkowitz et al. 1992). Sialyl-Tn (S-Tn) is also under 
investigation as a diagnostic marker in breast (Sewell et al. 2006) and gastric cancers 
(Nakagoe et al. 2001).
Mucin-type O-glycans and alterations in cancer 
O-glycan Structure
Increased/ 
decreased 
in cancer*
Tn antigen GalNAca-Ser/Thr Î
STn antigen Sialyla2-6GalNAca-Ser/Thr T
Core 1, Gaipi-3GalNAca-Ser/Thr
T antigen 
Sialyl-T Sialyla2-3Gaipi-3GalNAca-Ser/Thr t
antigens Sialyla2-6(Gaipi-3)GalNAca-Ser/Thr
Core 2 GlcNAcpi-6(Gaipi-3)GalNAca-Ser/Thr -Î-T
Core 3 GlcNAcPl-3GalNAca-Ser/Thr 4/
Core 4 GlcNAcpi-6(GlcNAcpi-3)GalNAca-Ser/Thr T
Type 1 chain [GlcNAcpi-3 Gaipi-3]n
Type 2 chain [GlcNAcpi-3 Gaipi-4]n V
Sialyl-Lewisa
po\y-N-acetylactosamines 
Sialyla2-3Gaipi-3 (Fucal-4)GlcNAcpi-3Gal- Î
SLex Sialyla2-3Gaipi-4 (Fucotl-3)GlcNAcpi-3Gal- T
Sialyl-dimeric Sialyla2-3Gaipi-4 (Fucal-3)GlcNAcpi-3 T
Lewisx Galpl-4 (Fucal-3)GlcNAcpi-3Gal-
*The symbol 'T' denotes an increase in cancer,whereas the symbol T  denotes a 
decrease
in cancer. Fuc, fucose; Gal, galactose; GalNAc,N-acetylgalactosamine; GIcNAc, 
N-acety/glucosamine; sialyl, sialic acid; SLex, Sialyl-Lewisx; STn, Sialyl-Tn.
Table 1.2: Mucin type O-glycans in cancer. Adapted from (Brockhausen 2006)
Increased sialylation o f mucins has been demonstrated in IBD colonic mucosal 
expiants. The importance o f sialic acids in cancer metastasis was highlighted when it 
was shown that they prevent attachment of the cell to fibronectin and collagen type IV 
(Dennis et al. 1982). Sialyl-Tn expression has been correlated with poor prognosis in
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cancer patients; clones o f the breast cell line T47D over expressing sialyl-Tn and the 
enzyme responsible for its synthesis have slower cell growth, but increased cell 
motility, a feature of malignancy, as they had decreased adhesion to matrix protein 
(Julien et al. 2005). The sialic acids in cancer states can also be modified, for example 
sialic acid 9-O-acetylation is decreased in colon cancer (Yamashita et al. 1995).
Further alterations seen in human malignant colonic tissues affect Lewis 
antigens (Kim et al. 1986) known to be ligands which interact with various lectins and 
antibodies. In normal colonic mucosa type 1 and 2 chain extensions are formed, in 
colonic adenocarcinomas there is an increase type 2 chains, which are the precursor for 
the increased activities o f (a2-3)-sialyltransferases seen in colorectal cancer, resulting 
in higher expression o f sialyl-Lewisx (SLex) in particular sialyl-dimeric Lexisx antigen 
is correlated to poor prognosis.
Colonic mucins in colitis can also show reduced sulphation (Brockhausen 
2003, Brockhausen 2003) and UC mucosal samples show lower sulphate incorporation 
compared to IBD controls when cultured in vitro (Campbell et al. 2001). Mucins are 
able to inhibit cell-cell adhesion mediated by integrins and E-cadherin. A competitive 
inhibitor o f O-glycosylation, benzyl-a-GalNAc, was shown to increase E-cadherin- 
mediated cell adhesion by decreasing the inhibitory effect of O-glycosylated 
dysadherin (Tsuiji et al. 2003). South Asians diagnosed with colitis show do not show 
this reduced mucin sulphation and it has been suggested that this might be the reason 
for the lower rates of cancer in this population as compared to Europe (Probert et al. 
1995). There are reports o f alteration of specific sub classes of mucin in IBD and UC, 
based on the fractionation by chromatography of mucin samples (Podolsky et al. 1983, 
Podolsky et al. 1984), close examination of the results however shows that the 
techniques used are probably just showing overall mucus depletion seen in human UC
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(Raouf et al. 1991). Depleted mucus would give an altered interaction with luminal 
contents, perhaps an altered response to bacteria, which could lead to inflammation. 
The Cotton-top Tamarin, a New World monkey, also develops colitis which is 
indistinguishable from human UC (Boland et al. 1987). In this model there is also an 
increase in the TF antigen and mucin sub-class depletion similar to humans.
1.4.2 Mechanisms of altered glycosylation
In normal colonic tissues a large range o f O-glycan structures is seen. However 
in colon cancer increased expression o f the TF and Tn antigens are seen, both are 
markers o f poorly differentiated adenocarcinomas and have been correlated with 
advanced cancer. It is not known whether these alterations in glycosylation arise 
because of an alteration in the donor carbohydrate availability, altered substrate protein 
sequence or alterations in the glycosyltransferase enzymes. It has been shown that an 
alteration in the relative activities of glycosyltransferases or alterations in the 
localisation o f the glycosyltransferases can cause aberrant glycosylation, with some 
studies demonstrating that glycosyltransferase localisation is regulated by Golgi pH 
(Kellokumpu et al. 2002)
The increase in TF and Tn seen in colon cancer could be due to a change in 
glycotransferase levels (Brockhausen et al. 2001); a reduced level of Core 3 P1-3-77- 
acetylglucosamine (GlcNAc) is observed allowing the GalNAc peptide to be acted 
upon by the Core 1 and 2 enzymes thus providing a higher prevalence of TF antigens. 
In addition to this, the level of the transferase responsible for addition o f sialic acid to 
this structure, is increased, leading to increased levels of sialyl-TF (Schneider et al. 
2001). In normal colonic tissue there is a high mucin type M-enzyme (C2Gnt) activity, 
which alongside leucocyte-type L-enzyme (CIGnT) is responsible for the conversion
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of the TF antigen to the Core 2 structure. In tumorigenic cells derived from human 
adenoma cells this C2GnT activity was diminished, but in some other human colon 
cancer cell lines such as HT-29 the activity was still high (Vavasseur et al. 1994, 
Vavasseur et al. 1995). Overall, however, it seems that C2GnT is upregulated relative 
to CIGnT in most colon cancer tissues. This shift in relative activity would seemingly 
result in a decrease o f Core 4 structures and an overall increase in Core 2 structures 
which are the main bearers of SLex.
However, a detailed study of the relative expressions of glycosyl-, sialyl- and 
sulpho-transferases in colon cancer showed that although there are differences, these 
differences related poorly to the changes in the carbohydrate expression (Yang et al. 
1994). A further mechanism by which alteration in glycosylation could occur could be 
due to an alteration distribution of the glycosyltransferases in the Golgi and the manner 
and order by which they are able to act on their substrate. Proteins in the Golgi are 
fully folded and so only the accessible Ser/Thr residues can be glycosylated. Many 
studies have investigated the localisation of specific glycosyltransferases, for example 
the enzymes that synthesise Core 1 and Core 2 structures are seen mainly in the cis- 
Golgi (Roth et al. 1994, Rottger et al. 1998). A logical assumption is that proteins 
travelling through the Golgi from the cis- to trans- Golgi in normal cells will encounter 
the glycosyltransferases in an order that allows the stepwise addition o f glycans. In 
disease states the localisation of these glycosyltransferases could be disturbed resulting 
in incomplete or altered glycosylation (Egea et al. 1993)
Altered Golgi pH has been shown to cause altered glycosylation, possibly 
acting via a change in the localisation of the glycosyltransferases, or reducing the 
activity o f the glycosyltransferases. The pH was significantly more alkaline in HT-29 
and SW-48 colon cancer cell lines compared to control, and a 0.2 pH increase in pH
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induced an increase in TF antigen expression in control cells (Rivinoja et al. 2006). 
Drug-induced alkalinisation of the Golgi by bafilomycin Ai or monensin in goblet cell 
differentiated colonic cell line LS174T caused increased TF expression and mucin 
depletion as seen in colon cancer (Campbell et al. 2001). Furthermore an altered Golgi 
structure in colon cancer cells, visualised by Golgi structural protein Giantin, is shown 
alongside alteration in glycosylation [Figure 1.5] (Kellokumpu et al. 2002).
In another human goblet cell differentiated cell line, HT-29 MTX 
(Methotrexate-conditioned), Campbell and colleagues have shown that pro- 
inflammatory cytokine tumour necrosis factor alpha (TNFa) could induce disease- 
associated glycosylation patterns, with an increased expression of TF antigen and a 
reduction in mucosal sulphation (Campbell 2002). However, further investigation is 
required to understand the impact o f cytokines on Golgi pH and the altered 
glycosylation seen. In cystic fibrosis opposite alterations in glycosylation are observed 
such as under-sialylation o f glycans, this is due to the hyper acidification of the trans- 
Golgi as the result o f the dysfunctional cystic fibrosis transmembrane conductance 
regulator (CFTR) gene product (Poschet et al. 2001). Alternative splicing has also been 
identified as being involved in an altered glycosylation profile. Notably the adhesion 
molecule CD44 shows expression of TF antigen on its higher molecular weight 
variants as compared to the standard CD44 from both normal and colon cancer tissues 
which do not express TF antigen (Singh et al. 2001). Higher molecular weight CD44 
splice variants with TF expression are expressed in colitis and provide a link between 
cancer associated changes and splice variants. This and other reports, therefore, show 
that amino acid sequence of the CD44 plays a part in (9-glycosylation but does not 
explain the change in glycosylation of secreted mucins (Campbell et al. 2001).
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Figure 1.5: Structural organisation of the Golgi apparatus in colorectal cancer cell 
lines, visualised by anti-Giantin immunohistochemistry (Kellokumpu et al. 2002). The 
Golgi apparatus of colon cancer cells is fragmented and scattered around the nuclei and 
the cytoplasm compared to the control non-cancerous normal rat kidney (NRK) cell 
line. All the cell lines also were positive for the expression of the TF antigen.
1.5 Functional consequences of altered glycosylation
1.5.1 The colonic epithelium
The human colonic epithelium [Figure 1.6] is a physical barrier of cell 
membranes perpetrated with tight junctions, which is further protected by the secretion 
of mucin glycoproteins and trefoil peptides by goblet cells (Podolsky et al. 1984), and 
the integrity of which is paramount as the human intestine is colonised with between 
500-1000 different bacterial species (Egert et al. 2006). The colonic epithelium as well 
as providing an effective barrier has also been demonstrated to be integral to the 
immune response and must be able to discriminate between resident flora and enteric 
pathogens.
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Figure 1.6: Human colonic epithelium (adapted from
http://www3.umdnj.edu/histsweb). Red arrow  -  Mucosa, Blue arrow  -  Submucosa, 
G reen arrow  - Muscularis Externa, Black arrow  - Taenia coli
1.5.2 Bacterial-epithelial interactions
In order for bacterial pathogens to colonise the colon and eventually cause 
disease it is usually necessary for them to successfully adhere to the epithelium. This 
initial ability to adhere will enable them to resist the fluid flow of the luminal contents 
and peristalsis of intestinal contraction (Lu et al. 2001) and once bound these bacteria 
can become resident in the gut. The interactions of bacteria and the epithelium are 
complex and involve interactions between the bacterial surface determinants and the 
host epithelium receptors. Pathogens share similar mechanisms of interactions with the 
host, but individual bacteria possess unique abilities to exploit the host processes. The 
glycocalyx is a layer of glycoconjugates expressed at the surface epithelium and these 
oligosaccharides can serve as receptors for microorganisms [Figure 1.7]. The
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commensal bacteria o f the gut have a role in the prevention of pathogenic bacteria 
adherence by steric hindrance and covering the expressed glycoconjugates. However, 
it has also been shown that indigenous microflora can influence the expression of 
glycoconjugates, by inducing the expression of fucosylated glycoconjugates on the 
host intestinal epithelium, which provides a lectin-like receptor for pathogens (Bry et 
al. 1996).
Luminal
pathogens
Figure 1.7: Crosstalk between intestinal bacteria and the host epithelium. Colonisation 
by indigenous microflora induces the expression o f fucosylated glycoconjugates on the 
host intestinal epithelium. The expression of the glycoconjugates provides lectin-like 
receptors for the attachment of luminal pathogens and eventually confers susceptibility 
to pathogen colonisation and disease (Lu et al. 2001)
The functional importance of altered glycosylation such as the increased 
expression o f oncofetal antigens and how they are related to the progression of disease 
are still under investigation and it is highly probable that they may lead to the 
recruitment o f ‘non-pathogenic’ bacteria, which results in epithelial inflammation. It
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has been demonstrated by Martin and colleagues that there are increased numbers of 
mucosa-associated bacteria, particularly adherent and invasive E. coli, in patients with 
Crohn’s disease and colon cancer. These E.coli, which lack known pathogenicity 
genes, do not have to adhere to induce expression and release o f the pro-inflammatory 
cytokine interleukin 8 (IL-8) (Martin et al. 2004). However many of these E.coli 
express haemagglutinins which allow them to adhere to intestinal epithelial cell lines 
and subsequently cause IL-8 release mediated by extracellular-regulated kinase (ERK) 
and mitogen-activated protein kinase (MAPK) and inhibited by mesalamine 
(Subramanian et al. 2008). It has also previously been demonstrated that the truncated 
glycans can act as ligands for microbial and plant lectins, which can lead to an increase 
in mucosal proliferation (Ryder et al. 1994). It is, therefore, of clear interest to 
investigate this complex interaction between altered glycosylation, inflammation and 
disease progression.
1.5.3 Bacteria and inflammation
There are around 500-1000 bacterial species that have been identified so far in 
the human gut, the colon being most populated with anaerobes with bacterial counts of 
~1014 per gram o f luminal content (Egert et al. 2006). 16S RNA sequence analyses 
show that the dominant bacterial species in human faeces and the colon are low G+C 
content Gram positives (Firmicutesj and Gram negative Bacteroidetes (Backhed et al.
2005). A commensal or symbiotic relationship exists in humans with its colonic 
bacterial flora. Humans provide a nutrient rich environment and the bacteria play a role 
in developing the mucosal immune system, providing essential nutrients and prevent 
colonisation o f pathogenic bacteria (Eckburg et al. 2005).
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1.5.4 Normal bacterial flora as a prerequisite for inflammation
Recent studies have highlighted the balance in the relationship between the 
normal colonic bacterial flora and the host as it has been shown that the normal 
bacterial flora is a prerequisite for the development of inflammation and inflammation- 
related colorectal tumours. The emergence of genetically engineered mouse models 
which require the normal colonic flora to develop colorectal tumours and inflammation 
has helped greatly in furthering the understanding of this process. The T-cell receptor 
beta chain/ p53 (TCRp/p53) double knockout mouse colitis model mimics the 
development of adenocarcinoma in UC with 70% of the mice developing 
adenocarcinomas of the ileocecum under normal housing conditions and no colonic 
adenocarcinomas in those housed in germ-free conditions (Kado et al. 2001). Similar 
observations have been made with interleukin-10 (IL-10) knockout (Balish et al. 
2002) and Gpxl/Gpx2 double knockout mice (Chu et al. 2004). A well-characterised 
mouse model of inflammation is that of the IL-10 knockout. IL-10 is a cytokine 
affecting the growth and differentiation of many hemopoietic cells in vitro (Yang et al.
2006) and in particular is a suppressor of macrophage and T-cell functions. Under 
conventional housing conditions there is an increase in morbidity with all male mice 
and 50% of female mice dying at 4 months and significant inflammation is observed. 
The abnormal changes include thickening of the mucosa, disorganisation of the crypts, 
epithelial ulceration and accumulation of bacteria. When housed under germ-free 
conditions all mice survived up at least 8 months (Sellon et al. 1998). Other 
inflammation models that develop inflammation with the normal bacteria flora include, 
transforming growth factor P-1 (Tgfpi/Rag2) (Engle et al. 1999), Smad3 (Zhu et al.
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1998) and cytokeratin 8 gene knockouts (Habtezion et al. 2005), but these models have 
not been tested under germ-free conditions.
Numerous studies have utilised the 16S RNA sequence diversity to establish 
differences in the microbial flora in health disease states. A significant decrease in the 
proportion of bacteria belonging to the Firmicutes (Manichanh et al. 2006) and 
Clostridium leptum (Sokol et al. 2006) phylum have been reported in Crohn’s disease 
and a reduction in Clostridium coccoides phylum in ulcerative colitis (Sokol et al. 
2006). Examining the bacterial flora at a mucosal level shows differences in the bio 
mass film, with >60% of the biofilm mass attributed to Bacteroides fragilis in patients 
with IBD, 30% in self-limiting colitis and <15% in irritable bowel syndrome (IBS) 
(Swidsinski et al. 2005). However, a study by Prindiville et al (2004) showed no 
significant evidence that one specific organism is associated with IBD. At present it 
not possible to associate mucosal infection by a specific bacteria with IBD although 
there is evidence for some change in the microflora in disease, which is not secondary 
to the effect of inflammation i.e. changes that are not specifically associated with 
lesion sites.
1.5.5 Role of non pathogenic bacteria in inflammation
Evidence supporting a causal relationship between Helicobacter pylori 
infection and the pathogenesis of gastric carcinomas, stemmed from animal models 
and epidemiological studies, resulting in H. pylori being classified as a group 1 
carcinogen in 1994 by the world health organisation (1994). This relationship 
triggered an interest in to the association between intraepithelial E.coli and colorectal 
cancer. It was found that the colonic mucosa of patients with colorectal carcinoma, but 
not normal colonic mucosa, has an increase in mucosa-associated E.coli, and that
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E.coli was present in non cancerous mucosa distant to the tumour (Swidsinski et al. 
1998). In IBD there is evidence for quantitative alterations in the mucosa-associated 
flora and the mucus-associated flora with evidence for a novel class of E.coli that lacks 
conventional pathogenicity genes (Darfeuille-Michaud et al. 1998). It has been shown 
that both the mucosa associated E.coli from CD and colon cancer samples can induce 
the release o f pro-inflammatory cytokines and that they do not have to adhere to the 
epithelial membrane to cause an inflammatory response (Martin et al. 2004). The close 
association o f the bacteria to the membrane is capable o f inducing stress in the 
bacterial cell due to the oxygen-rich environment. This could cause the activation of 
the SOS operon protein in the bacteria (Broom et al. 1993). The degradation o f this 
protein leads to the formation of jV-formyl-methionyl-leucyl-phenylalanine (fMLP). 
This formylated chemotactic peptide is able to elicit IL-8 release from the host 
epithelial (Leiper et al. 2001). This supports the hypothesis that non-pathogenic E.coli 
may play a key role in the pathogenesis of colon cancer.
1.5.6 Mechanisms by which bacteria can cause inflammation
The mechanisms by which commensal bacteria without known pathogenicity 
genes cause an inflammatory response by the host are still under study. Altered 
glycosylation such as the increase in cell surface oncofetal antigens, could be 
responsible for the recruitment of bacteria with lectins specific for TF and sialyl Tn. It 
is known that the protozoan parasite responsible for amoebiasis, Entamoeba 
histolytica, possesses a TF binding lectin, which is crucial to its pathogenicity (Leroy 
et al. 1995). This recruitment of bacteria to the mucosa could then lead to an immune 
response and through various pathways result in inflammation.
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Interleukin 8 (IL-8) is a pro-inflammatory cytokine which is produced as a 
result o f a number of different pathways, and also implicated in intestinal inflammation 
(Crabtree et al. 1994). One o f the pathways known to induce IL-8 is the nuclear 
transcription factor kappa B pathway (NFkB), which regulates the promoters of a 
variety o f genes whose products are critical for inflammatory processes such as IL-8, 
IL-1B and Cox-2. Cox-2 is induced by IL-8 and causes inflammation through the 
production o f prostaglandins, which inhibit apoptosis and promote cellular 
proliferation. Immune and inflammatory responses in the gut and other immune- 
competent tissues often involves NFkB. Proinflammatory stimuli activate NFkB 
through tightly regulated phosphorylation, ubiqutinisation and proteolysis o f a 
physically associated class of inhibitor molecule, IkB (Carlotti et al. 2000). Salmonella 
typhimurium has already been shown to induce epithelial IL-8 expression via Ca - 
mediated activation of the NFkB pathway (Gewirtz et al. 2000). Another mechanism 
by which these bacteria could stimulate a host response is through MAPKs. MAPK 
pathways are well conserved major signalling systems involved in the transduction of 
extracellular signals into cellular responses in many organisms including mammals 
(Kolch 2000). One of the best characterised MAPK pathways is the Ras/MAPK signal 
transduction pathway (also known as the ERK p44/42 pathway), which is responsive 
to signals from receptor tyrosine kinase, haematopoietic growth factor receptors and 
some G protein coupled receptors, which promote cell proliferation or differentiation; 
this pathway could be activated by IL-8 release stimulated by bacteria. It has also been 
shown that bacterial DNA can elicit IL-8 release from HT-29 colon cells through Toll­
like receptor 9 (TLR-9) expressed on the cell surface via a MAPK-dependent, NFkB 
independent, pathway (Akhtar et al. 2003). Phorbol esters such as PMA (phorbol 12- 
myristate 13-acetate) function as tumour promoters and have been implicated in the
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immune response. PMA activates PKC, which can mediate signalling through a 
MAPK pathway, which is either Ras-dependent or Ras-independent (Lee et al. 2002); 
this pathway could be involved in a host response to bacteria.
1.6 Inflammatory bowel disease and risk of colon cancer
Inflammatory bowel disease is a chronic inflammatory disorder separately 
known as ulcerative colitis (UC) and Crohn’s disease (CD). Crohn’s disease, also 
known as regional enteritis, is inflammation of the gastrointestinal tract characterised 
by transmural inflammation and skip lesions, most often affecting the distal ileum and 
caecum. Ulcerative colitis affects the colon and causes more superficial and non­
granulomatous ulceration (Papadakis et al. 2000). Epidemiological studies have shown 
that IBD is a disease that predominantly affects Western society with as many as 1.4 
million persons in the United States and 2.2 million persons in Europe affected. 
Differences in race and ethnicity seemingly are now narrowing and it is becoming 
clear that environmental factors are most influential in expression of the disease 
(Loftus 2004). The incidence o f IBD was shown not to be more frequent in northern 
compared to southern Europe (Shivananda et al. 1996), however, most recent studies 
have included eastern European countries (Lakatos et al. 2006) and a have 
demonstrated that IBD incidence can be distributed on a developed-developing country 
gradient (Frangos 2007, Frangos 2007).
IBD can be categorised as an idiopathic inflammatory disease, as its etiology is 
unknown. Many factors such as genetic, infectious and immunological have all been 
implicated resulting in range o f clinical problems for the patient and now there is 
strong evidence to suggest that chronic inflammation increases risk of colorectal 
cancer (CRC). The risk o f developing CRC increases with duration (Itzkowitz 2002),
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CRC is rarely seen until after 7 years of colitis, thereafter risk increases by 0.5-1% a 
year. The extent of the area affected by colitis is also a determining factor as risk of 
CRC increases with greater colonic surface area affected increases. The efficacy of 
treatment of IBD with anti-inflammatory drugs, especially 5-aminosalicylates in 
reducing colorectal dysplasia also points to the link between inflammation and cancer 
development (Itzkowitz et al. 2004). There are a number mechanisms understood 
which could lead to this chronic inflammation.
Research into the genetics of IBD patients have long shown that 
polymorphisms in the NOD2 (CARD 15) gene to be associated with the risk of 
developing CD (Cho et al. 2007). It encodes a protein selectively expressed in 
macrophages and it is plausible that this alteration may be the cause of the altered 
macrophage response. The relative risk of developing CD in homozygous or 
heterozygous genotypes is estimated to be between 10- and 40- fold greater than that 
o f the general population (Hugot 2006). Although studies have shown it is not as 
simple as just alterations in the NOD2 gene alone and that a combination with as yet 
unknown are responsible for the increase in risk of developing CD (Hugot et al. 2007). 
There is also support for another genetic component to IBD and a prime candidate is 
the vitamin D3 receptor, which has an immunosuppressive capacity, a polymorphism 
in which could be related to the aberrant regulation o f mucosal response (Csaszar et al. 
2001). CD patients have also been shown to have increased incidence of 
homozygotes for the Taql polymorphisms compared to controls or UC patients 
(Simmons et al. 2000). How this relates to the pathogenesis o f the disease is unclear, 
but it may also be linked to immune regulation. One remarkable hypothesis is that CD 
subjects may have been positively selected by having resistance to infectious diseases. 
This would reinforce evidence that polymorphic genes that have modest effects by
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themselves could in combination with environmental factors play a role in the 
pathogenesis of the disease (Csaszar et al. 2001)
The evidence to suggest that cancer risk is due to inflammation and not a co­
inherited phenomenon is detailed by a study in Sweden: 30,000 cases of IBD were 
investigated and it showed that there was no significantly increased risk of colorectal 
cancer in first degree relatives (Askling et al. 2001), however a family history o f 
colorectal cancer did increase risk. This was also seen in a Danish study of 4,496 
patients with IBD (Fonager et al. 1998) and in a more recent but smaller study of an 
Italian population (632 patients) (Riegler et al. 2006).
The present evidence, therefore, supports the hypothesis that colorectal cancer 
susceptibility is increased by extent and duration of inflammation. IBD associated 
cancer, therefore, is an excellent model for inflammation-associated cancer. Arguably 
the colon is in a mild state of continual inflammation as a result of the normal micro 
flora, it is also plausible that an altered host response to normal bacterial gut flora is 
responsible for the chronic inflammation seen in IBD [Figure 1.8]. This could be in 
part due to altered glycosylation allowing recruitment of dietary lectins and bacteria 
that are normally allowed to pass through the gut lumen.
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Figure 1.8: Mechanisms for colon cancer development as a consequence of altered 
glycosylation (Rhodes et al. 2002)
1.7 Lectins
1.7.1 P lant lectins
A lectin, from the Latin le c tu s : to gather or select (Boyd et al. 1954), by 
definition is a carbohydrate binding protein of non immune origin. Lectins occur 
frequently in nature and may be soluble or membrane bound. They are involved in a 
diverse array of biological processes, such as clearance of glycoproteins from the 
circulatory system (Ashwell et al. 1982), leucocyte recruitment to inflammatory sites 
(Melrose et al. 1998) and cancer metastasis (Gabius 1988). Classically lectins were 
deemed to have at least 2 sugar binding sites as lectins with only one binding site will 
not agglutinate or precipitate sugar-containing structures, however, it is now 
recognised that agglutination is not a defining characteristic of a lectin. Lectins have
29
the ability to interact with carbohydrates in a highly specific non-covalent fashion 
which is usually reversible. A lectin’s specificity is normally defined by the 
monosaccharides and oligosaccharides that inhibit its activity (in some cases the 
inhibition of the agglutination properties). Work by Sharon has classified lectins into 5 
groups according to the monosaccharide ligand to which the lectin has most affinity 
(Lis et al. 1998). The five groups being: mannose, galactose/iV-acetylgalactosamine, N- 
acetylgalactosamine, fucose and A-acetylneuraminic acid. It is noted that usually lectin 
specificity is high, and that a lectin generally will bind specific sugar configurations 
e.g. will only bind glucose and not galactose.
Plant lectins have a tightly globular structure and are often resistant to digestion 
by mammalian enzymes allowing them to pass through the gut lumen were they 
remain active. The first pure plant lectin to be identified was concanavalin A (ConA) 
isolated from jack beans and its hemagglutination properties were described over 
seventy years ago (Sumner et al. 1935). The function o f lectins in plants is unclear, but 
they are thought to have a role in immunity and cell-cell interactions (Van Damme et 
al. 2004). Microbial lectins often are adhesins that can be directly involved in the 
pathogenic effects o f enteric bacteria. Direct evidence for the first animal lectin was 
observed when studying the turnover of glycoproteins in the blood. In order to attach a 
tritium label to the terminal sequence o f sialyl-Gal-GlcNAc, the sialic acid had to be 
either be removed or altered by mild periodate oxidation. The glycoproteins 
terminated with sialic acid were retained in the blood for a number of days whereas the 
galatose terminated glycoproteins were rapidly cleared (Ashwell et al. 1982). This led 
to the discovery o f the asialoglycoprotein receptor in the liver, responsible for 
recognition of (3-linked galactose or GalNAc residues (Stockert 1995), and involved in 
the clearance o f ageing desialylated glycoproteins from circulation. The further study
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of animal lectins has shown that the primary amino acid sequence o f a protein could be 
used to predict carbohydrate binding properties with the discovery of the hyaluronan- 
binding properties of CD44 and prediction that selectins would recognise 
carbohydrates (Varki 1998). The diverse roles and classification o f animal lectins 
[Table 1.3].
Lectin family Typical saccharide 
ligands
Subcellular
location
Examples of functions
C aln ex in G lC ]M an9 E R P ro te in  so rting  in  the  
en d o p lasm ic  reticulum .
M -ty p e  lec tin s M an 8 E R E R -asso c ia ted  degradation  
o f  g lycop ro te in s.
L -ty p e  lec tin s V ario u s E R , E R G IC , 
G olgi
P ro te in  so rting  in the 
en d o p lasm ic  re ticu lum .
P -ty p e  lectin s M an  6 -phospha te , 
o thers
S ecreto ry
p athw ay
P ro te in  so rting  post-G olg i, 
g ly co p ro te in  traffick ing , 
E R -asso c ia ted  degradation  
o f  g lycop ro te in s, enzym e 
ta rg e tin g .
C -ty p e  lec tin s V ario u s C ell m em b ran e , 
ex trace llu la r
C ell ad h esio n  (se lectins), 
g ly co p ro te in  c learance, 
in n a te  im m unity  
(co llec tin s).
G a le c tin s P -G alac to sides C y top lasm ,
ex trace llu la r
G ly ca n  cro sslin k in g  in the  
ex tra ce llu la r m atrix .
I- ty p e  lectin s 
(s ig lecs)
S ia lic  ac id C ell m em b ran e C ell adhesion .
R -ty p e  lec tin s V ario u s G olg i, C ell 
m em brane
E n zy m e targe ting , 
g ly co p ro te in  horm one 
tu rnover.
F -b o x  lectin s G1cN A c2 C ytop lasm D eg rad a tio n  o f  m isfo lded  
g lycop ro te in s .
F ic o lin s G lcN A c, G a lN A c C ell m em brane , 
ex trace llu la r
In n a te  im m unity .
C h itin ase -lik e
lectin s
C h ito -o lig o sacch arid es E x trace llu la r C o llag en  m etabo lism  
(Y K L -40).
F -ty p e  lec tin s F u c-te rm in a tin g
o lig o sacch arid es
E x trace llu la r In n a te  im m unity .
In te le c tin s G al, g a lac to fu ran o se , 
p en to ses
E x trace llu la r/ce ll
m em brane
In n a te  im m unity . 
F ertiliza tio n  and 
em b ry o g en esis .
Table 1.3 Classification and functions of animal lectins
(Adapted from http://www.imperial.ac.uk/research/animallectins/ctld/lectins.html)
31
1.7.2 Plant lectins as molecular tools
Plant lectins can be utilised as molecular tools due to their specific recognition 
o f carbohydrate structures; originally their ability to recognise specific carbohydrate 
determinants in human blood cells was utilised for blood typing. Their specificity for 
carbohydrate structures is also useful in lectin-blotting assays (equivalent to Western 
blotting) and histological staining, although some caution must be shown as some 
lectins display non-specific binding. Lectins can be utilised in the characterisation of 
a n im a l  cell glycoconjugates when the binding properties o f the lectin have been 
characterised, which has become especially useful in the recognition of aberrant 
glycosylation in colonic disease. Purification of glycoconjugates is also possible if the 
lectin is immobilised, and a high purity of glycoconjugate can be isolated, especially 
when combined with HPLC (Merkle et al. 1987).
1.7.3 TF and Tn binding lectins
Since it has been shown that there is an increase in TF antigen expression in 
colonic disease, TF/Tn antigen binding lectins have been utilised to demonstrate this 
change in glycosylation. There are four well known dietary TF-binding lectins, all of 
which lack cytotoxicity and can be eaten raw.
The legume family o f lectins is the largest, with around 100 members. They 
typically consist of two or four identical subunits of 25-30 kDa each with one binding 
site which have a tightly bound Ca2+ or Mn2+. They are also characterised by a high 
content of (3-sheets and a lack of a-helices (Sharon et al. 1990). The primary 
sequences o f over 15 legume lectins have been established, with remarkable 
homologies. An important legume lectin is peanut agglutinin, isolated from Arachis
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hypogaea, which exhibits an open quaternary structure where the homotetramer 
possesses neither 2 nor 4 fold symmetry as shown by X-ray crystallography. The PNA 
tetramer can be described as a dimer of a dimer with similarities to the lectin Grijfonia 
simplifolia (Banerjee et al. 1994) The PNA lectin has high affinity for the TF antigen 
with 4 strong invariant hydrogen bonds, alongside numerous Van der Waals 
interactions. The boletaceae family of lectins includes six lectins of similar 
homological sequence. O f this family, the lectin from the edible mushroom Agaricus 
bisporous was one o f the first isolated and noted for its erythrocyte agglutinating 
activities (Presant et al. 1972). It is able to reversibly bind the TF antigen and also its 
sialylated form. Jacalin is another TF antigen binding lectin, which is derived from the 
Jack fruit Artocarpus integrifolia, it can also bind human IgA. Structurally Jacalin 
consists of complex subunit of around 60 kDa, which recognises the terminal galactose 
o f the TF antigen and also has some specificity to the V-acetylgalactosamine structure 
(Tachibana et al. 2006); it can bind in the presence or absence of sialic acid. The lectin 
obtained from Amaranthus caudatus (ACA), which is an important food source in 
South America is also capable of binding to TF and sialyl-TF (Yu et al. 2001). A 
commonly used Tn antigen binding lectin is isolated from Vicia villosa (VVA) the 
hairy vetch seed. VVA preferentially recognises a  or P linked terminal N- 
acetylgalactosamine, especially a single a  V-acetylgalactosamine.
1.8 Effects of lectins on proliferation of colonic epithelial cells
The incidence o f colorectal cancer is about 28,000 cases per annum in the 
United Kingdom and it is the second most common cause o f cancer-related deaths in 
the world (Evans et al. 2002). Much work on the understanding of the pathogenesis of 
the disease has focussed on diet. A protective role against colorectal cancer
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development has long been associated with a high intake of cereal fibre. Dennis 
Burkitt conducted research in to the dietary habits and cancer incidence in several 
populations from developed and developing countries, which demonstrated that low 
dietary fibre intake could increase risk of colorectal cancer (Burkitt 1972). However 
this association has not been successfully demonstrated by a number of recent 
epidemiological studies (Alberts et al. 2000, Asano et al. 2002) and notably the nurses 
cohort study (Fuchs et al. 1999) also showed no protective effect from the 
consumption of high amounts of dietary fibre. However the protective effects may be 
due to non starch polysaccharides (NSP) not found in cereals, but certain vegetable and 
fruit with fibres high in galactose (Bingham 1990). It has been hypothesised that these 
galactose epitopes on non starch polysaccharides may inhibit the galactose binding 
lectins such as PNA, preventing their interaction with the colonic epithelium (Evans et 
al. 2002).
PNA lectin is one of the most commonly ingest dietary lectins with specificity 
for the TF antigen. PNA lectin has been shown to stimulate proliferation o f HT-29 
human colonic epithelium cells (Ryder et al. 1992), SW837 rectal adenocarcinoma and 
HCT-15 human colonic carcinoma cells (Kiss et al. 1997) and is able to remain active 
in the digestive tract, as PNA extracted from faeces is still able to agglutinate 
desialylated red blood cells (Ryder et al. 1992). Further studies to determine the 
effects of PNA on abnormal colonic epithelium which express the TF antigen, 
measured the crypt cell proliferation rate (CCPR). UC, CD and colonic polyps biopsy 
samples showed an average 25% greater CCPR upon stimulation with 25 pg/ml PNA 
compared to normal colonic biopsies. UC biopsies showed an almost doubled CCPR 
when stimulated with PNA (Ryder et al. 1994). PNA is also able to stimulate 
proliferation in vivo of rectal epithelium; patients with normal colonic mucosa who
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ingested 100 g of peanuts a day for 5 days had a 41% increase in rectal mucosal 
proliferation (Ryder et al. 1998). Additional studies have indicated that high molecular 
weight variant CD44v6 which expresses TF and is expressed in inflamed and 
neoplastic colonic epithelia as a result of altered mRNA splicing, is bound by PNA 
lectin. Binding stimulated phosphorylation of the hepatocyte growth factor c-MET 
which is known to associate with CD44v6, followed by downstream activation of 
p44/p42 mitogen activated protein kinase (MAPK). The activation o f c-MET and 
MAPK can be competitively inhibited by asialofetuin which is a TF-expressing 
glycoprotein and PNA proliferation effects are also diminished by addition o f MAPK 
inhibitor PD98059. These effects were demonstrated in FIT-29 and T84 colonic cancer 
cell lines but not CaCo-2 colonic cancer cells which do not express CD44v6 (Singh et 
al. 2006). This overall clearly demonstrates that PNA is able to interact with the TF 
antigen presented in the colonic epithelium stimulating cellular proliferation with its 
effects mediated through activation o f MAPK.
A number of other lectins also stimulate proliferation in various neoplastic 
colonic cell lines. Wheat germ lectin (WGA), which binds ./V-acetylglucosamine and 
neuraminic acid, and Con A both stimulate proliferation at high concentrations in 
SW837, HCT-15, LoVo colonic cancer cells and Griffonia simplicifolia I-A4 (GSA) 
predominantly stimulated proliferation in LoVo colonic cancer cell lines (Kiss et al. 
1997), LS174t and SW1116 colonic cancer cells (Chen et al. 1994). The broad bean 
lectin Vicia faba agglutinin (VFA) also stimulated proliferation o f LS174t, SW1222 
and HT-29 cells and also stimulated the differentiation of LS174t cells into gland-like 
structures (Jordinson et al. 1999). The lectin from Amaranthus caudatus (ACA) which 
recognises TF and sialyl-TF is able to cause dose-dependent stimulation of 
proliferation in HT-29 cells (Yu et al. 2001). Taken together, these reports give direct
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evidence that edible lectins are able to have profound effects on human colonic 
epithelial cell lines. The mechanisms for the functional consequences o f these effects 
are still under investigation but this type of interaction is likely to be of significant 
importance in the relationship between diet and gastro-intestinal proliferation leading 
to intestinal cancer, However, apart from the PNA these lectins have not been studied 
in vivo.
The mushroom lectin, ABL, and lectin from the jackfruit, JAC, have the 
opposite effect on HT-29 colonic epithelium cells by reversibly inhibiting proliferation 
with no apparent toxicity to the cells (Yu et al. 1993, Yu et al. 2001). JAC at a 
concentration of 20 pg/ml caused a 46% reversible inhibition o f HT-29 cells with this 
activity inhibited by incubation with TF expressing glycoproteins (Yu et al. 2001). 
ABL immobilised on agarose, which is therefore not internalised, showed no effect on 
cellular proliferation. Electron microscopy of gold-conjugated ABL revealed that ABL 
was internalised to the endocytotic vesicles and multivescular bodies. This was also 
confirmed by confocal microscopy of fluorescein isothiocynate-conjugated ABL 
which showed perinuclear accumulation and also inhibited proliferation, which 
signified a possible interference with nuclear protein import. This was confirmed when 
ABL prevented heat shock protein 70 translocation from the cytoplasm to the nucleus 
upon heat stress. Further to this, in digitonin-permeabilised HT-29 cells, nuclear uptake 
o f a NLS-peptide conjugated to BSA was inhibited by pre-incubation with ABL, 
indicating that ABL specifically blocks NLS-dependent nuclear protein import (Yu et 
al. 1999). Pulse labelling experiments following the location of the ABL has 
highlighted the nuclear localisation and reversibility of the ABL binding and hence 
reversibility o f its anti- proliferative effect (Yu et al. 2000). The determination of a 
cytoplasmic ligand for ABL was achieved through ABL lectin affinity
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chromatography of digitonin-released cytosolic proteins. The major glycoprotein 
purified expressed sialyl-TF, which was selected for A^-terminal sequencing and 
identified as oxygen regulated protein 150 (Orpl50). This 7V-terminally truncated 
cytoplasmic isoform, which expresses sialyl-TF is essential in NLS-nuclear protein 
import, reinforcing the evidence that ABL mediates its anti-proliferative effects as a 
consequence of the inhibition of NLS-nuclear protein import. The ABL lectin is 
another example of how a common edible lectin is able to interact with colonic 
epithelial cells.
1.9 Nuclear localisation sequence (NLS)-dependent nuclear protein import
A defining feature of eukaryotic organisms is the cell nucleus. The nuclear 
envelope is a barrier that nuclear proteins, which are synthesised in the cytoplasm, and 
RNA have to be transported across in regulated manner (Gorlich 1997). The import of 
proteins into the nucleus occurs through nuclear pore complexes (NPC), which allow 
the passive diffusion o f macromolecules of less than ~40 kDa (Paine et al. 1975). The 
rate of transport across the nucleus is believed to be between -100 and -1,000 cargoes 
per minute per NPC (Ribbeck et al. 2001). Proteins greater in size up to around several 
million Dalton in weight are actively transported through the NPC if they contain the 
appropriate targeting signal using soluble transport factors and carrier molecules 
(Stewart 2007). An NPC is a huge molecular assembly o f -120 MDa made up of 
distinct sub complexes that spans the double membrane of the nuclear envelope 
[Figure 1.9]. The NPC is formed by an 8-fold symmetrical framework around a central 
pore, in the plane of the nuclear envelope its structure is best described as hour glass 
with an overall length of -90  nm, it narrows towards the centre to ~40nm (Lim et al.
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2006). Fibres also extend from the central body into the cytoplasm and nucleus; these 
fibres form a basket like stmcture in the nucleus but not the cytoplasm.
Figure 1.9: Nuclear pore complex (Stewart 2007)
The stmcture of the pore channel of ~30 nm through which the proteins are 
transported is not completely understood, but is thought to contain high concentrations 
of nuclear pore protein chains of little formal stmcture allowing the NPC to be plastic 
and deform on the transport of large molecules (Beck et al. 2004). The NPC is 
constmcted of multiple copies of different proteins called nucleoporins, which are 
modularly assembled to form subcomplexes. The nucleoporins are located 
symmetrically around the NPC on both the cytoplasmic and nuclear side and are 
constmcted of a number of common protein folds such as a-helical solenoids 
(Schwartz 2005).
There are a number of nuclear import pathways, each responsible for 
the import of specific macromolecules in to the nucleus (Pemberton et al. 2005). They 
share common characteristics and follow a sequence of protein recognition in the
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cytoplasm, translocation through the NPC and release of the protein into the nucleus. 
The proteins are targeted by a short nuclear localisation sequence (NLS), which is 
different according to the pathway. In the classical nuclear protein import pathway, the 
NLS is bound by adaptor protein importin-a which forms an import complex with 
carrier protein importin-P in the cytoplasm, this import complex then is translocated 
through the NPC [Figure 1.10]. A NLS can be either monopartite with a single cluster 
o f 4-5 basic residues, such as the SV40 large T-antigen, or bipartite with two clusters 
o f basic residues, such as nucleoplasmin. The molecular recognition and attachment of 
the NLS is mediated by the tandem series of Armadillo repeats, which are responsible 
for the structure of importin-a, which has a concave inner surface allowing binding 
sites formed of an array of Trp, Asn and acidic residues (Fontes et al. 2000). A few 
cargo proteins can, however, bind directly to importin-P rather than through importin- 
a. The N-terminus of importin-a contains an importin-P binding domain (IBB), which 
contains a cluster of basic residues similar to that of the NLS, through which it binds 
importin-p. This IBB has an important auto-inhibitory role, due the similarity of its 
basic residues to the NLS it will compete for attachment to importin-a with NLS’s 
when not attached to importin-p. This contributes to cargo release as the accumulation 
o f NLS cargo in the nucleus is dictated by the affinity of NLS cargo for importin-a and 
the concentration of importin-a receptor (Kobe 1999).
Translocation o f the trimeric complex o f importin-a/p and NLS containing 
cargo is mediated by FG-nucleoporins in the NPC it is dissociated by RanGTP. When 
RanGTP binds to importin-P it induces a conformational change increasing the 
helicoidial pitch o f importin-P causing the release of the IBB domain and freeing the 
importin-a cargo complex (Lee et al. 2005). The release of the cargo by importin-a is 
achieved, as the affinity to the cargo is reduced due to the IBB competing for the NLS
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of the cargo. Dissociation is accelerated by FG-nucleoporins located at the nuclear face 
of the NPC. FG-nucleoporins such as Nupl, which has high affinity for the 
importina/p import complex and can bind CAS the export carrier, increases the 
concentration of the complex at the nuclear face of the pore and increases its binding to 
RanGTP and CAS (Liu et al. 2005). Nup2 also concentrates these factors and also 
actively displace the NLSs from the importin-a (Matsuura et al. 2003).
Figure 1.10: The NLS-nuclear protein import sequence (Stewart 2007)
The final step is the recycling of importin-a/p to the cytoplasm where Importin- 
P is complexed with Ran GTP and importin-a is actively exported with CAS. CAS 
coils around both RanGTP and importin-a, the IBB domain can only bind to CAS after 
the release of the cargo, thus preventing the cycling of the cargo back to the cytoplasm.
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The formation of the CAS/importin-a/RanGTP complex has to contend with the Nup2 
protein which aids the dissociation of the cargo. This is achieved through higher 
binding affinity o f CAS than Nup2 to importin-a displacing the NLSs and revealing 
the IBB domain, these steps occur in a stepwise concerted fashion and Nupl and Nup2 
being utilised as scaffolds to aid the process (Matsuura et al. 2005). Once in the 
cytoplasm the export complexes o f importin-p/RanGTP and CAS/importin-a/RanGTP 
have the RanGTP hydrolysed by RanGDP and accessory protein RanBPl freeing the 
importin-a/p, and allowing them to repeat the cycle.
Glycobiology is key to understanding many biological processes particularly 
cell-cell and cell-protein interactions. There is a need for better understanding of 
mechanisms for altered glycosylation in disease and for the consequences of this 
altered glycosylation for cellular function. This thesis will focus on investigating the 
importance of glycosylation on cellular processes which are vital to the cell, with 
particular emphasis on the appearance of the oncofetal Thomsen-Friedenreich antigen 
on a cytoplasmic protein that is implicated in protein transport into the nucleus. This 
thesis will explore the possible role for this truncated antigen and investigate whether 
other cytoplasmic proteins also express the TF antigen. Finally this thesis will 
investigate the relationship between the structure o f the Golgi apparatus, where the 
majority of glycosylation processes are thought to occur and altered glycosylation.
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CHAPTER 2
GENERAL METHODS
This chapter contains details of all the major techniques and methods used in 
this thesis. Specific methods are described in each chapter.
2.1 Materials
All plastic including flasks (T25 cm2, T75 cm2 and T150 cm2), 6 well, 12 well 
and 24 well plates all purchased from BD Bioscience (USA).
All chemicals were o f analytical grade and purchased from Sigma-Aldrich (Dorset, 
UK) unless otherwise stated.
2.2 Cell lines
Human colon cancer cell-line HT29 was obtained from the European 
Collection of Animal Cell Culture at the Public Health Laboratory Service (Wiltshire, 
UK). The HT-29 cell line was first established from a colonic adenocarcinoma from 
44 year old female Caucasian (Fogh 1971). When these cells are grown under the 
standard conditions, they form a multilayer of nonpolarized cells that display an 
undifferentiated phenotype (Cohen et al. 1999). If grown in a hexose-free medium they 
develop into a foetal small intestine-like state with the expression of brush border 
enzymes and development of micro villi; they are widely used for the study of 
epithelial malignancy in the colon.
The HT-29 MTX cells are a homogeneous, mainly gastric mucin (MUC5AC)- 
secreting population that has been obtained by stepwise adaptation o f HT-29 cells to 
10‘6 or 10~5 M methotrexate (MTX) (Lesuffleur et al. 1990). They were a kind gift from 
Dr Lesuffleur (Unité de Recherches sur la Différenciation et la Neuroendocrinologie 
de Cellules Digestives, France). HT-29 MTX are a more differentiated cell line which
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makes them suitable for experiments involving the effects of bacteria interaction on 
glycoconjugates.
2.2.1 Cell culture
Cells were grown as monolayers in Dulbecco’s modified Eagle’s medium 
(DMEM) (Sigma; Dorset, UK) supplemented with 10% FCS, 100 pg/ml penicillin, 
lOOpg/ml streptomycin and 4 mM glutamine (all purchased from Sigma; Dorset, UK). 
Cells were maintained at 37°C in a humidified atmosphere of 5% CO2 , 95% air. The 
cells were released from the flask with 3ml trypsin (0.5mg/ml in versine) and routinely 
passaged at a 1:8 sub culture ratio when they had become 60% - 80% confluent. Cells 
at ~80% confluence were used for all experiments. The cells were used up for a 
maximum of 12 passages.
2.2.2 Cell freezing
In order to maintain cell stock levels 80-90% confluent cells were washed 
twice with PBS and released from the flasks with trypsin. The cell clumps were 
dispersed by gentle pipetting after the addition of DMEM routinely used for cell 
culture. The cell number was counted and the cell suspension was centrifuged at lOOOg 
for 5 mins. Freezing medium [20% (v/v) FCS, 7% (v/v) dimethylsulphoxide (DMSO, 
Sigma) and 73% (v/v) DMEM] was prewarmed to 37 °C and was added to the pellet to 
make a cell density of 106 cells/ml. The cell suspension was immediately transferred to 
lm l freezing vials (lml/vial) and put into a box containing dry ice and kept at -80°C. 
24 h later the freezing vials were transferred in to liquid nitrogen.
2.2.3 Cell thawing
Cells reaching 12 passages were discarded and new cells taking from stocks 
frozen in liquid nitrogen. The freezing vials were withdrawn from the liquid nitrogen
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bank and placed in a 37°C water bath. Once the frozen cells had just melted, 20 ml of 
fresh 37°C culture medium was added and the mixture was centrifuged at 1000 g for 5 
mins. The cell pellet was dispersed in 10 ml culture medium and seeded T75 cm 
culture flasks with 2-5 x 105 cells per flask. After one day of culture the medium was 
replaced. The cells were used between 2-12 passages.
2.3 Protein measurement
All protein concentrations were determined using the Bicinchoninic Acid 
method (BCA) (Smith et al. 1985) with a commercially available kit (Sigma, UK). The 
BCA assay primarily relies on the reaction causing the peptide bonds in protein reduce 
Cu2+ ions from the cupric sulphate to Cu1+, this is a temperature dependant reaction 
and therefore temperature was kept at 37°C. The amount o f Cu reduced is 
proportional to the amount of protein present in the solution. Next, two molecules of 
bicinchoninic acid chelate with each Cu1+ ion, forming a purple-coloured product that 
strongly absorbs light at a wavelength o f 562 nm.
The kit consists of:
• BCA solution
• Copper (II) sulphate pentahydrate 4% solution.
• bovine serum albumin (BSA), for the standard curve
A standard curve was constructed and samples added to plate as below:
• 100 pi copper sulphate solution was added to 5ml of the BCA solution.
• 20 pi of a serially diluted BSA standard ranging from 0 - 4  mg/ml was plated 
in 96 well plate and the solution of unknown protein concentration, with 200 
pi o f the BCA/Copper sulphate solution
• The plate was then incubated at 37°C for 30 min
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• The plate was then removed and allowed to cool before the absorbance read at 
562 nm (Tecan, Sunrise)
2.4 Bacterial strains and growth conditions
HM427 E. coli was previously isolated from a patient with Crohn’s disease, the 
bacteria was classified as being localised beneath the mucus layer (mucosa-associated) 
(Martin et al. 2004). K12 was also used, it is an E.coli which was first isolated in 1921 
from the stool o f a malaria patient and it has been maintained in laboratory stocks as a 
pure strain for the last 75 years. E. coli K12 was the bacterial strain of choice in 
biochemistry labs because it was easy to grow and amenable to metabolic studies. All 
isolates were grown on Columbia agar plates with overnight incubation in air, at 37°C.
2.5 SDS polyacrylamide gel electrophoresis (PAGE)
SDS-Page was performed to separate cellular proteins according to size 
following the Laemmli method (Laemmli 1970). 1mm and 1.5ml thick polyacrylamide 
gels were cast using a self assembly system (Biorad, Hemel Hempstead, UK). 
Solubilised proteins were separated by SDS-PAGE either on 6%, 10% or 12% gels 
with a 3% stacking gel.
The preparation and composition of the reagents was as follows:
Resolving buffer 4X: Tris-base 36.3 g, pH 8.8 then make up to 200 ml with H2O 
Stacking Buffer 4X: Tris-base 12.0 g, pH 6.8 then make up to 200 ml with H2O 
Running buffer: Tris-base 30.67 g, Glycine 64,04 g, 2.2 g SDS (Sigma, UK) and H2O 
up to 4000 ml (pH8.3)
Ammonium persulphate: 10% Ammonium persulphate (w/v) (Sigma, UK)
SDS: 10% (w/v) (Sigma, UK)
Acrylamide: 30% (w/v) (Sigma, UK)
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Sample buffer: 4X stacking buffer 2.5 ml, Glycerol 1.0 ml (Sigma, UK), 
Mercaptoethanol 0.5 ml (Sigma, UK), 20% SDS in H20  1.0 ml, 1% Bromothymol 
blue 25 pi (Sigma, UK).
Table 2.1: Composition of resolving gels
R eagen t 6%  re so lv ing  gel 10%  reso lv ing
gel
12%  reso lv ing  
gel
A c ry lam id e
(3 0 % )
2 .0  m l 3.33 m l 4 .0  m l
R eso lv in g
B u ffe r
2.5 m l 2.5 m l 2.5 m l
D e io n ised  H 20 5.35 m l 4 .2  m l 3 .35  m l
10%  SD S 100 p i 100 p i 100 p i
T E M E D 5 p i 5 p i 5 p i
1 0 %
A m m o n iu m
p e r s u lp h a te
50 p i 50  p i 50 p i
Table 2.2: Composition of stacking gel
R eagen t S tack ing  gel
A cry lam id e
(3 0 % )
1.33 m l
S tack ing  B u ffe r 2.5 m l
D e io n ised  H 20 6.1 m l
10%  SD S 100 p i
T E M E D 10 p i
10%
A m m o n iu m
p ersu lp h a te
50 p i
The sample under examination was mixed 1:1 with sample buffer and heated at 
100°C fir 5 min in an eppendorff heater. Between 20 pi and 80 pi were loaded on to 
each lane on 6%, 10% or 12% resolving polyacrylamide gels which were run at 200V 
in running buffer (25 mM Tris, 192 mM glycine, 10% SDS) until the bromophenol 
blue reached the 0.5 cm from the bottom. After the electrophoresis the gels were 
stained with coomassie R250 (Sigma, UK) in destain solution (Ethanol 100ml, acetic 
acid 100ml (BDH Chemicals, UK, H20  to 1000ml) or electrotransferred to a 
nitrocellulose membrane.
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A prestained molecular weight standard marker (Sigma, UK) was used 
throughout the experiments. The markers were reconstituted with 0.5 mL of 8 M urea 
and 0.5 mL o f 2 X sample buffer when first received.
Table 2.3: Composition of prestained marker
Prestained marker kDa
a 2-Marcroglobulin from Human Blood Plasma 174
P-Galactosidase from E. coli 115
Lactoferrin from Human Milk: 90
Pyruvate kinase from Rabbit Muscle 58
Fumarase from Porcine Heart 48.5
Lactic dehydrogenase from Rabbit Muscle 36.5
Trisphosphate Isomerase from Rabbit Muscle 26.6
2.6 Western blotting and lectin blotting
To transfer the proteins resolved by electrophoresis to a nitrocellulose 
membrane, the gel was first soaked in transfer buffer (Tris 6.06 g, Glycine 28.83 g, 
methanol 400 ml and H2 O to 2000ml). The gel was then sandwiched in a transfer 
cassette between a nitrocellulose membrane and 3 mm filter paper either side. On each 
outermost side a transfer sponge was placed and the cassette placed into the transfer 
apparatus (Bio-Rad, Hemel Hempstead, UK) with an ice pack for 1 h at 100V, in 
transfer buffer.
After transfer the membranes were blocked with PBS-buffered saline (PBS) 
containing 1% (w/v) BSA, 0.1% (v/v) Tween-20 (PBS-T) for lh  in sealed container 
placed on a rolling platform. Membranes were then probed with appropriate primary 
antibodies [Table 2.4], followed by 3 washes of 10 minutes each in a sealed container 
placed on a rolling platform in PBS-T. The membranes were then incubated with 
peroxidase-conjugated secondary anti Ig antibodies (Dako; Glostrup, Denmark), or 
lectins [Table 2.5] which are peroxidise-conjugated or biotin-conjugated in which case 
Extravidin peroxidise (Sigma; Dorset, UK) was used as a secondary reagent followed
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by 6 washes in PBS-T of 10 minutes each in sealed container placed on a rolling 
platform and a final wash in PBS for 10 minutes. Signal detection was achieved using 
a chemiluminescence Super-signal immunoblotting detection kit (Pierce; Rockford IL, 
USA) which was detected with a Fluor-S multi-imager (Bio-Rad; Hemel Hempstead, 
UK). Equal loading was confirmed using an anti-tubulin antibody. Densitometric 
analysis o f immunoreactive protein bands was performed using Quantity One software 
(Bio-Rad; Hemel Hempstead, UK).
Table 2.4: Description of antibodies
A n t i b o d y
( S o u r c e )
R a i s e d
i n / p u r i f i e d
f r o m
M o n o c l o n a l /
p o l y c l o n a l
S t o c k
c o n c e n t r a t i o n
D i l u t i o n
IP IH
B u f f e r
O rp l50
(IBL
Hamburg:
10301)
M ouse Monoclonal lm g/m l 1:5000 1:200 n/a PBS-T
Hsp70
(Bioquote:
SPA-810)
M ouse Monoclonal lm g/m l 1:2000 n/a 1:200 PBS-T
Hsp70
(Sigma:
H5147)
M ouse M onoclonal lm g/m l 1:5000 n/a 1:200 PBS-T
Hsp90
(Abeam
AB58950)
M ouse M onoclonal lm g/m l 1:5000 1:500 n/a PBS-T
Tubulin
(Sigma)
M ouse Monoclonal lm g/m l 1:1000 n/a n/a PBS-T
Erp72
(BD
Bioscience)
M ouse Monoclonal lm g/m l 1:1000 n/a n/a PBS-T
Giantin
(Sigma)
Rabbit Monoclonal lm g/m l 1:5000 1:500 1:500 PBS-T
Ran
(BD
bioscience:
610340)
M ouse Monoclonal lm g/m l
1
1:5000 1:500 1:500 PBS-T
Table 2.4: Description o f antibodies used in experiments. WB= western blot, IP=
immunoprécipitation, IH= immunohistochemistry
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Table 2.5: Description of lectins
L e c t i n
( C a t
n u m b e r )
P u r i f i e d  f r o m l i g a n d S t o c k
c o n c e n t r a t i o n
D i l u t i o n
Purification
B u f f e r
ABL 
(EYlabs) 
Biotinylated 
(B A -50001- 
01)
Agaricus
bisporus
(common
mushroom)
TF/sialyl
TF
lm g/m l 1:2000 1ml/1ml 
(v/v)
PBS
JAC
Biotinylated
(B-1155)
Artocarpus 
integrifolia (Jack 
fruit)
TF/sialyl
TF
lm g/m l 1:2000 lm l/lm l
(v/v)
PBS
M A L II
Biotinylated
(B-1265)
M aackia
amurensis
Sialic acid
(o2,6
linked)
lm g/m l 1:2000 n/a PBS
PNA-
Biotinylated
(B-1075)
Arachis
hypogaea
(Peanut)
TF lm g/m l 1:2000 n/a PBS
VVA-
Biotinylated
(B-1235)
Vicia villosa 
(Hairy vetch 
seeds)
Tn lm g/m l 1:2000 n/a PBS
Table 3: Description of lectins used in experiments JAC, MAL II, PNA and VVA 
sourced from Vector (Peterborough, UK), ABL sourced from EY labs (CA,USA) 
except WB= western blot
2.7 Slot blotting
Nitrocellulose membrane was soaked in PBS for 10 minutes before use. Cells 
were directly lysed in slot blot buffer (4 x stacking buffer 2.5 ml, Glycerol 1.0 ml 
(Sigma, UK), Mercaptoethanol 0.5 ml (Sigma, UK), 20% SDS in H2O 1.0 ml) and 
were loaded on to the respective well after dilution with lOOpl of Tris buffer to ensure 
even distribution of proteins. The vacuum pump was then allowed to run for 10 mins, 
before removal o f membrane washing 3 times in PBS and blocking with 5% BSA in 
PBS-T in sealed container placed on a rolling platform. The nitrocellulose membrane 
could then be used for western/ lectin blotting.
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2.8 Statistical analysis
Sample groups were analysed using one-way analysis of variance (ANOVA) followed 
by selected pair-wise comparisons o f treatment means using Bonferroni’s modified t- 
test (StatsDirect v2.3.1; StatsDirect Ltd; Sale, UK). Differences were considered 
significant when P<0.05.
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CHAPTER 3
HYPOTHESES AND AIMS
3.1 HYPOTHESES
1. Cytoplasmic Orpl50 is modified by sialyl-TF and is involved in NLS-dependent 
nuclear protein import.
2. Unsubstituted or sialic acid-substituted TF carbohydrate structures may also 
occur on cytosolic proteins other than Orpl50.
3. Alterations in cellular O-glycosylation will cause an alteration in the NLS-dependent 
nuclear protein import of Hsp70.
4. Bacteria may interact with the colon epithelial cells to disrupt the Golgi apparatus and 
affect glycosylation.
3.2 AIMS
• To purify and characterise the different isoforms o f Orpl 50.
• To characterise the role of Orp 150 in NLS-nuclear protein import.
• To purify sialyl-TF expressing cytoplasmic glycoproteins.
• To characterise purified proteins utilising mass spectrometry and lectin 
binding.
• To analyse the effects of bafilomycin, TNFa, 5-CDP and benzyl GalNAc on TF and 
sialic acid expression on HT-29 MTX cells.
• To evaluate the effect of inhibitors of glycosylation on NLS-dependent nuclear protein 
import by studying the nuclear localisation of Hsp70 upon heat shock.
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•  T o  u tilise  s iR N A  to  d o w n re g u la te  th e  G a ltran sfe rase  resp o n sib le  fo r th e  gen e ra tio n  o f  
C o re l  g ly c a n s  b y  an a ly s in g  T F  ex p ressio n  o n  H T -2 9 -M T X  cells.
•  T o  in v es tig a te  th e  e ffec t o f  th e  s iR N A  G a ltran sfe rase  o n  N L S -d e p en d en t nuc lea r 
p ro te in  im port.
•  T o  in v es tig a te  th e  e ffec t o f  b ac te ria l su p ern a tan t H M 4 2 7  on  th e  s tru c tu re  o f  th e  G olgi 
an d  T F  ex p ress io n  in co lo n  ep ith e lia l cells.
•  R e le a se  o f  th e  p ro -in fla m m a to ry  cy tok ine , IL -8 , to  b e  m easu red  as  a  p o s itiv e  con tro l to  
m o n ito r  th e  re sp o n se  o f  ep ithe lia l ce lls  to  b ac te ria l in teractions.
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CHAPTER 4
PURIFICATION OF CONSTITUTIVE CYTOPLASMIC ORP150 AND 
CHARACTERISATION OF ITS GLYCOSYLATION
4.1 HYPOTHESIS
Cytoplasmic Orpl50 is modified by sialyl-TF and is involved in NLS-dependent 
nuclear protein import.
AIMS
• To purify and characterise the different isoforms of Orpl 50
• To characterise the role o f Orpl50 in NLS-nuclear protein import
4.2 INTRODUCTION
It was traditionally thought that glycosylation was limited to cell membrane 
and secreted molecules, as a result of the believed restricted localisation of 
glycotransferases to the ER/Golgi. It has now been shown that glycosylation exists on 
certain cytoplasmic and nuclear proteins, this was best exemplified by the discovery of 
O-GlcNAc (Hart et al. 1989). It was recently shown by our group that a truncated 
cytoplasmic constitutively expressed isoform of Orpl 50 is glycosylated by the addition 
of sialyl-TF antigen (Yu et al. 2002) and this is so far one o f only two reports that 
demonstrate this carbohydrate antigen on a cytoplasmically localised protein. The 
other is alpha-synuclein, a protein that is ubiquitinated by parkin in a process that is 
altered in Parkinson’s disease (Shimura et al. 2001). Further study o f Orpl50 and its 
intriguing glycosylation may lead to a better understanding o f O-glycosylation and 
possibly to uncovering o f a novel glycosylation mechanism.
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4.2.1 Oxygen-Regulated protein 150 KDa (Orpl50)
Oxygen-Regulated protein 150 KDa (Orpl50) has been demonstrated to have a 
number o f roles and functions, the best described of which is as an endoplasmic 
reticulum localised stress protein (Tamatani et al. 2001). Orpl50 was first purified as a 
novel stress protein in cultured rat astrocytes which had been subjected to hypoxia 
(Kuwabara et al. 1996). Astrocytes are the most abundant cell in the central nervous 
system, which are involved in the nurture of neurons and their protection from cellular 
stress. It was revealed that Orpl50 protein levels that were induced by 24 h of hypoxia, 
rose slightly on reoxgenation and returned to normal after 24 h (Kuwabara et al. 1996). 
The Orpl50 expression was the result of de novo protein synthesis, as it could be 
inhibited by cycloheximide, and other forms of stress such as 2-deoxyglucose, 
hydrogen peroxide, cobalt chloride or tunicamycin failed to induce expression of 
Orpl50 indicating that the Orpl50 stress protein is induced selectively under oxygen 
deprivation (Kuwabara et al. 1996).
Orpl50 was later found to be expressed in cultured human aortic smooth 
muscle cells and mononuclear phagocytes that were exposed to oxygen deprivation, 
and thought to play a part in a protective mechanism in human atherosclerotic plaques 
allowing mononuclear phagocytes to withstand cellular stress on exposure to hypoxia 
and modified low density lipoprotein (Tsukamoto et al. 1996). Ikeda and colleagues 
were the first to clone the cDNA encoding the human stress form of Orpl50 from 
hypoxic astrocytes (Ikeda et al. 1997). A deduced amino acid sequence o f 999 residues 
indicates the presence o f a signal peptide at the A-terminus and an ER retention 
sequence (KDEL) at the C-terminus. This form of Orpl50 also shows close sequence 
similarity with Chinese hamster 170 kDa glucose-regulated protein (Grp 170) with the 
A-terminal portion o f the sequence also showing similarity with the well conserved
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ATP binding domains o f the Hsp70 family o f proteins. Ikeda and colleagues also 
demonstrated that the induction of Orpl50 in U373 astrocytoma cells was not limited 
to hypoxia, but also induced by 2-deoxyglucose and tunicamycin treatment (Ikeda et 
al. 1997). When the entire human Orpl50 gene was sequenced, analysis of the 
transcription initiation sites and transcriptional regulatory sequences uncovered at least 
three distinct mRNA species from alternative promoters (Kaneda et al. 2000). In a 
detailed study Kaneda and colleagues demonstrate that two of the mRNA species 
begin from alternative exon 1 (1A or IB), and the third one starts from exon 2, which 
is located 6 nucleotides upstream of the initial AUG initiation codon. The transcript 
beginning with exon IB was preferentially induced by hypoxia and a cis-acting 
segment which has a role in the stress-dependent induction was discovered at the 5’- 
end o f exon 1A. This could account for the selective induction o f transcription from 
exon IB. The induction o f Orpl50 is distinct from the unfolded protein response 
(UPR), or ER stress response pathway (Yoshida et al. 1998), and the Orpl50 gene 
showed no enhancers similar to the hypoxia-inducible factor 1 (HIF-1) (Semenza et al. 
1991). In vitro analyses o f translation of the third mRNA, indicates the constitutive 
expression o f an A-terminally truncated form, lacking the ER signal peptide as a result 
o f altered translation and suggesting localisation in the cytosol. Little is known about 
the function of Orpl50, however the stress-dependent induction from exon IB and ER 
localisation would suggest a role in protection against ER stress induced deletions 
(Kaneda et al. 2000).
Other studies of Orpl50 show a role in the regulation of tumour angiogenesis 
via processing o f vascular endothelial growth factor (VEGF) (Ozawa et al. 2001, 
Ozawa et al. 2001). Thus, reduction o f Orpl50 by adenoviral mediated antisense 
ORP150 cDNA transfer, caused a reduction in tumorigenicity and angiogenicity in
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human prostate cancer cells (Miyagi et al. 2002). Orpl50 protein levels have been 
shown to be elevated in breast cancer (Stojadinovic et al. 2007) and anti-Orpl50 
autoantibody levels in Type 1 diabetic patients are higher compared with non-diabetic 
subjects, suggesting that ER stress is increased in Type 1 diabetes (Nakatani et al. 
2006). Orpl50 has also been shown to protect dopaminergic neurons against MPTP (1- 
methyl-4-phenyl-l,2,3,6-tetrahydropyridine), a drug used to induce experimental 
Parkinsons disease (Kitao et al. 2007).
4.2.2 Cytoplasmic Orpl50 as a ligand for edible mushroom lectin (Agaricus 
bisporous)
Experiments investigating the effects of TF-binding lectins on cellular 
proliferation demonstrated that PNA lectin stimulates proliferation o f HT-29 human 
colon cancer cells (Ryder et al. 1992). This effect was also seen in vivo, stimulating the 
proliferation of the rectal epithelium in patients who had low-level expression of TF in 
their colonic mucosa and who ate a pack o f peanuts per day for 5 days (Ryder et al. 
1998). ABL, (Agaricus bisporus, the edible mushroom lectin), and jacalin lectins both 
display the opposite effect on HT-29 colonic epithelium cells by reversibly inhibiting 
proliferation with no apparent toxicity to the cells (Yu et al. 1993, Yu et al. 2001). It 
was further shown that ABL needed to be internalised to have its antiproliferative 
effect as ABL immobilised on agarose beads showed no effect on proliferation. 
Electron microscopy of gold-conjugated ABL revealed that ABL was internalised to 
the endocytotic vesicles and multivescular bodies. This was also confirmed by 
confocal microscopy o f isothiocyanate-conjugated ABL which also inhibited 
proliferation and showed perinuclear accumulation, which signified a possible 
interference with nuclear protein import. This was confirmed when ABL prevented 
heat shock protein 70 translocation from the cytoplasm to the nucleus upon heat stress.
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Further to this, in digitonin-permeabilised HT-29 cells, nuclear uptake of a NLS- 
peptide conjugated to BSA was inhibited by pre-incubation with ABL, indicating that 
ABL specifically blocks NLS-dependent nuclear protein import (Yu et al. 1999). Pulse 
labelling experiments following the location of the ABL have highlighted the nuclear 
localisation and reversibility of the ABL binding and hence reversibility of its anti­
proliferative effect (Yu et al. 2000).
The determination of a cytoplasmic ligand for ABL was achieved through ABL 
lectin affinity chromatography of digitonin-released cytosolic proteins. The major 
glycoprotein purified expressed sialyl-TF and was identified by JV-terminal sequencing 
as the 7V-terminally truncated form of Orpl50.
4.2.3 Orpl50 and NLS-dependent nuclear protein import
Thus, ABL inhibits the proliferation of HT-29 cells, and its intracellular ligand 
was shown to be Orpl50, extractable from a digitonin-released cytosolic extract. The 
NLS-dependent nuclear import o f proteins is also inhibited by ABL. NLS-dependent 
nuclear protein import mediates nuclear import o f large proteins (>40-60 kDa). The 
classical NLS presented on a protein to be translocated in to the nucleus contains short 
stretches of basic amino acids which are recognized by an adapter protein, importin-a. 
Importin a  then binds to importinp, and the cargo-importin complex then translocates 
into the nucleus through nuclear pore complexes (Nakielny et al. 1999). RanGTP is 
responsible for the dissociation of the cargo-importin complex (Gorlich et al. 1996). 
The subsequent return of the importin-a is achieved by forming a trimeric complex 
with cellular apoptosis susceptibility gene protein (CAS) and RanGTP which is then 
translocated to the cytoplasm. Importin-P is bound to RanGTP before its return to the 
cytoplasm. Conversion of RanGTP to Ran GDP by GTPase-activating protein 
(RanGAPl) and Ran-binding protein (RanBPl) causes the dissociation of the Ran-
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importili complexes freeing the importin proteins for reuse. RanGDP then returns to 
the nucleus with NTF2 (nuclear transport factor 2) and is converted back to RanGTP 
(Gorlich et al. 1996) .The localisation of Ran is therefore predominately in the nucleus 
with rapid oscillating movements to the cytoplasm. Orpl50 is the intracellular ligand 
for ABL and therefore is implicated in the NLS-dependent nuclear protein import, the 
localisation o f Ran upon depletion of Orpl50 protein is examined in this study.
Further experiments have now been performed to characterise the 
glycosylation of Orpl50 and assess its role in NLS-dependent nuclear protein import.
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4.3 METHODS
4.3.1 Materials:
The anti-Orpl50 antibody was obtained from IBL (Hamburg). Biotinylated 
Mushroom lectin (ABL), Hrp-ABL lectin, Biotinylated Jacalin (Jac), Hrp-Jac were all 
obtained from Vector (Peterborough, UK). Peroxidase-conjugated secondary anti Ig 
antibodies were obtained from Dako (Glostrup, Denmark). Anti Hsp70 antibody was 
obtained from Sigma (Poole; UK). ER resident proteins ERp72 and protein disulfide 
isomerase PDI obtained from BD Biosciences (Oxford; UK). Jacalin-bound agarose 
beads obtained from Vector (Peterborough, UK). siRNAOrpl50 transfection reagents 
obtained from Dharmcon (Perbio science, UK)
4.3.2 Glucose starvation of HT-29 cells
A T75cm2 flask of HT-29 human colon cancer cells, was cultured as a 
monolayer to 60% confluence in DMEM at 37°C in a humidified atmosphere o f 5% 
CO2 , 95% air, then washed 2 times with PBS, and then incubated for a further 24h in 
glucose-free DMEM. The monolayers were then washed 3 times with PBS before 
being directly lysed in Lammelli’s sample buffer and run on a 6% SDS PAGE 
electrophoresis gel, before immunostaining with anti-Orpl50 antibody.
4.3.3 Lectin purification
Ten T75 flasks of HT-29 cells were grown to 60% confluence, before 
starvation o f glucose for 24 h. The cells were released with 3 ml trypsin and washed 3 
times with PBS each time centrifuge at 70 g  for 1 min (1000 rpm; MSE microcentaur, 
Sanyo Gallenkamp PLC, UK). The cells were collected then suspended in 15ml sterile 
PBS and sonicated (5 x 10s pulses at 28% amplitude; GEX 400 Ultrasonic Processor; 
Sigma) on salt ice followed by ultra centrifugation for 1 h at 4°C (Beckman’s). 10 ml
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of jacalin-bound agarose beads (Vector, UK) were added and left to incubate for 12 h 
at 4°C. The beads were loaded 20 cm x 1cm column plugged with glass fibre enabling 
the beads to be washed with 60 ml sterile PBS, removing the unbound proteins. The 
proteins bound to the jacalin lectin were eluted with 20 ml 0.8 M galactose. The 
resulting eluate was loaded in to viscous tubing and subjected to dialysis in 2 litres of 
water which was changed at regular intervals and left overnight at 4°C. The volume 
was then reduced by freeze-drying in 6 equal aliquots at -40°C.
4.3.4 Digitonin permeabilisation of cells
HT-29 cells were grown as a monolayer to 60% confluence in a T150cm2 
flask, washed 2 times with PBS before incubation in DMEM without glucose for 24 h. 
Cells were then washed 2 times in ice cold PBS and the flask put on ice. Five ml ice- 
cold digitonin (50pl/ml) was added for 5 min to the flask to puncture the outer 
membrane of the cells. The digitonin-released fraction was then extracted and freeze 
dried at -40°C overnight. The cells remaining in the plate were lysed directly with 
sample buffer. Samples were then run on SDS electrophoresis gel and transferred to 
nitrocellulose membrane and western blot analysis with anti Orpl50 (IBL, Hamburg) 
antibody performed.
4.3.5 siRNA Orpl50 treatment 
Cell plating:
HT-29 cells were diluted in antibiotic-free DMEM with 5% FCS to a plating 
density o f 5.0 x 104 cells/ml. 100 pi of cells were placed into each well o f a 96 well 
plate and incubated for 24 h.
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Transfection with siRNA:
To perform the experiment in triplicate the following protocol was followed: 
a 2 pM siRNA solution in IX siRNA buffer (Dharmacon) was prepared, from this 17.5 
pi was added to 17.5 pi serum-free/antibiotic-free medium. In a separate tube 1.4 pi of 
DharmaFECT4 (Dharmacon) was added to 33.6pl o f FCS-free/antibiotic-free DMEM. 
These tubes were pipetted up and down and left for 5 minutes before mixing them 
together and leaving to stand for a further 20 minutes. To this solution 280 pi 
antibiotic-free DMEM was added and to each well 100 pi was added. The plate was 
incubated at 37°C in a humidified atmosphere of 5% C02, 95% air for 48 h. In each 
experiment non-specific siRNA (Dharmcon) was used as a negative control.
4.3.6 Hsp70 and Ran localisation
HT-29 cells were seeded at lx l0 4 on glass cover slips, 24 h prior to siOrpl50 
treatment. After 2 days o f siRNA treatment the cells were heat-treated for 1 hour at 
42°C, and then fixed forlOmins in freshly prepared paraformaldehyde followed by 3 
washes with PBS. The fixed cells were then blocked with 300 pi of 5% goat serum 
(Dako; Glostrup, Denmark) for 1 hour at room temperature, followed by the addition 
o f anti Hsp70 antibody (Bioquote, York) 1:200 (v/v) concentration or anti-Ran 
antibody (Bioscience, Cambridge) 1:500 concentration, for 2 h. The cells were then 
washed 2 times with PBS and then the FITC conjugated secondary antibody (Dako; 
Glostrup, Denmark) was added, at 1:500 (v/v), for 1 h in the dark. The cells were then 
washed 3 times in PBS and the cover slips mounted on glass slides with a PI nuclear 
counter-stain mounting solution. The localisation o f Hsp70 or Ran was then visualised 
using an Olympus camera and the percentage nuclear Hsp70 or Ran calculated used 
AQM software.
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Hsp70: Experiments were performed 5 times, each time 10 individual cells for each 
category were chosen at random from the slide for AQM analysis. Inter assay 
coefficient o f variance (COY) 8%, intra assay COY 8.71% for all experiments.
4.3.7 2-D electrophoresis
HT-29 cells were grown to 60% confluence in a 24 well plate, prior to direct 
lysis of each well with 150 pi 2-D lysis buffer (8 M urea, 2 M thio urea, 4% Chaps, 1% 
DTT, 5 nM sodium vanadate, 40m M Tris) on ice. The sample was then left on a 
shaker for 1 h before centrifugation at 8000 g for 5 min. For the initial isoelectric 
focusing, 125 pi of sample was placed in a strip holder and a 4-7non-linear IPG 
(immobilised pH gradient) strip gel side down was applied and covered in mineral oil.
Focusing conditions for 7 cm IPG strips
Ramp Linear
Temp 20°C
Rehydration active@50v for 12 hours
Pause after hydration No
Step 1 250V for 15min (linear ramp)
Step 2 4000V for 2 h
Step 3 4000V to 20000V/hours (rapid ramp)
Step 4 500V hold
The IPG strips were then rehydrated for 15 mins gel side up in 12 ml 
equilibration buffer (30% glycerol (v/v), 6 M urea, 2% SDS (w/v) and 50ml 1.25 M 
Tris-HCL to pH 6.8 in distilled H2O) containing 240 mg DTT, followed by 15 mins in 
12 ml equilibration buffer containing IAA (iodoacetamide).
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The 6% 1-D SDS-PAGE gel was prepared previously and after removal o f the 
butan-2-ol from the surface the iso-electrical focusing strip was laid on top ensuring a 
good contact between the two. A prestained marker with Coomassie blue was added at 
this point in a well on the end. Melted agarose was added to seal the strip in place. The 
gel was then run at 200V in running buffer (25 mM Tris, 192 mM glycine, 10% SDS) 
and electrotransferred to nitrocellulose membrane for 1 h, at 100V, in transfer buffer 
(25 mM Tris, 192 mM glycine and 20% (v/v) methanol). Identical gels were 
Coomassie stained and samples cut out from the gel.
In gel digest for 2D PAGE:
Bands were extracted using a scalpel and placed in an eppendorff tube 
followed by destaining with 50 mM ACN (Acetonitrile), 50mM ammonium 
bicarbonate at 37°C for 15 min. This was repeated until stain removed, and supernatant 
discarded. Gel plugs were then dehydrated in 100% ACN until opaque (10 ptl/plug) 
and incubated at 37°C for approx 30-45 min. Gel plugs were then rehydrated in 50 mM 
ammonium bicarbonate and trypsin (9 pi ammonium bicarbonate and 1 pi trypsin 
stock, 100 ng/pl) over-night at 37°C, and stopped with 2 pi formic acid.
Supernatants were removed and analysed using an UltiMate nano-liquid 
chromatograph (LC Packings) connected to a Waters (Manchester, UK) Q-TOF Micro 
electrospray tandem mass spectrometer, operated in positive ion mode. 
Chromatography was using a p-Precolumn C l8 cartridge (LC Packings) connected to 
a PepMap C18 column (3pm 100A packing; 15cmx 75pm i.d.), using a linear gradient 
o f 5%(v/v) solvent B [0.1% v/v formic acid in 80% (v/v) acetonitrile in water] in 
solvent A [0.1% (v/v) formic acid in 2% (v/v) acetonitrile in water] to 100% solvent B 
over 60min at a flow rate o f 200nl/min. The spectrometer was operated in Data
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Directed Analysis (DDA) mode, where a survey scan was acquired from m/£ 400- 
1500, with switching to MS/MS on multiply charged ions. MS/MS mass spectrum 
acquired over mass range 80-2000Da.
For the MS/MS data, MS/MS ion searches of the NCBI database were undertaken 
using the MASCOT search engine (http://www.matrixscience.com) to yield protein 
identifications. Searches were performed without restriction o f protein Mr or pi and 
one trypsin miscleavage was allowed. Peptide mass tolerance and fragment mass 
tolerance were set to 2.0kDa and ±0.8kDa, respectively. Furthermore, partial peptide 
sequences were determined by manual interpretation o f MS/MS data using the PepSeq 
software within the MassLynx package (Waters). The resulting sequences were then 
used to search the NCBI database using the BLAST algorithm and the option to search 
for short nearly exact matches (www.ncbi.nbm.nih.gov/BLAST/). Thus, high 
confidence identifications were made when statistically significant MASCOT search 
scores (<0.05) were consistent with the protein experimental pi and mW and when the 
manually-derived partial peptide sequences matched the database protein sequence.
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4.4 RESULTS
4.4.1 Demonstration that Orpl50 has two isoforms; a constitutive and a stress- 
inducible form
HT-29 colon cancer epithelial cells, when grown under normal conditions, 
have a single band after SDS-PAGE and Orpl50 immunoblotting corresponding to 
constitutively expressed Orpl50. Upon glucose starvation another band appears of 
slightly lower molecular weight representing the stress inducible form [Figure 43.1]
Figure 4.1: Immunoblot of two isoforms of OrplSO
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Figure 4.1. Anti-Orpl50 immunoblot. A T75cm flask o f HT-29 human colon cancer 
cells was cultured to 60% confluence and then washed twice with PBS, and then 
incubated for a further 24 h in glucose free-medium. The cells were released with 
trypsin then lysed in sample buffer and the cell extracts electrophoresed on an SDS 
PAGE (6% w/v) electrophoresis gel. Two distinct bands are observed, a constitutively 
expressed isoform and a slightly lower molecular weight stress-inducible form.
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HT-29 cells were grown to 60% confluence under normal conditions, then 
released by with trypsin and cells recovered by centrifugation. The cells were 
sonicated then centrifuged, and the resulting whole cell lysate was subjected to lectin 
affinity chromatography purification with agarose-linked jacalin or ABL which both 
bind TF in its native or sialylated form. Both jacalin and ABL were able to isolate 
Orpl50, however jacalin is also able to isolate 2 other proteins of molecular weight 
~110kDa and ~90kDa [Figure 4.2], Jacalin binding glycoproteins of a similar 
molecular weight have been found in human astrocytes and shown to have TV-terminal 
sequence similarity with Hsp70 protein (Ikeda, J., et al. 1997).
4.4.2 The constitutive but not the inducible form  o f  Orpl50 can be isolated by Jacalin
or AB- lectin affinity purification
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Figure 4.2: Immunoblot of glycoproteins purified by Jacalin and ABL lectin 
affinity purification
Jacalin ABL Whole cell lysate
Figure 4.2: Anti Orpl50 immunoblot. Jacalin and mushroom lectins conjugated to 
agarose beads are both able to isolate constitutive Orpl50 protein from a whole cell 
lysate. The jacalin lectin is shown to bind at least two other proteins.
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Following this, HT-29 glucose-starved cells were subjected to lectin affinity 
chromatography, and it is shown that only the constitutive form and not the stress 
inducible form is isolated by the jacalin lectin [Figure 4.3].
Figure 4.3: Jacalin affinity purification of constitutive Orpl50
Figure 4.3: Anti-Orpl50 immunoblot. Jacalin affinity purification: 1 flask of HT-29 
cells was grown to 60% confluence and then starved o f glucose for 24 h. The cells 
were extracted with trypsin and placed in PBS and washed. The solution was then 
sonicated and ultra-centrifuged for 1 h. To the resulting supernatant, jacalin-bound 
agarose beads were added and left to incubate for 12 h. The beads were washed and the 
bound proteins eluted with 0.8 M Galactose. A dialysis against water was then 
performed before freeze drying and running samples on SDS PAGE 6% at 200V. The 
jacalin lectin is able to bind constitutive Orpl50, and release the protein again after 
washing with 0.8 M galactose. The lectin recognises the sialyl-TF or TF structure 
which therefore seems to be expressed only on the constitutive form.
Glucose
Inducible form of Orpl50
Constitutive Orpl50
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4.4.3 but.... mass spectrometry o f Orpl50 fails to reveal sialyl TF
Lectin affinity purification with jacalin was used to purify constitutive 
Orpl50 [Figure 4.3] to be analysed by nano LC-ESI-MS/MS on a Q-STAR mass 
spectrometer (Imperial College London). The returned data indicated the presence of 4 
high mannose N-glycopeptides the most abundant of which were Man5-8GlcNAc2. One 
further glycopeptide was observed at m/z 7473+ indicating the presence o f a single 
HexNAc. No evidence for the presence o f sialyl-TF or TF was returned. Possible 
explanations for the lack o f identification o f sialyl-TF might include: variation in 
glycosylation under different conditions and loss o f or damage to 0-glycans during 
processing for mass spectrometry, this is discussed later.
Figure 33: Purification of constitutive O rp l50
A B c
Figure 4.3: Five 150 cm2 flasks o f 60% confluent HT-29 cells were harvested by 
scraping into 15ml ice cold PBS. The cells were sonicated and ultra centrifuged for 1 
h. Jacalin bound agarose beads were added to the supernatant and left to incubate for 
12 h. The beads were washed and the bound proteins eluted with 0.8 M galactose. A 
dialysis against water was then performed before freeze drying and running samples on 
SDS electrophoresis gel stained by coomassie (C). A ponceau S red stain (A) then an 
anti- Orpl50 western blot (B) was performed on an SDS-PAGE gel run at the same 
time. The green arrow indicates Orpl50.
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4.4.4 The constitutive Orpl50 isoform is localised in the cytoplasm
The localisation of the 2 isoforms of Orpl50 was determined through 
digitonin permeabilisation, allowing the cytoplasmic contents to be isolated. 
Immunoblotting demonstrates that the constitutive isoform is present in the digitonin- 
released cytoplasmic fraction; the stress inducible form is not [Figure 4.4].
Figure 4.4: Representative immunoblot showing localisation of constitutive 
O rpl50
Figure 4.4: Anti-Orpl50 immunoblot. HT-29 cells were grown to 60% confluence in 
a T150cm flask then starved for 24h of glucose. Cells were washed 2 times in ice cold 
PBS. 5ml digitonin (50 pl/ml) was added for 5 min to puncture the outer membrane of 
the cells. The digitonin extract was then freeze-dried. The cells remaining on the plate 
were lysed directly with sample buffer. Digitonin selectively permeabilises the outer 
cell membrane whilst keeping the internal membranes and compartments intact, 
yielding a cytoplasmic fraction (Holaska et al. 2001). This is confirmed by the lack of 
Erp72, which is an ER localised protein, in the digitonin-released sample. The
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localisation o f the constitutive form thus appears to be in the cytoplasm. HT-29 cells 
were starved o f glucose to induce the stress form of Orpl50 as shown in the control 
lane. The two isoforms o f Orpl50 are clearly seen in the control and digitonin-treated 
fractions, however, the inducible isoform is not seen in the digitonin-released fraction.
4.4.5 Silencing RNA used to down regulate Orpl50 protein expression in HT-29 cells 
to allow assessment o f its role in nuclear protein import
The mushroom lectin, ABL, has previously been shown to reversibly inhibit 
cellular proliferation with no apparent toxicity to the cell (Yu et al. 1993). Further 
investigation has shown that ABL most likely causes this inhibition o f proliferation by 
preventing NLS-dependent nuclear protein import. The internal ligand for ABL was 
revealed by lectin affinity purification utilising ABL, which results in the isolation of 
Orpl50 (Yu et al. 2002). The use of siRNA to downregulate the Orpl50 protein 
expression should be an effective tool to assess the role of Orpl50 in NLS-dependent 
nuclear protein import.
Silencing RNA directed towards Orpl50 caused a decrease in Orpl50 protein 
expression, as measured by densitometry after immunoblotting [Figure 4.5]. This 
decrease was first significant after 2 days with an average (±SD) 71 ± % reduction 
from control (p<0.005) [ANOVA] (n=6) inter assay coefficient o f variance 7.1% and 
also observed on Day 3 65 ± 2% (n=3) (p<0.005). After 4 days Orpl50 protein 
expression increased again with only a 12 ± 1% (n=3) reduction observed [Figure 4.6], 
These data were obtained from 3 time course experiments over 4 days, and a further 3 
experiments for siRNA transfection over 2 days. Any further experiments with siRNA 
Orpl50 utilised a 2 day transfection, as it resulted in the optimum reduction of Orpl50 
protein expression.
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Figure 4.5: Representative immunoblot of Orpl50 protein expression after siRNA
treatment.
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Figure 4.5: Anti-Orpl50 western immunoblot. HT-29 cells were treated with siRNA 
Orpl50 for 1-4 days prior to lysis and SDS-PAGE. The representative immunoblot 
shows each day’s control on the left and treated with siRNA on the right. Statistical 
analysis o f densities is displayed in Figure 4.6.
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Figure 4.6: OrplSO protein reduction after siRNA treatment
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Figure 4.6: A 4 day time course incubation with siRNA to silence Orpl50 results in 
knock down of Orpl50 protein expression, which by days 2 and 3 had reached 71 ± 
2% and 65 ± 2% respectively (n=3). This was (*** p<0.001) compared to day 0.
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Following this time course experiment the effect o f siRNA Orpl50 was studied 
at 2 Days incubation [Figure 4.7]. It was shown that siRNA Orpl50 reduced Orpl50 
protein expression after a 2 day incubation by an average 63 ± 6%.
Figure 4.7: Representative immunoblot of 2 day siRNA Orpl50 treatment of HT- 
29 cells
Figure 4.7: Anti-Orpl50 western immunoblot. lxlO5 HT-29 cells were treated with 
siRNA Orpl50 or siRNA control for 2 days prior to direct lysis and SDS-PAGE.
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Table 4.1: Percentage reduction of Orpl50 protein with 2 day siRNA Orpl50
treatment
E x p t  1 E x p t  2 E x p t  3 E x p t  4 E x p t  5 E x p t  6 A v e r a g e
D ensity o f  siRNA 
control band
75 67 69 70 75 66 70 ±4
D ensity o f  siRNA 
O rp l5 0  band
24 20 30 29 27 25 26±4
%  Reduction 68 70 56 58 64 62 63±6
Figure 4.8: Percentage Orpl50 reduction after 2 day siRNA orpl50 treatment
120
siControl s iO rp l5 0
Figure 4.8: HT-29 cells with 2 day treatment with siRNA Orpl50 show an average 63 
± 6% reduction o f Orpl50 protein expression (p<0.001, n=6)
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4.4.6 A reduction o f Orpl50 protein expression using siRNA leads to a subsequent 
reduction o f Hsp70 nuclear localisation upon heat shock
The role o f Orpl50 in NLS-dependent nuclear protein import was 
investigated by reducing the Orpl50 protein expression with siRNAs. HT-29 cells 
were transfected with siRNA Orpl50 or siRNA Control for 2 days prior to 
investigation into localisation of Hsp70. Hsp70 can clearly been seen to translocate 
from the cytoplasm and concentrate in the nucleus after heat treatment (1 h at 42°C) 
[Figure 4.9], This movement was quantified with AQM software and the % nuclear 
fluorescence calculated, each experiment was repeated 5 times, each time 10 cells were 
randomly selected from slide, with the inter assay coefficient of variance <8%, intra 
assay coefficient o f variance <8% for all experiments.
For the control cells nuclear fluorescence (±SD) was 46±4% (n=50), 
compared with heat treated control 58±3% (n=50), (pO.OOl). HT-29 cells transfected 
with siRNA control under normal conditions displayed a nuclear fluorescence of 
46±4% (n=50) which is comparable to the control cells. SiRNA control transfected 
cells after heat treatment displayed a nuclear fluorescence of 59±2% (n=50) which is 
also comparable to heat treated control cells. SiRNA Orpl50 transfected cells after 
heat treatment had a nuclear fluorescence of 51±3% (n=50, which when compared to 
siRNA control heat treated cells is a 61% reduction in Hsp70 translocation into the 
nucleus (pO.OOl) [Figure 4.10,4.11].
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Figure 4.9: Hsp70 localisation in HT-29 cells
Hsp70 PI staining
No heat
Upon heat
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SiRNA Control/heat
Figure 4.9: Representative immunohistochemistry (x40 objective) of the localisation 
of Hsp70 as visualised in Green. The Red is a nuclear PI stain. The Hsp70 is seen to be 
localised more strongly in the nucleus under heat shock in control cells. This effect is 
reduced in the siRNA Orpl50-treated cells, but is unaffected in the siRNA control 
cells. The overall average reduction (n=5), in nuclear fluorescence after transfection 
with siRNA Orpl50 is 60% compared to the siRNA control (COV 4%).
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Figure 4.10: Hsp nuclear fluorescence with heat treatment after 2 day SiRNA 
Orpl50 treatment
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Figure 4.11: Percentage inhibition of Hsp70 localisation following heat treatment 
after 2 day SiRNA Orpl50 treatment
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Fig 4.10 and 4.11: 2 day Treatment o f HT-29 cells with siRNA Orpl50 results in a 
subsequent reduction in Hsp70 nuclear fluorescence after heat treatment when 
compared to siRNA control heat treated cells. Hsp70 nuclear fluorescence was 
59±2% for siRNA control cells (n=50) and siRNA Orpl50 cells 51±3% (n=50), 
siRNA control with no heat treatment mean was 46±4% (n=50) [Figure 4.10]. Thus 
there was an overall mean reduction o f Hsp70 nuclear localization after 2 day 
treatment with siRNA Orpl50 of 61% when compared to siRNA control cells 
(p=<0.001 ***) [Figure 4.11]
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4.4.7 Hsp70protein level was not affected by siRNA treatment
The protein expression level of Hsp70 was measured by measuring the 
density o f bands on immunoblots from 3 repeated experiments [Figure 4.12]. The 
overall protein levels were seen as expected to increase upon heat shock, control 
density mean (±SD) was 43±7 arbitrary densiometric units (ADU) and after heat shock 
65±6 ADU (p<0.001). Transfection with siRNA control caused no significant change, 
no heat 40±10 ADU, and heat 63±12 ADU. Transfection with siRNA Orpl50 also 
caused no significant change, no heat was 41±11 ADU and heat was 65±6A U [Figure 
3.13]
Figure 4.12: Representative immunoblot showing Hsp70 protein expression is not 
affected by siO rpl50 treatm ent
Heat ’ 7  I + ~ ~
Con siRNA Orpl50 siRNA Con
Figure 4.12: Anti-Hsp70 immunoblot. The Hsp70 protein expression of FIT-29 cells 
with or without 2 day siRNA control or Orpl50 treatment and with or without heat 
stress was calculated via western blotting and subsequent densitometry of bands. 
Overall no change in Hsp70 protein expression was observed in response to 
siRNAOrpl50 although heat stress as expected caused an increase in expression.
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Figure 4.13: Hsp70 protein expression with siRNA OrplSO treatment
Figure 4.13: HT-29 cells with or without siRNA treatments and with or without heat 
stress. Overall Hsp70 protein expression is seen to increase with heat stress but protein 
expression was not altered by siRNA treatments. Transfection with siRNA control 
caused no significant change, no heat mean (±SD) 40±10 ADU, and heat 63±12 ADU. 
Transfection with siRNA Orpl50 also caused no significant change, no heat 41±10 
ADU and heat was 65±14 ADU.
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4.4.8 Localisation o f Ran is unaffected by reduced Orpl50 protein levels
Previous investigations have shown that Ran is co-immunoprecipitated with 
Orpl50 and Ran is also isolated by ABL affinity purification o f cell extracts as shown 
by immunoblotting (Yu et al. 2002), therefore, it is possible that Orpl50 may form a 
functional complex with Ran inside the cell. An interaction o f Orpl50 and Ran would 
imply that Orpl50 could be involved in the cycling o f Ran-GTP and Ran GDP 
between the nucleus and the cytoplasm, a process that is vital in the control of 
nucleocytoplasmic transport. Ran resides predominantly in the nucleus, shuttling 
rapidly between the nucleus and cytoplasm. This investigation, therefore, assessed 
whether the nuclear localisation of Ran is disrupted by reducing Orpl50 protein levels 
in HT-29 cells by siRNA and also observed with the effects of heat stress.
Ran localisation was unaffected by siRNA Orpl50 with and without heat 
stress. Ran localisation has been shown to be spread from the nucleus into the 
cytoplasm under heat stress (Miyamoto et al. 2004), this was not observed in the 
present study, however, there was an overall background level o f Ran observed in the 
cytoplasm. The experiment was repeated 3 times and measured in 20 cells chosen at 
random. Ran was FITC labeled and the nuclear fluorescence calculated as a measure of 
Ran localisation. For all experiments the inter assay coefficient of variance was less 
than 3.4% and the intra assay coefficient of variance was less than 8.5%. The control 
cells showed a nuclear fluorescence (±SD) of 58980±4921 fu (fluorescent units) 
(n-60), which was comparable to siRNA control cells 59368±2761 fu (n=60) (ns). The 
heat-treated control cells showed no significant increase in Ran nuclear localisation 
with a nuclear fluorescence of 59883±5114 fu (n=60), neither did siRNA control 
transfected cells show significant change in Ran localisation after heat treatment with a 
nuclear fluorescence o f 60523±3585 fu (n=60). The siRNA Orpl50 transfected cells
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showed similar nuclear Ran fluorescence to controls 60144±4507 fu (n=60) and after 
heat treatment 61356±4198 fu (n=60) [Figure 4.14 and 4.15].
Thus siRNA Orpl50 had no significant effect on the localisation of Ran.
Figure 4.14: Localisation of Ran after siRNA treatments, with or without heat 
stress
No Heat Heat
DAPI Ran DAPI Ran
Figure 4.14: Representative immunohistochemistry of Ran localisation (green), 
nuclear DAPI counter stain (Blue) (images captured with a x40 objective). HT-29 cells 
with or without siRNA control or Orpl50 treatment and with or without heat stress 
(42°C for lh), were fixed on coverslips. The localisation of Ran is predominantly 
nuclear and appears unaffected by siRNA Orpl50 treatment or heat treatment.
82
Figure 4.15: Ran localisation measured by nuclear fluorescence
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Figure 4,15: HT-29 cells with or without siRNA treatment and with or without heat 
stress were fixed on coverslips. Calculation of nuclear fluorescence as a measure of 
Ran localisation using AQM software reveals no significant difference with or without 
heat, or after siRNA treatment.
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4.4.9 Constitutive Orpl50 can be visualised as 2 isoforms using 2-D analysis
At least 3 splice variant mRNAs have been identified for Orpl50, as 
described in the introduction to this chapter (Kaneda et al. 2000). In this thesis a 
constitutively expressed cytoplasmic isoform and a stress inducible isoform have 
already been investigated utilising 1-D SDS PAGE electrophoresis and these were 
seen as two distinct bands [Figure 4.1] The current experiment uses 2-D SDS PAGE 
electrophoresis to investigate the possibility o f a further isoform of Orpl50 which 
could not be visualised by 1-D electrophoresis. A whole cell lysate o f HT-29 cells 
cultured under normal conditions was subjected to 2-D electrophoresis after which 
Orpl50 western blotting revealed 2 individual spots, whereas 1-D electrophoresis 
showed only one band. Subsequent ABL lectin blotting reveals that only one of these 
spots is bound by the lectin [Figures 4.16 and 4.17]
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Figure 4.16: Orpl50 immunoblot of 4-7 linear 2-D 6% electrophoresis gel
pH 4 pH 7
kDa +
<— 2 isoforms of constitutive Ofpl50
Figure 4.16: Anti Orpl50 western immunoblot. HT-29 cells were lysed directly in 2-D 
lysis buffer and run on 4-7 nonlinear strips before 1-D electrophoresis on a 6% poly 
acrylamide gel. The resulting anti-Orpl50 western blot reveals 2 distinct protein spots 
o f the same molecular weight. Experiment repeated in duplicate
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Figure 4.17: ABL biotinylated lectin blot of 4-7 linear 2-D 6 % electrophoresis gel
1 isoform of constitutive Orpl50
Figure 4.17: ABL lectin western immunoblot. 2-D electrophoresis analysis [Figure 
4.16] reveals 2 possible isoforms of the constitutively expressed isoforms of Orpl50 as 
shown by the 2 distinct spots after Orpl50 antibody western blotting. Of the 2 forms of 
the constitutively expressed isoforms, only one appears to be bound by ABL lectin, as 
indicated by the circle. The ABL blot is performed on the same membrane as figure 
4.16 after treatment with stripping buffer.
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3.5 DISCUSSION
The initial experiments in this chapter clearly demonstrate 2 forms o f Orpl50. 
For the first time a constitutively expressed cytoplasmic isoform of Orpl50 released by 
digitonin permeabilisation is shown to be distinct from the stress inducible ER 
localised form, with an apparent lower molecular weight on a 1-D SDS-PAGE gel. 
This constitutive cytoplasmic isoform is recognised by both ABL and jacalin lectins 
suggesting that it is modified by the oncofetal TF antigen in its sialylated form. It was 
also shown by using a whole cell lysate that had been subjected to 24 h glucose 
starvation that only the constitutive isoform can be isolated using jacalin affinity 
chromatography, indicating that the inducible form is not modified by sialyl-TF. Initial 
work to immunoprecipitate Orpl50 in sufficient quantities for analysis failed. A 
thorough examination o f the protocol and experimentation with the parameters still 
failed to isolate Orpl50, suggesting that the antibody was not suitable. Therefore a 
lectin purification method was utilised to isolate Orpl50 during these experiments.
2-D electrophoresis demonstrated that the constitutive Orpl50 band seen on 
ID gels contained two distinct proteins o f the same molecular weight, of which only 
one was recognized by the sialyl TF binding ABL lectin. A detailed study by Kaneda 
and colleagues demonstrated that there are 3 mRNA’s for the Orpl50 protein 
produced by alternative promoters, one of which contains an inducible element 
(Kaneda et al. 2000). This would fit with the discovery that the constitutive band can 
be separated into two proteins.
Lectin affinity purification with Jacalin was used to purify constitutive 
Orpl50 to be analysed by nano LC-ESI-MS/MS on a Q-STAR mass spectrometer 
[Figure 4.3], The returned data indicated the presence of 4 high mannose N- 
glycopeptides the most abundant of which were Man5.gGlcNAc2 . One further
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glycopeptide was observed at m/z 7473+ indicating the presence o f a single HexNAc 
but the analysis did not return any evidence for the presence o f sialyl-TF. This 
evidence is contrary to my experimental data through a lectin binding approach which 
gives strong evidence for the presence o f sialyl-TF. However, it is possible that the 
lack o f sialyl-TF under mass spectrometry analysis could have occurred due to the low 
abundance o f constitutive Orpl50 provided for the mass spectrometry analysis. The 1- 
D SDS-PAGE gel when stained with coomassie showed only the faintest band that had 
to be aligned with identical anti-Orpl50 western blots. Even with the high sensitivity 
o f the mass spectrometry it is possible that there was a degradation o f the sample and 
this coupled with a low abundance o f protein meant that no sialyl-TF was revealed. 
The evidence from ABL and jacalin lectin blotting and purification is still compelling 
especially with the known specificity o f the lectin binding. An alternative explanation 
might be that ABL and jacalin have some affinity for high mannose A-glycans. It has 
been shown that jacalin has some affinity for galactose terminated N-glycans but this 
has not been shown for ABL.
Orpl50 has previously been described as the ligand for ABL lectin which is 
able to reversibly inhibit cellular proliferation of HT-29 cells (Yu et al. 2002). It was 
not understood how an ER-associated protein would be involved in NLS-dependent 
nuclear protein import, but this can now be explained in part by the presence o f this 
cytoplasmic isoform. This is similar in some respects to calreticulin, also a known ER- 
associated protein, that has a cytoplasmic isoform that is involved in nuclear export 
signal (NES) -related nuclear protein import by acting as a receptor and forming an 
assembly with NES-protein and RanGTP (Holaska et al. 2001). In this study it is 
shown that a reduction in Orpl50 by siRNA caused a subsequent reduction in Hsp70
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translocation into the nucleus upon heat stress. This confirms earlier evidence of a role 
for Orpl50 in NLS-dependent nuclear protein import.
Although previous work had shown that Orpl50 co-associated with 
RanGTPase (Yu et al. 2002) siRNA Orpl50 was shown in the present study to have no 
effect on the cellular localisation o f Ran. Further studies are needed to elucidate the 
mechanism by which Orpl50 is involved in NLS-dependent nuclear protein import.
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CHAPTER 5
IDENTIFICATION OF CYTOPLASMIC PROTEINS EXPRESSING
0-LINKED TF
5.1 HYPOTHESIS
Unsubstituted or sialic acid-substituted TF carbohydrate structures may also occur on 
cytosolic proteins other than Orpl50.
AIMS
• To purify sialyl-TF expressing cytoplasmic glycoproteins
• To characterise purified proteins utilising mass spectrometry and lectin binding
5.2 INTRODUCTION
The previous chapter has presented evidence for an TV-terminally truncated 
cytoplasmic form of Orpl50 which expresses sialyl-TF. This is one of only two reports 
to date o f a cytoplasmic glycoprotein expressing sialyl-TF; the other is the protein 
alpha-synuclein (Shimura et al. 2001). The appearance o f sialyl-TF on cytoplasmic 
proteins is not readily explained by conventional knowledge of the O-glycosylation 
process and, therefore, warrants close investigation. This study sets out to investigate 
the presence o f other cytoplasmic proteins that express this novel form of cytoplasmic 
glycosylation.
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5.2.1 Cytoplasmic glycosylation
In the past it was thought that glycosylation was limited to secreted and cell 
membrane proteins due to the restricted localisation of required glycosyltransferases to 
the Golgi and ER. However there is now clear evidence for the existence of 
cytoplasmic glycosylation, exemplified by the discovery of 0-GlcNAc (Hart et al. 
1989, Hart et al. 1989) which is P-N-acetylglucosamine (9-linked to the hydroxyl 
groups o f Ser/Thr. The enzymes responsible for the addition of O-GlcNAc, O-GlcNAc 
transferase (OGT), and removal, P-N-acetylglucosaminidase (O-GlcNAcase), have 
been characterised (Iyer et al. 2003) and shown to be localised in the cytoplasm (Hart 
et al. 1989). The biological role of O-GlcNAc is still being uncovered, but so far it has 
been shown to be involved in a regulatory mechanism, which shares similarities with 
phosphorylation such as the dynamic cycling o f the proteins (Comer et al. 2000). 
There are reports of cytoplasmic structures expressing various other sugars such as 
galactose, glucose and mannose, JV-acetylgalactosamine, and sialic acid (Hart, G.W. 
1999), mostly demonstrated by lectin binding, but these intra-cellular glycoconjugates 
have generally not been identified. The functional roles o f these other forms o f O- 
glycosylation have not been elucidated, although it has been shown that concealment 
o f O-GlcNAc on nucleoporin p62 by a further attachment o f galactose has no effect on 
protein import (Miller et al. 1994). Earlier work from our group has demonstrated that 
ABL specifically blocks NLS-dependent nuclear protein import (Yu et al. 1999), and 
that the internal ligand for the lectin is an //-terminally truncated isoform of Orpl50, 
implying the expression of sialyl-TF on this protein. The role for sialyl TF in this 
process is unclear, but it has been suggested that some sugars such as glucose-, fucose- 
, mannose- or A-acetylchitobiosides could serve as nuclear localisation signals in a 
mechanism separate from the classical nuclear NLS dependent pathway (Duverger et
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al. 1995, Duverger et al. 1996). This pathway also utilises energy and can be inhibited 
by wheat germ lectin, but does not require cytosolic transport factors (Duverger et al. 
1995). From the strong evidence for cytoplasmic glycosylation it is plausible that there 
are other cytoplasmic pathways in existence. The expression o f sialyl-TF on proteins in 
the cytoplasm could either be the result o f an as yet unknown glycosylation pathway or 
the entry o f traditionally glycosylated proteins into the cytoplasm. In this chapter 
experiments are described that investigate the possible existence of other cytoplasmic 
glycoconjugates that express TF or sialyl-TF.
5.2.2 Mucin type 0-glycosylation and the sialyl-TF antigen
Mucin type O-glycosylation is a post-translational modification in which the 
monosaccharide GalNAc is added from a nucleotide donor, UDP-GalNAc, to the 
serine or threonine residues of the fully folded and assembled protein, catalysed by a 
polypeptide GalNAc transferase (GalNAcT). This feature sets it apart from the other 
forms o f O-glycosylation such as O-GlcNAc (Hart 1997), O-Mannose and O-Fucose 
(Harris et al. 1993). A family of GalNAc transferases is responsible for the addition of 
GalNAc to the serine and threonine residues o f which up to 20 members have been 
identified (Ten Hagen et al. 2003). This process occurs in the Golgi apparatus (Colley 
1997) and specific regions of the endoplasmic reticulum or an inter ER-Golgi 
compartment (ERGIC) (Bieberich et al. 2000, de Graffenried et al. 2004, Young 
2004). The 0-GlcNAc transferase is present in the cytoplasm and nucleus (Hart et al. 
1989) but there is no evidence to date that any o f the GalNAc transferases are active in 
the cytoplasm.
Core structures are built up after the action o f the GalNAcTs; many O-glycans 
contain the Core 1 structure formed by the addition o f galactose in a (31-3 linkage to
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GalNAc (Galp 1 -3GalNAca-Ser/Thr), which is catalysed by the glycosyltransferase: 
Core 1 p i -3 glycosyltransferase (Core 1 GalT). This Core 1 disaccharide is also called 
the Thomsen Friedenreich antigen which in its unsubstituted form behaves as an onco­
fetal antigen as it is only seen in the fetus and in cancer and other disease states but not 
in normal epithelia. It is the substrate for many glycosyl and sialyl transferases and in 
normal healthy tissue is usually concealed by further glycosylation.
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5.3 METHODS
5.3.1 Materials:
Biotinylated edible mushroom lectin, Agaricus bisporus, (ABL), Hrp-ABL 
lectin, Biotinylated Jacalin (Jac), Hrp-Jac were all obtained from Vector 
(Peterborough, UK). Peroxidase-conjugated secondary anti-Ig antibodies were from 
Dako (Glostrup, Denmark). Digitonin was obtained from Sigma (Poole; UK) and the 
anti Hsp90 mouse monoclonal antibody from Abeam (Cambridge; UK). Control 
mouse immunoglobulins were obtained from Santa Cruz biotechnology (Heidelberg, 
Germany).
5.3.2 Digitonin permeabilisation of cells
HT-29 cells were grown as a monolayer to 60% confluence in a T 150cm2 
flask, washed twice in PBS before incubation in DMEM without glucose for 24 h. 
Cells were washed twice in ice cold PBS. Five ml ice-cold digitonin (50 pl/ml) was 
added for 3mins to the flask to puncture the outer membrane of the cells. The 
digitonin-released fraction was then extracted and freeze dried at -40°C overnight. The 
cells remaining in the plate were lysed directly with sample buffer. Samples were then 
run on SDS electrophoresis gel, either 6% or 12% as described in methods chapter and 
transferred to nitrocellulose membrane and lectin blot analysis performed.
5.3.3 Lectin affinity purification 
Jacalin lectin affinity purification
Ten T75cm2 flasks o f HT-29 cells were grown to 60% confluence. The cells 
were released with 3 ml trypsin (1 mg/ml) and washed 3 times in PBS each time 
centrifuged at 70g for lm in (lOOOrpm; MSE microcentaur, Sanyo Gallenkamp PLC, 
UK) to collect cells. The cells were then suspended in 15 ml sterile PBS and sonicated
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(5 x 10s pulses at 28% amplitude; GEX 400 Ultrasonic Processor; Sigma) on salt ice 
followed by ultra centrifugation at 500,000 g for 1 h at 4°C (100,000rpm; Beckman 
TL 100 Ultracentrifuge, Minnesota, USA). Ten ml o f jacalin bound agarose beads 
(4mg lectin/ml gel) (Vector, UK) were added and left to incubate for 12 h on an orbital 
shaker at 4°C. The beads were loaded into a 20cm x 1cm column plugged with glass 
fibre enabling the beads to be washed with 60 ml sterile PBS, removing unbound 
proteins. The proteins bound to the jacalin lectin were eluted with 20ml 0.8M 
galactose. The resulting eluate was subjected to dialysis in 2 litres of deionised water 
which was changed at regular intervals and left overnight at 4°C. The volume was 
then reduced by freeze drying in 6 equal aliquots at -40°C.
ABL lectin affinity
A T75cm2 flask of HT-29 cells was grown to 60% confluence. The cells were 
then washed 3 times in PBS before removal with 3 ml of trypsin (1 mg/ml) and washed 
a further 3 times in PBS and each time centrifuged at 7 Og for 1 min (1000 rpm; MSE 
microcentaur, Sanyo Gallenkamp PLC, UK) to collect cells. The cells were then 
suspended in 2 ml sterile PBS and sonicated (5 x 10s pulses at 28% amplitude; GEX 
400 Ultrasonic Processor; Sigma) on salt ice followed by ultra centrifugation at 
500,000 g  for 1 h at 4°C (100,000 rpm; Beckman TL 100 Ultracentrifuge, Minnesota, 
USA). One hundred pi of ABL bound agarose beads (4mg lectin/ml gel) (TCS group, 
Buckingham, UK) were added and left to incubate on an orbital shaker for 12h at 4°C. 
The beads were collected by pulse centrifugation, 170g for 15s (1500rpm; MSE 
microcentaur, Sanyo Gallenkamp PLC, UK) and washed 5 times in PBS. Sixty pi of 
sample buffer was then added to release the proteins and beads were then boiled for 5 
minutes to dissociate the lectin-ligand from the beads. The beads were collected by 
centrifugation and SDS-PAGE performed as described in methods chapter.
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5.3.4 Immunoprécipitation
Immunoprécipitation of Hsp90 was performed in order to isolate the protein to 
be utilised for lectin analysis to verify its glycosylation. HT-29 cells were grown to 
60% confluence in a T150cm2 flask and washed twice in the flask with ice-cold PBS. 
One ml ice-cold modified RIPA buffer containing protease and phosphatase inhibitors 
(Perbio science, Northumberland, UK) was added and adherent cells scraped off with 
a plastic cell scraper that had been cooled in ice-cold distilled water. The cell 
suspension was then transferred into a centrifuge tube and the suspension placed on an 
orbital shaker at 4°C for 15 minutes to lyse cells. The lysate was centrifuged at 15,000 
g  in a precooled centrifuge at 4°C for 15 minutes and the supernatant was immediately 
transferred into a fresh centrifuge tube and the pellet discarded.
The cell lysate was pre-cleared to reduce non-specific binding of proteins to the 
agarose by adding 50 pi o f Protein A/ G agarose beads slurry per 1 ml of cell lysate 
and incubating at 4°C for 10 minutes on a rocker or orbital shaker. The Protein A/G 
beads were removed by centrifugation at 170 g  at 4°C for 10 minutes (1500rpm; MSE 
microcentaur, Sanyo Gallenkamp PLC, UK) and the supernatant transferred in to a 
fresh centrifuge tube. The protein concentration o f the cell lysate was calculated using 
a bicinchoninic acid assay (Sigma, Poole; UK) and the cell lysate diluted to 5pg/pl 
total cell protein with PBS. Five pi of the Hsp90 antibody (lmg/ml) (Abeam, 
Cambridge; UK) was added to 1ml o f cell lysate in an Eppendorff. To another 1ml of 
cell lysate, 5 pi of control mouse immunoglobins (1 mg/ml) (Santa Cruz biotechnology, 
Heidelberg, Germany), was added.
The cell lysate/antibody mixture was gently rocked on an orbital shaker for 2 
hours at 4 °C. The immunocomplex was captured by adding 50 pi Protein A/G agarose 
bead slurry and gently rocking on an orbital shaker for 1 h at 4 °C. The agarose beads
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were collected by pulse centrifugation for 15 seconds in the microcentrifuge at 170g 
("1500 rpm; MSE microcentaur, Sanyo Gallenkamp PLC, UK). The supernatant was 
discarded and the beads washed 5 times with 1 ml ice-cold PBS.
The agarose beads were resuspended in 60 pi 2x sample buffer and mixed 
gently. The agarose/sepharose beads were then boiled for 5 minutes to dissociate the 
immunocomplexes from the beads. The supernatant was collected following 
centrifugation at 170 g  for 10 minutes at 4°C (1500 rpm; MSE microcentaur, Sanyo 
Gallenkamp PLC, UK) and SDS-PAGE performed as described in the methods 
chapter. For some samples the supernatant was transferred to a fresh microcentrifuge 
tube and stored at -20°C for later use.
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5.4 RESULTS
5.4.1 ABL lectin binds proteins in a cytoplasmic fraction ofHT-29 cells
A cytoplasmic fraction of HT-29 cells was first prepared by digitonin-selective 
membrane permeabilisation. A T150 cm2 flask was washed 2 times in PBS before the 
addition o f 5ml ice cold digitonin (50 pg/ml) for 3 min to puncture the outer 
membrane o f the cells. The digitonin-released fraction was then extracted and freeze 
dried at -40°C overnight, the remaining cells were lysed directly with sample buffer. 
After separation on a 12% SDS-PAGE gel an ABL mushroom lectin blot was 
performed [Figure 5.1]. This demonstrated the appearance of bands in the cytoplasmic 
fraction that are not apparent or less apparent in the remaining digitonin-treated cells. 
This suggests the existence of sialyl-TF-expressing proteins in the cytoplasm. To 
ensure that the digitonin treatment resulted in a pure cytoplasmic fraction the presence 
o f two endoplasmic reticulum (ER) localised proteins, disulfide isomerase (PDI) and 
Erp72, were tested for by western blotting. They were both absent from the 
cytoplasmic fraction.
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Figure 5.1: ABL blot of a digitonin-released fraction, resolved on a 12% SDS- 
PAGE gel
A  B  C D
Figure 5.1: 12% electrophoresis gel. ABL-biotinylated blot. Lane A: Whole cell 
lysate, Lane B: Remaining digitonin-treated cells, Lane C: Digitonin-released fraction 
10 pg, Lane D: Digitonin- released fraction 20 pg.
HT-29 cells were grown to 60% confluence in a T150cm2 flask. Cells washed 
twice with ice cold PBS. Five ml digitonin (50pl/ml) was added for 5mins to puncture 
the outer membrane of the cells. The digitonin-released fraction was then extracted and 
freeze-dried. The cells remaining in the plate were lysed directly with sample buffer. 
Erp72 and PDI are ER-localised proteins, so demonstrating that the ER had not been 
punctured during the digitonin treatment. Four ABL-binding glycoproteins are shown 
by arrows that are relatively over expressed in the cytoplasmic fraction.
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5.4.2 Mass spectrometry analysis o f an ABL purified sample with bands excised from a 
12% SDS electrophoresis gel reveals no clear protein matches due to insufficient 
purity
To isolate the glycoproteins that express sialyl-TF in the cytoplasm, lectin 
affinity purification with ABL of the cytoplasmic fraction was utilised. A cytoplasmic 
fraction was prepared and the agarose-bound ABL beads added to the solution. The 
beads were washed and the bound proteins eluted by directly adding sample buffer. 
The proteins were run on a 12% SDS gel, an identical copy was removed for sta in in g  
using coomassie R250 and the other transferred on to a nitrocellulose membrane and 
used for an ABL lectin blot [Figure 5.2].
Bands that occurred in the ABL purified fraction and 1 band from the 
cytoplasmic fraction that was recognised by ABL were cut from the gel and analysed 
by mass spectrometry. None of the bands gave a clear identification however, due to 
several proteins existing in one band.
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Figure 5.2: Coomassie stained gel and ABL blot of an ABL purified cytoplasmic 
fraction resolved on a  12% SDS-PAGE gel
Figure 5.2: 12% SDS-PAGE, ABL-biotin blot and coomassie stained gel. Lane A: 
Whole cell lysate, Lane B: Remaining digitonin-treated cells, Lane C: Digitonin- 
released fraction 10 pg, Lane D: ABL lectin affinity purified. An ABL lectin affinity 
purification of the cytoplasmic fraction was performed to isolate cytoplasmic proteins 
expression sialyl-TF. Arrows mark bands excised from gel which were further 
analysed by mass spectrometry. None of the bands analysed contained a sufficiently 
pure protein for a clear identification.
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5.4.3 Mass spectrometry analysis o f an ABL purified sample with bands excised from 
6% SDS electrophoresis gel reveals a few possible candidate proteins
In order to separate proteins further with an aim o f identifying glycoconjugates 
localised in the cytoplasm which express sialyl-TF, a 6% SDS PAGE gel was used to 
resolve the proteins purified with the ABL lectin. This was to overcome the problems 
encountered with the 12% SDS PAGE gel, which did not result in sufficient 
separation. Proteins were purified with ABL lectin as before and after resolving on the 
6% SDS PAGE gel, either stained with coomassie [Figure 5.3] or an identical copy 
transferred to nitrocellulose and utilised for ABL lectin blotting [Figure 5.3]. Two 
protein bands were selected for extraction and mass spectrometry analysis. The data 
received from the mass spectrometry analysis [Tables 5.1-5.8] revealed that Hsp90 P is 
the major candidate for the identity o f Protein 1 with 6 peptides identified and 10.6% 
coverage o f the sequence. The other peptides identified suggest the presence of a 
number o f proteins including spermatogenesis associated 1, tubulin tyrosine ligase-like 
family, member 11 (Homo sapiens), pyruvate kinase 3 isoform 2 (Homo sapiens) and 
programmed cell death 6 interacting protein (Homo sapiens), however only one 1 
peptide o f each was identified. In the protein 2 band, two major candidates arose, 
eukaryotic translation elongation factor 1 alpha 1 which had 3 peptides identified 
with 10.2% coverage o f the sequence and tubulin, beta, 2 (Homo sapiens), which also 
had 3 peptides identified and 8.3% coverage of the sequence. Another protein with 1 
peptide identified was nuclear transport factor like export factor 1 (Homo sapiens).
The most promising identification was deemed to be Hsp90p, which is of a 
comparable molecular weight compared to the band excised and also with the strongest 
identification, with most peptides identified.
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Figure 5.3: Coomassie stained gel and ABL blot of an ABL purified cytoplasmic 
fraction resolved on a 6% SDS-PAGE gel
Figure 5.3: Coomassie stained gel (A) and an ABL-biotin blot (B). A cytoplasmic 
fraction was obtained by treatment with digitonin. This fraction was utilised in an ABL 
lectin purification and the proteins isolated ran on a 6% SDS-PAGE gel. Two bands 
were excised and analysed by mass spectrometry. Protein 1 was identified as having 6 
peptides homologous to human Hsp90(3 and protein 2 as having 3 peptides 
homologous to eukaryotic translation elongation factor 1 alpha 1.
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The peptide sequences identified by mass spectrometry for protein 1 are detailed 
below. The significance o f the peptides identified were assessed using Mascot. 
Mascot incorporates a probability based implementation of the Mowse algorithm. The 
Mowse algorithm is an excellent starting point because it accurately models the 
behaviour o f a proteolytic enzyme. Matches using mass values (either peptide masses 
or MS/MS fragment ion masses) are always handled on a probabilistic basis. The total 
score is the absolute probability that the observed match is a random event.
Given an absolute probability that a match is random, and knowing the size of 
the sequence database being searched, it becomes possible to provide an objective 
measure of the significance of a result. A commonly accepted threshold is that an event 
is significant if it would be expected to occur at random with a frequency of less than 
5%. This is the value which is reported in the tables.
Table 5.1: Heat shock 90kDa protein 1, beta [Homo sapiens]
6 peptides, 65 spectra, 10.6% coverage
Residues Peptide sequence p-value
42-54 R.ELISNASDALDK.I 9.9999
73-83 K.IDIIPNPQER.T 9.9999
83-96 R.TLTLVDTGIGM+16TK.A 9.9999
205-220 K.HSQFIGYPITLYLEK.E 0.00034
539-551 K.EGLELPEDEEEK.K 0.0037
625-640 K.HLEINPDHPIVETLR.Q 0.00045
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Table 5.2: spermatogenesis associated 1
1 peptides, 1 spectra, 3.2% coverage
Residues Peptide sequence p-value
10-19 K.IPIDNYPIQ.T 0.00058
Table 5.3: tubulin tyrosine ligase-like family, member 11 [Homo sapiens] 
1 peptides, 1 spectra, 2.0% coverage
Residues Peptide sequence p-value
186-197 P.VQGLCPHGKPR.D 0.008033
Table 5.4: pyruvate kinase 3 isoform 2 [Homo sapiens] 
1 peptides, 1 spectra, 2.1% coverage
Residues Peptide sequence p-value
33-44 R.LDIDSPPITAR.N 0.0118
Table 5.5: programmed cell death 6 interacting protein [Homo sapiens] 
1 peptides, 2 spectra, 1.8% coverage
Residues Peptide sequence p-value
358-374 K.M+16VPV S VQQSLAA YNQR.K 2.0116
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The peptide sequences identified by mass spectrometry for protein 2 are detailed 
below.
Table 5.6: eukaryotic translation elongation factor 1 alpha 1 
3 peptides, 4 spectra, 10.2% coverage
Residues Peptide sequence p-value
6-21 K.THINIVVIGHVDSGK.S 0.0011109
248-256 R.LPLQDVYK.I 0.0026363
267-291 R.VETGVLKPGM+16VVTFAPVNVTTEVK.S 0.0469230
Table 5.7: tubulin, beta, 2 (Homo sapiens) 
3 peptides, 3 spectra, 8.3% coverage
Residues Peptide sequence p-value
63-78 R.AVLVDLEPGTM+16DSVR.S 9.999
163-175 R.IM+16NTFSVVPSPK.V 0.00102
242-252 R.FPGQLNADLR.K 0.03151
Table 5.8: NTF2-like export factor 1 (Homo sapiens) 
1 peptides, 1 spectra, 7.9% coverage
Residues Peptide sequence p-value
38-49 R.LYMGTATLVWN.G 0.0192
106
5.4.4 Investigation into the glycosylation o f Hsp90 reveals possible expression o f 
sialyl-TF
To confirm the presence of Hsp90P in the sample o f cytoplasmic ABL purified 
proteins and to assess Hsp90p glycosylation, the sample was again resolved on another 
6% SDS PAGE gel. The subsequent anti-Hsp90 (Sigma, Poole, UK) western blot with 
an antibody specific for both Hsp90 a  and (3 reveals the presence of Hsp90 in the ABL 
purified sample. An ABL lectin blot reveals numerous protein bands, which would be 
expected, careful alignment with the Hsp90 western blot shows that there may be a 
corresponding band, further suggesting the presence of TF or sialyl-TF on Hsp90 
[Figure 5.4]
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Figure 5.4: ABL lectin blot and Hsp90 blot of cytoplasmic ABL purified proteins 
resolved on a 6% SDS-PAGE gel
Figure 5.4: ABL lectin blot (A) and anti- Hsp90 western blot (B). The same sample of 
cytoplasmic proteins purified with ABL lectin that was analysed by mass spectrometry 
was resolved on a 6% SDS PAGE gel. The anti-Hsp90 western blot shows a clear band 
in the ABL purified proteins lane, indicating that ABL lectin is capable of identifying 
and isolating Hsp90.
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5.4.5 Hsp90 immunoprécipitation and subsequent ABL lectin blot reveals possible TF 
or sialyl-TF expression
To further confirm the presence o f sialyl-TF on Hsp90(3, immunoprécipitation 
was performed to isolate the protein. HT-29 cells were seeded at lx l 05 and grown until 
60% confluent. The cells were extracted in ice cold RIPA buffer and sonicated on salt 
ice. The cells were then centrifuged at 15,000 g at 4°C for 30 min. The supernatant was 
removed and 5 pi of the anti-Hsp90 antibody (lpg/m l, mouse monoclonal) was added, 
and left for 2 h at 4°C before the addition of 50 pi Protein A/G agarose (Perbio, 
Northumberland, UK) and then left for a further 2 hours. The beads were washed 5 
times with PBS and sample buffer added, before resolving on a 6% SDS-PAGE gel. 
An Hsp90 immunoblot reveals that Hsp90 is precipitated by the antibody and that it is 
not precipitated by the control mouse immunoglobins. An ABL lectin blot was 
performed on an identical blot showing the presence o f a band corresponding to Hsp90 
band, thus implying that ABL can recognise Hsp90 and that therefore Hsp90 expresses 
sialyl-TF [Figure 5.5].
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Figure 5.5: Imm unoprécipitation of Hsp90 and ABL lectin blotting
Figure 5.5: Anti-Hsp90 western blot (A) and ABL lectin blot (B): HT-29 cells were 
seeded at lxlO5 and grown until 60% confluent. The cells were extracted in ice cold 
RBPA buffer and sonicated on salt ice. The cells were then centrifuged at 14,000 rpm at 
4°C for 30 mins. The supernatant was removed and the anti-Hsp90 antibody added, 
and left for 2 hours at 4°C before the addition of Protein A/G agarose and then left for 
a further 2 hours. The beads were washed 5 times with PBS and sample buffer added, 
before resolving on a 6% SDS-PAGE gel. An Hsp90 western blot reveals that Hsp90 
protein has indeed been precipitated and that none was isolated by the control mouse 
immunoglobins [Figure A], An ABL lectin blot was performed on an identical blot 
showing the presence of a band corresponding to Hsp90. Alignment of the blots 
supported the binding of ABL to Hsp90, implying the presence of sialyl-TF.
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5.4.6 Jacalin lectin purification also isolates Hsp90
The carbohydrate binding specificities o f ABL and Jacalin are very similar and 
both are able to recognise sialyl-TF. This further experiment utilises jacalin lectin to 
purify a whole cell lysate as previously described in an earlier chapter. An Hsp90 
western blot reveals that Hsp90 is isolated by jacalin affinity purification, implying the 
presence o f sialyl-TF [Figure 5.6]
Figure 5.6: Hsp90 immunoblot of jacalin lectin purified sample
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Figure 5.6: 6% SDS-PAGE, Anti-Hsp90 immuno-blot. HT-29 cells were grown to 
60% confluence and then starved o f glucose for 24 h. The cells were extracted with 
trypsin and placed in PBS and washed. The solution was then sonicated and ultra 
centrifuged for 1 h. Jacalin-bound agarose beads were added and left to incubate for 12 
h. The beads were washed and the bound proteins eluted with 0.8 M Galactose. 
Dialysis against deionised water was then performed before freeze drying and running 
samples on a 6% SDS-PAGE electrophoresis gel. An Hsp90 western blot reveals that 
Hsp90 is isolated by the jacalin lectin purification, implying the expression of sialyl- 
TF.
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5.5 DISCUSSION
The previous chapter demonstrated the presence of a truncated cytoplasmic 
isoform of Orpl50 that was bound by ABL. ABL is known to bind the onco-fetal 
carbohydrate TF antigen and its sialylated form, thus implying the expression of TF or 
sialyl-TF on Orpl50. Orpl50 was not bound by PNA which recognises TF only in its 
unsubstituted form, further treatment of Orpl50 with sialidase then allows PNA to 
bind implying that it is sialyl-TF and not TF expressed on Orpl50 (Yu et al. 2002). 
This discovery led to an investigation to uncover other possible glycoconjugates in the 
cytoplasm which also express sialyl-TF or unsubstituted TF. To date various sugars 
have been shown to be expressed by proteins in the cytoplasm but apart from 
glycoproteins expressing 0-GlcNAc, few of the proteins have been identified. In the 
experiments detailed here ABL lectin was shown to bind to at least 4 protein bands 
which are apparent in the cytoplasmic fraction but to a lesser extent in the remaining 
cells after digitonin treatment [Figure 5.1]. This initial discovery was followed by ABL 
lectin purification of cytoplasmic proteins which after resolving on a 6% SDS-PAGE 
gel led to 2 bands being further analysed by mass spectrometry. This led to the 
identification of Hsp90p with 6 peptides identified and 10.6% coverage of the 
sequence [Figure 5.3]. Hsp90p was selected for further analysis due to the strong 
identification of the peptides and was also easily identified amongst a few other 
proteins in the band analysed. The probable expression of sialyl-TF on Hsp90p was 
shown by ABL lectin blotting after immunoprécipitation of Hsp90.
The digitonin-released cytoplasmic fraction was free from 2 known ER 
localised proteins, Erp72 and PDI, giving confidence that a cytoplasmic fraction free 
from contaminates was achieved. The binding specificities of the lectins have been 
studied extensively; ABL lectin is very specific in its binding for the Gaipi-3GalNAc
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as well as to sialic acid modified Gaipi-3GalNAc (Irazoqui et al. 1999). Jacalin lectin 
is also highly specific for the TF and sialyl-TF antigen but it has also been 
demonstrated that glycopeptides containing multi-antennary jV-linked oligosaccharides 
with terminal a-galactose residues can bind jacalin (Do et al. 1998). The known 
specificities of the lectin bindings should allow for the isolation of glycoconjugates 
that express sialyl-TF and TF.
The evidence from this investigation suggests that Hsp90p expresses sialyl-TF 
or TF and that there may possibly be other proteins with similar glycosylation in the 
cytoplasm. The presence o f this glycosylation is intriguing and the mechanisms by 
which Hsp90p acquires this modification or how it appears in the cytoplasm need 
further investigation. Hsp90 is an abundant molecular chaperone which is found in the 
cytosol of eukaryotic cells. It is involved in the folding o f cell regulatory proteins and 
in the re-folding of stress denatured polypeptides (Bagatell et al. 2004). It also plays a 
role in cellular signalling as it is essential in maintaining the activity of key signalling 
factors which include protein kinases and steroid hormone receptors (Picard et al. 
1990, Xu et al. 1993). In vertebrates there exist two distinct genes that encode a 
constitutive form, Hsp90p, and an inducible form Hspa. The functional differences 
between the two forms o f Hsp90 are poorly understood and further homologues of 
Hsp90 have also been found in the endoplasmic reticulum: Glucose regulated protein 
94 (Grp94) and mitochondrion TRAP1 (Bagatell et al. 2004). All of these proteins 
have a similar structural plan and are therefore expected to have similar mechanisms of 
action. Their structure contains a constitutive heterodimer with its main intersubunit 
contacts within the COOH-terminal 190 residues (Nemoto et al. 1995). There is also a 
highly conserved NH2-terminal domain of about 25kDa which is the binding site for 
ATP. Polypeptide binding by Hsp90 has been shown to be ATP-dependent (Panaretou
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et al. 1998) and cytosolic Hsp90 interacts with a range o f co-chaperones in 
multichaperone complexes. Most o f the co-chaperones bind via helix-tum-helix 
tetratricopeptide repeat (TPR) motifs, which are found fused to a series of different 
functional domains such as protein phosphatase (PP5) (Chen et al. 1996). Much work 
at present is focused on the complex interaction o f chaperones in the development of 
cancer. Chaperones are upregulated under stress conditions to maintain the normal 
protein folding environment and they have been shown to be upregulated in a variety 
o f tumours. It has been shown that chaperones can serve as biochemical buffers at the 
phenotypic level for the genetic instability that is characteristic of many human 
cancers, thus supporting the concept that their altered utilisation during oncogenesis is 
critical to the development of human cancers, allowing tumour cells to tolerate the 
mutation of multiple critical signalling molecules that would otherwise be lethal 
(Bagatell et al. 2004). The discovery that Hsp90 complexes can be inhibited by 
antibiotics such as geldanamycin (GA), which bind to the NH 2-terminal domain 
(Whitesell et al. 1994) has also furthered understanding of the role of heat shock 
proteins in tumorigenesis. The glycosylation of Hsp90 has not been extensively 
investigated, but there are many JV-glycosylation sites on Hsp90, as deduced from the 
amino acid sequence and work by Hart and colleagues identified Hsp90 as an O- 
GlcNac modified protein (Wells et al. 2002).
The present investigation demonstrates that Hsp90P is modified with sialyl-TF 
or TF but the possible role for this modification on this chaperone is uncertain. 
Furthermore the mechanism by which Hsp90 could be modified by sialyl-TF or TF 
and exist in the cytoplasm needs further investigation. To further confirm the presence 
o f sialyl-TF or TF on Hsp90P, a carbohydrate mass spectrometry analysis is required. 
Hsp90p was successfully immunoprecipitated in this study and, therefore, it should be
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uncomplicated to isolate the protein in sufficient quantity to be analysed. This study 
showed the possible existence of a number o f proteins that express sialyl-TF or TF; 
these also warrant further investigation as they could lead to a better understanding of 
cellular glycosylation. Further experiments to identify other cytosolic proteins that 
express sialyl-TF could utilise 2-D electrophoresis to yield further protein separation, 
combined with lectin blotting. Subcellular fractionation such as differential 
centrifugation or sedimentation through a sucrose gradient to back up evidence on the 
localisation of the proteins could also be performed.
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CHAPTER 6
EFFECT OF ALTERED GLYCOSYLATION ON NLS-DEP ENDENT 
NUCLEAR PROTEIN IMPORT
6.1 HYPOTHESIS
Alterations in cellular O-glycosylation may cause an alteration in the NLS-dependent 
nuclear protein import of Hsp70
AIMS
• To analyse the effects of bafilomycin, TNFa, 5-CDP and benzyl GalNAc on TF and 
sialic acid expression on HT-29 MTX cells
• To evaluate the effect of inhibitors of glycosylation on NLS-dependent nuclear protein 
import by studying the nuclear localisation of Hsp70 upon heat shock
• To utilise sLRNA to downregulate the Galtransferase responsible for the generation of 
Corel glycans by analysing TF expression on HT-29-MTX cells
• To Investigate the effect of the siRNA Galtransferase on NLS-dependent nuclear 
protein import
6.2 INTRODUCTION
The functional role of glycosylation is becoming revealed and it is now clear 
that complex carbohydrates are involved in many biological processes such as protein 
folding, structural stability and oligomerization and also in the immune response and 
host pathogen interactions (Merry et al. 2005). A possible role in NLS-dependent 
nuclear protein import for the constitutively expressed cytoplasmic isoform of Orpl50 
has been shown in a previous chapter and it has also been shown that this isoform
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expresses the sialyl-TF antigen. The functional importance of glycosylation and the 
effects o f known O-glycosylation inhibiting drugs in the NLS-dependent nuclear 
protein import are not yet known and are investigated in this chapter. siRNA was used 
in this study to down-regulate the Gal-transferase responsible for the addition of 
galactose to A-acetylgalactosamine is utilised to further explore the role of the TF 
antigen in NLS-dependent nuclear protein import.
6.2.1 Heat shock proteins
The Hsp70 family encompasses at least 11 proteins which are all closely 
related. O f these proteins some act as molecular chaperones ensuring the correct early 
folding of nascent protein chains, others are stress inducible and implicated in the 
protection and repair o f stress induced protein damage (Tavaria et al. 1996). Heat 
stress induces the expression of Hsp72/73 in the cytoplasm, which is then transported 
into the nucleus via the NLS-dependent nuclear protein import mechanism, this 
movement is examined in this chapter and visualised with FITC conjugated antibodies.
6.2.2 O-glycosylation inhibiting drugs
Four differently acting O-glycosylation inhibitors have been selected for use in
these experiments:
6.2.2.1 5-cytosine diphosphate (5-CDP)
Alterations o f  carbohydrate structure and composition of cell surface 
glycoproteins and glycolipids have been shown to have an influence on the metastatic 
potential of tumour cells (Kobata et al. 2005). There has been shown to be a direct 
correlation between tumour metastasis and number of sialic acids (Zhao et al. 2007),
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with hypersialylation being the result of increased sialyltransferase activity (Collard et 
al. 1986). The inhibition of sialyltransferases can be achieved with a number of 
compounds. Some of the most effective of these are the family of cytosine phosphates 
with increasing inhibitory potency from 5-cytosine monophosphate (5-CMP), 5- 
cytosine diphosphate (5-CDP) to 5-triphosphate (5-CTP) for inhibition of the a-2, 6 - 
sialyltransferase of rat liver. The best inhibitor of a2-3-sialyltransferase from the 
porcine submandibular gland was 5-CDP which inhibited both sialyltransferases 
equally at 85% and 89% (Kleineidam et al. 1997). In the present experiments 5-CDP 
was selected for its overall inhibition o f sialyltransferases.
6.2.2.2 GalNAc-a-0-benzyl
GalNAc-a-O-benzyl (benzyl-GalNAc) is an inhibitor of mucin type O 
glycosylation (Huet et al. 1998). Short term exposure to benzyl-GalNAc has been 
demonstrated to reduce mucus secretion, to decrease sialylation of newly synthesised 
mucins and to increase TF antigen expression in post-confluent HT-29 colonic cancer 
cells (Huet et al. 1995). These effects have also been shown in LS174T cells (Kuan et 
al. 1989) and KATOII cells (Byrd et al. 1995). Permanent exposure to benzyl-GalNAc 
leads to dramatic changes in HT-29 cells such as reduced mucus secretion, swelling of 
the cells with intracellular accumulation o f numerous vesicles (Hennebicq-Reig et al. 
1998) and causes apical membrane proteins such as MUC1, DPP-IV, and CEA to 
accumulate in the cytoplasm and, therefore, no longer be expressed at the apical 
membrane, without modification of polarised cells. Exposure to benzyl-GalNAc 
causes a decrease in the NeuAca2-3 sialylation o f these proteins, thus suggesting a 
possible role for sialylation for the targeting o f apical membrane proteins (Huet et al. 
1998). These effects are reported to be the result of the metabolism of GalNAc-a-0-
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benzyl into Gal p i-3 GalNAc-a-O-benzyl, which is responsible for the competitive 
inhibition o f Gal pi-3 GalNAc a2-3sialyltransferase (Huet et al. 1995). Further to this 
the massive accumulation of benzylated oligosaccharides in the HT-29 cells is also 
thought to alter cellular processes (Zanetta et al. 2000). These results cannot always be 
readily extrapolated to other cell lines, this is clearly demonstrated by the lack of effect 
of benzyl-GalNAc on Caco-2 cells. This is explainable as the main sialyltransferase 
expressed in these cells is STóGal I, which is not affected by benzyl-GalNAc. 
However, HT-29 MTX cells treated with benzyl-GalNAc have profound changes in 
mucin oligosaccharide chains. Exposure o f HT-29-MTX cells to benzyl-GalNAc 
caused a decrease in intracellular mucins, sialic acid and galactose content and an 
increase in the TF antigen and Tn antigen expression. The expression of MUC5Ac was 
also inhibited and no overlying mucus layer detected (Delannoy et al. 1996, 
Hennebicq-Reig et al. 1998).
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6.2.2.3 Bafllomycins
The family of bafllomycins Ai, Bi, Ci and D are macrolide antibiotics with a 
16-membered lactone ring, first isolated from the fermentation o f Streptomyces spp. 
(Wemer et al. 1984). They all inhibit growth of Gram positive bacteria and fungi in a 
disc diffusion assay and bafilomycin C\ has been reported to inhibit the enzymatic
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activity o f the Na+,K+, ATPase inhibitors (Huang et al. 1984). Bafilomycin Ai has been 
shown to be a useful tool in distinguishing among the three main types of ATPases, as 
it has no effect on the FiF0 ATPases of bacteria and mitochondria, the E iE2 ATPases 
such as the K+ ATPase from ox brain and the Ca2+ATPase from the sarcoplasmic 
reticulum are moderately sensitive. The membrane ATPases from neurospora 
vacuoles, chromaffin granules are extremely sensitive, making it a relatively specific 
potent inhibitor of vacuolar FC ATPases (V-ATPases) in both prokaryotic and 
eukaryotic organisms (Bowman et al. 1988). Structurally the vinylic methoxy group 
adjacent to a carbonyl function, the dienic system and the hydroxyl at position 7 are 
important for the V-ATPase inhibitory activity (Gagliardi et al. 1999). Bafilomycin can 
therefore, be used experimentally to inhibit Golgi acidification.
6.2.3 Effect of Golgi pH on glycosylation
Altered glycosylation may result from altered expression or localisation of 
glycotransferases (Brockhausen et al. 2001, Sewell et al. 2006, Taylor-Papadimitriou 
et al. 1999). However, the molecular basis for increased TF expression cannot be so 
readily explained, due to a poor correlation between TF expression and the observed 
enzymatic changes in cancer cells. Altered MUC1 glycosylation in breast cancer cells 
is an example o f this, with predominant changes involving a change from Core 2, to 
Core 1 type structures, as a result o f a lack o f the Core 2 N-
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acetylglucosaminyltransferase 1 (C2GnTl) or competition from the a2-3- 
sialyltransferase (a2-3STl), which is seen to be increased in breast cancer cells 
(Dalziel et al. 2001). However, C2GnT 1 is not consistently altered and breast cancer 
cells produce large amounts of unsialylated MUC1-associated oligosaccharide chains, 
even though there is an increase in terminal sialyltransferase activity (Brockhausen et
al. 1995).
The pH of the Golgi apparatus is crucial for normal cellular glycosylation to 
occur. The Golgi apparatus under normal conditions has a pH, which progressively 
becomes more acidic, from pH6.7 at the ds-Golgi to pH6.3 at the trans-Golgi 
(Paroutis et al. 2004). This acidic pH is crucial for controlling the localisation of 
glycosyltransferases and ensuring their optimum activity (Varki 1998). Bafilomycin Ai 
is able to specifically inhibit the vacuolar H+ATPases o f the Golgi (Moriyama et al. 
1989) and causes an alkalinisation of the Golgi apparatus (Wu et al. 2000). This 
alkalinisation of the Golgi by bafilomycin Ai causes structural changes in the Golgi 
apparatus (Kellokumpu et al. 2002) [Figure 6.1] that correlate with an increase in 
cancer-associated carbohydrate antigens such as TF in breast and colorectal cancer 
cells (Rivinoja et al. 2006).
The addition of bafilomycin Ai or the weak base ammonium chloride (NH4CI) 
and subsequent increase in Golgi pH of HeLa and LS174T cells causes re-localisation 
o f jV-acetylgalactosaminyltransferase 2 ; p l - 2  A-acetylglucosaminyltransferase I, and 
p i -4 galactosyltransferase 1, normally localised to the Golgi stack, the medial/trans- 
Golgi and the trans-Golgi/TGN, respectively (Axelsson et al. 2001). Increase of the 
Golgi pH in cultured LS174T goblet-differentiated cells with bafilomycin Ai has been 
shown to mimic the decreased mucin sulphation and increased TF antigen expression 
seen in colon cancer (Campbell et al. 2001).
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Figure 6.1: Disorganisation of the Golgi apparatus in cultured NRK cells treated with 
drugs that block Golgi acidification (Kellokumpu et al. 2002).
6.2.4 RNA interference and RNA silencing
The impact of specific glycosyltransferases can be assessed in a cell line by 
using RNA interference or silencing. The RNA interference (RNAi) pathway was first 
observed in petunias, in a phenomenon then called cosuppression, where the 
introduction of a pigment producing gene under the control o f a powerful promoter 
caused the suppression of both the introduced gene and the homologous endogenous 
gene (Napoli et al. 1990). Cosuppression was found to exist in other species o f plants 
and fungi where it was called “quelling” (Cogoni et al. 1996). A further discovery was 
made from the injection o f dsRNA into the gonads of Caenorhabditis elegans, which 
resulted in potent gene silencing and established dsRNA as the inducer of RNAi (Fire 
et al. 1998). Short interfering RNAs (siRNAs) were first implicated in plants as part of 
the post translational gene silencing in plants (PTGS) (Hamilton et al. 1999) which led 
to the work on the Drosophila system, which demonstrated that dsRNA was processed
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into siRNAs of 21-25bp in length which could then cause mRNA cleavage 
corresponding to the introduced dsRNA (Elbashir et al. 2001), forming the basis o f the 
RNAi pathway. Higher eukaryotes have many antimicrobial defence mechanisms, 
which are based on the recognition of conserved molecular patterns which includes 
double stranded RNA (dsRNA). The RNA interference (RNAi) pathway is an antiviral 
immune response to dsRNA, which is a key component in the genomic replication of 
viral DNA and not normally present in eukaryotic cells (Cullen 2002). This ancient 
and highly conserved innate cellular response can be induced artificially by the 
addition of exogenous dsRNA or short interfering RNA (siRNA) stimulating the RNAi 
pathway. Early efforts to utilise the RNAi phenomenon for gene suppression were 
disrupted, as it was found that dsRNA larger than 30bp caused an interferon-mediated 
response causing apoptosis of the cells. The RNAi pathway is by nature extremely 
sequence specific, responding to dsRNAs by selectively degrading mRNAs that are 
homologous in sequence to the dsRNA inducer. RNAi is, therefore, capable of 
blocking the expression of not only viral, but host cell genes, upon the introduction of 
homologous dsRNA. This enables the specific knockdown of proteins by the 
introduction o f sequence specific dsRNAs [Figure 6.2].
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Figure 6.2: General pathway of RNAi in vitro
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Figure 6.2: The general pathw ay of RNAi in vitro (Sontheimer 2005).
The mechanism for RNA silencing by inducing the RNAi pathway in 
mammalian cells in vitro commences with the introduction of dsRNA which is cleaved 
in to 21-23bp siRNA duplexes by the ribonuclease-III enzyme Dicer (Doi et al. 2003) 
[Figure 5.2]. siRNAs bear 5'-phosphate groups and 2-bp 3' overhangs, both of which 
are important for subsequent siRNA-induced silencing complex (siRISC) assembly 
(Sontheimer 2005). Alternatively the siRNAs can be chemically synthesised and be 
introduced directly into the cytoplasm with use of transfection reagents. During the 
effector phase of the RNAi pathway the siRNA is unwound (Martinez et al. 2002) by
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an unwindase enzyme leading to the assembly of RISC. It is this activated effector 
complex that recognises the target by siRNA to mRNA base pairing, and cleavage of 
the mRNA strand is achieved through its endoribonuclease activity (Liu et al. 2004). 
This process is accelerated by the presence of ATP, which increases enzyme turnover 
by promoting siRNA-product unwinding and product release (Haley et al. 2004). The 
remaining ‘guide’ strand associates with the PAZ domain o f an Argonaute (Ago2) 
protein (Lingel et al. 2004) at which point the RISC complex is ready to mediate its 
effects and cleave the specific mRNA.
The formation of the RISC complex is still being elucidated, but the main 
features of this process are now understood with the majority o f the work being 
achieved in the Drosophila melanogaster system [Figure 6.3]. After dsRNA 
processing the siRNA will either stay attached to the Dicer (Dcr2)-R2D2 heterodimer 
it was generated by or be taken up by another Dcr2-R2D2 complex in a formation 
previously known as R l. The R2D2 will bind the more thermodynamically stable 
end o f the siRNA and the Dcr2 the less stable end, this asymmetric binding facilitates 
the determination o f the guide strand of siRNA from the strand which will be loaded 
into the RISC complex later on. The siRNA then enters the RISC-loading complex 
(RLC) which was known before as R2, and associated with other as yet unknown 
RISC factors and one o f the siRNA strands (the ‘passenger’ strand) is discarded
[Figure 6.3]
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Figure 6.3: The assembly of RISC in the D r o s o p h ila  m e la n o g a s te r
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Figure 6.3: The assembly of RISC (Sontheim er 2005)
6.2.5 SiRNA G altransferase
After the addition of GalNAc to the serine or threonine residues of the 
glycoprotein, the formation of Core 1, by the addition of galactose is controlled by a 
core (31-3 Galtransferase. To date there is only one known Galtransferase specific for 
transfering galactose onto GalNAc on O-linked chains (Ju et al. 2002). In the present 
study RNA silencing is employed to suppress this transferase and, therefore, prevent 
the formation of Core 1 and also preventing any further elongation. The importance
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of the TF antigen in NLS-dependent nuclear protein import can thus be assessed by 
using siRNA technology to suppress the formation of the TF antigen with analysis o f 
Hsp70 translocation in to the nucleus upon heat shock.
6.2.6 Tumour Necrosis factor (TNFa)
Although TNFa is not a classical glycosylation inhibitor; the alterations in
glycosylation observed in colon cancer and inflammatory bowel disease have been 
induced in cultured goblet cell differentiated cell lines by TNFa. Alterations such as 
aberrant mucin synthesis and expression, increased TF antigen expression and 
reduction in mucosal sulphation have been shown (Campbell et al. 2000, Campbell et 
al. 2002). TNFa also increased cell surface expression of the cancer related 
carbohydrate antigen sialyl Lewisx (Kuninaka et al. 2000) and Lewisy in response to 
interferon gamma and interferon alpha (Flieger et al. 2001).
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6.3 METHODS
6.3.1 Hsp70 localisation
HT-29 cells were seeded at lxlO4 on glass cover slips, 24 h prior to siOrpl50 
treatment. After 2 days siRNA treatment, the cells were heat-treated for lh  at 42°C, 
and then fixed for 10 min in freshly prepared paraformaldehyde followed by 3 washes 
with PBS. The fixed cells were then blocked with 300 pi of 5% (v/v) goat serum 
(Dako; Glostrup, Denmark) for 1 h at room temperature, followed by the addition of 
anti-Hsp70 antibody (Bioquote, York) 1:200 concentration, for 2 h. The cells were 
then washed 2 times with PBS and then the FITC conjugated secondary antibody 
(Dako; Glostrup, Denmark) was added, concentration 1:500, for 1 h in the dark. The 
cells were then washed 3 times with PBS and the cover slips mounted on glass slides 
with a PI nuclear counter-stain mounting solution. The localisation of Hsp70 was then 
visualised using an Olympus camera and the % nuclear Hsp70 calculated used AQM 
software.
Hsp70: Experiments were performed 5 times and the slides were blind labeled, each 
time 1 0  individual cells for each category were chosen at random from the slide for 
AQM analysis. Inter assay coefficient of variance 8.3%, intra assay coefficient of 
variance 8.7% for all experiments.
Hsp70 control experiment =Inter assay coefficient of variance (COV): 8.3%,
Intra assay COV 4.1%
Hsp70 heat control experiment = Inter assay coefficient o f variance (COV): 8.0%, 
Intra assay COV 3.0%
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6.3.2 0-Glycosylation inhibitors
HT-29-MTX cells were grown as monolayers in 24 well plates to 60% 
confluence; they were then treated with the inhibitors at the following final 
concentrations chosen from previous work in the laboratory and literature: 5-CDP: 1 
mM (Kleineidam et al. 1997), TNFa: 2 ng/ml (Campbell et al. 2000, Campbell et al. 
2002) , benzyl GalNAc 2 nM (Huet et al. 1998), bafilomycin 0.01 pM (Campbell et al.
2001)
6.3.3 FACS analysis
HT-29-MTX cells were grown as monolayers in 6  well plates to 60% 
confluence and treated with the O-glycosylation inhibitors, as described previously. 
The cells were washed 3 times with PBS in the well before addition of a non 
enzymatic dissociation solution, 1 ml/well (Sigma; Dorset, UK), the cells were 
incubated at 37°C until dissociated. The cells were washed twice with 1ml ice cold 
PBS and collected each time by centrifugation at 70 g for 1 min (1000 rpm; MSE 
microcentaur, Sanyo Gallenkamp PLC, UK). The cells were then fixed in 1% 
paraformaldehyde for 10 minutes on ice and then washed 3 times with PBS. Following 
this the cells were incubated with 200 pi of either biotinylated PNA (Vector, UK) or 
Vicia villosa (VVA) (Vector, UK) at a concentration o f lmg/ml, in a PBS solution 
containing 1% BSA. Again the cells were washed 3 times with PBS, before incubation 
with a 1:200 dilution of Avidin-FITC in a PBS-BSA 1% solution, in the dark. The 
cells were washed 3 times with PBS and resuspended in 200pl PBS ready for the 
FACS analysis. The experiment was repeated 3 times. Each time 10,000 gated events
were recorded.
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6.3.4 siRNA Galtransferase
Cell plating:
HT-29 cells were diluted in antibiotic-free DMEM with 5% FCS to a plating 
density of 5.0 x 104 cells/ml. 100pi of cells were placed in to each well of a 96 well 
plate and incubated for 24 h.
Transfection:
To perform the experiment in triplicate the following protocol was followed: 
A 2 pM siRNA solution in siRNA buffer (Dharmacon) was prepared, from this 17.5 pi 
was added to 17.5 pi serum free/antibiotic free medium. In a separate tube 1.4 pi of 
DharmaFECT4 (Dharmacon) was added to 33.6 pi o f FCS-free/antibiotic-free DMEM. 
These tubes were pipetted up and down and left for 5 min before mixing them together 
and leaving to stand for a further 20 min. To this solution 280 pi antibiotic free 
DMEM was added and to each well lOOpl was added. The plate was incubated at 37°C 
in a humidified atmosphere o f 5% C 0 2 ,95% air for required time.
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6.4 RESULTS
Initial experiments to analyse the effects o f the O-glycosylation inhibitors on 
HT-29 MTX cells were performed by investigating the expression of TF and sialic 
acid. HT-29 MTX cells are a homogeneous, mainly MUC5AC (normal gastric mucin) 
secreting population o f well-differentiated goblet cells that has been obtained by 
stepwise adaptation o f HT-29 cells to 10'6or 1 O'5 M methotrexate (MTX) (Lesuffleur 
et al. 1990). HT-29-MTX cells were cultured for 2 days prior to the addition of the O- 
glycosylation inhibitors, bafilomycin 100 nM, TNFa 2 ng/ml, 5-CDP 1 mM, and 
benzyl GalNAc 2 nM. Subsequent lectin blotting with PNA lectin was utilised to 
assess the expression of the TF antigen. An initial time course experiment ranging 
from 0-3 days was first completed. It revealed that 48 h incubation with the O- 
glycosylation inhibitors caused the greatest increase in TF expression as assessed by 
PNA lectin blotting and densitometric analysis of the bands [Figure 6.4]. The time 
course was repeated 2 times. By Day 1 only benzyl GalNAc showed a significant 
increase in TF (p<0.05) [ANOVA]. By Day 2 bafilomycin, 5-CDP and TNFa 
(p<0.05) and benzyl GalNAc (p<0.001) all showed significant increase in TF, this was 
also observed on day 3 [Figure 6.5]. Consequently, 48 h incubation was used during 
subsequent experiments.
6.4.1 O-glycosylation inhibitors increase expression o fT F  in HT-29 M IX  cells
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Figure 6.4: Representative slot blots of PNA lectin binding. Time course of the
effect o f 0-glycosylation inhibiting drugs on PNA lectin binding.
PNA Actin
A B 
Hours I 1
C D E
24
A B C D E
48
72
Figure 6.4: PNA lectin blot. Lane A: control, Lane B: bafilomycin, Lane C: TNFa, 
Lane D: 5-CDP, Lane E: benzyl GalNAc.
HT-29 MTX cells were grown to 60% confluence in 24 well plates before the addition 
o f the O-glycosylation inhibitors at appropriate concentrations for 0-3 days. At the end 
o f each time point the cells were washed 3 times with PBS and lysed directly with 
sample buffer. The samples were then subjected to slot blot analysis and lectin blotting
with PNA lectin.
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Figure 6.5: Mean density of PNA binding after inhibitor treatment
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Figure 6.5: Time course (n=2) of the 4 0-glycosylation inhibiting drag treatments. 
HT-29 MTX cells were grown to 60% confluence in 24 well plates before the addition 
of the O-glycosylation inhibitors at appropriate concentrations for 0-3 days. At the end 
of each time point the cells were washed 3 times with PBS and lysed directly with 
sample buffer. The samples were then subjected to slot blot analysis and lectin blotting 
with PNA lectin, with analysis of the density of bands using Quantity One software 
(Bio-Rad; Hemel Hempstead, UK). By day 1 only benzyl GalNAc showed significant 
increase of PNA binding (p<0.05) [ANOVA], but by day 2 and 3 all inhibitors show 
significant increase in PNA binding (benzyl GalNAc ***= p<0.005, all others (*) 
=p<0.01) [ANOVA], the greatest overall increase was observed on day 2.
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Further investigation o f the effect of the O-glycosylation inhibitors at the 48h 
time point also demonstrated a significant increase in PNA binding. The experiment 
was repeated 4 times and the PNA binding assessed after slot blotting [Figure 6.6]. 
Benzyl GalNAc caused the most significant increase in PNA binding (pO.OOl), 
bafilomycin, TNFa and 5-CDP (p<0.05). [ANOVA] [Figure 6.7]
Figure 6.6: Representative slot-blot of the effect of O-glycosylation-inhibiting 
drugs on PNA lectin binding after 48h
PNA lectin Actin
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Figure 6.6: PNA lectin blot. Lane A: control, Lane B: Bafilomycin, Lane C: TNF 
alpha, Lane D: 5-CDP, Lane E: Benzyl GalNAc.
FIT-29 MTX cells were grown to 60% confluence in 24 well plates before the addition 
o f the O-glycosylation inhibitors at appropriate concentrations for 2 days. The cells 
were then washed 3 times with PBS and lysed directly with sample buffer. The 
samples were then subjected to slot blot analysis and lectin blotting with PNA lectin, 
with densitométrie analysis of the bands using Quantity One software (Bio-Rad; 
Flemel Hempstead, UK).
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Figure 6.7: TF expression determined by PNA lectin binding in HT-29 MTX cells
treated for 48 h with inhibitors
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Figure 5.6: The density o f PNA binding after treatment with O-glycosylation 
inhibitors for 48 h as determined by analysis o f the density of bands using Quantity 
One software (Bio-Rad; Hemel Hempstead, UK). Each O-glycosylation inhibitor 
showed significance (n=4) (* = p<0.01, *** = p<0.001), with benzyl GalNAc causing 
the greatest increase in TF expression (p<0.001) [ANOVA].
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Flow cytometry was utilised to further analyse the effects of the O- 
glycosylation inhibitors on the expression of the TF antigen, using a PNA-FITC 
conjugate. The experiment was repeated 3 times and each analysis was of 10,000 gated 
events [Figure 6.9]. The control gated mean (±SD) was 9±1 and only benzyl GalNAc 
appears to increase surface binding of PNA lectin as compared to control cells, with a 
gated mean o f 37±1 (n=3, p<0.005). HT-29-MTX cells treated with bafilomycin had a 
gated mean o f 12±1.3, TNFa a gated mean of 10±1 and 5-CDP a gated mean of 13±3 
(All n=3, and p>0.05). A graph of the gated mean shows clearly the increase in PNA 
binding [Figure 6.8].
6 .4 .2  B e n zy l G a lN A c  in crea ses  c e ll su rface  e x p ress io n  o f T F  on  H T -2 9  M T X  ce lls
Figure 6.8: Gated mean value of FACS analysis of PNA binding
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Figure 6.8: Gated mean values of HT-29-MTX cells which have been incubated with 
PNA-FITC prior to FACS analysis. Benzyl GalNAc, p<0.005 (**). All others not 
significant.
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Figure 6.9: FACs analysis of TF expression after inhibitor treatment
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Figure 6.9: FACS analysis of HT-29 MTX cells that were treated with the O- 
glycosylation inhibitors for 48 h prior to incubation with PNA-FITC conjugate. Only 
Benzyl GalNAc causes an increase of surface TF expression compared to control cells 
with a mean gated value of 37 (n=3, p<0.005). All other treatments had no significant 
effect.
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The effect o f O-glycosylation inhibitors on the expression of sialic acid was 
assessed. HT-29 MTX cells were cultured for 2 days prior to the addition of the O- 
glycosylation inhibitors, bafilomycin 100 nM, TNFa 2 ng/ml, 5-CDP 1 mM, benzyl 
GalNAc 2 nM and a further incubation of 48 h. Subsequent lectin blotting with MAL 
II lectin was utilised in order to assess the expression of sialic acid. The experiment 
was repeated 3 times, control mean density of MAL II binding was 122 ± 13 ADU. 
The only statistically significant change in sialic acid expression resulted from 
benzyl-GalNAc with a mean density 93 ± 5 ADU (p<0.05) and 5-CDP with a mean 
density o f 94 ± 8 ADU (p<0.05) [Figure 6.10 and 6.11].
6 .4 .3  O -g ly c o sy la tio n  in h ib ito rs  d e c re a se  s ia lic  a c id  co n ten t o fH T -2 9  M T X  ce lls
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Figure 6.10: Effect of 0-glycosylation inhibiting drugs on MALII lectin binding 
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Figure 6.10: Representative MAL II lectin blot. Lane A: control, Lane B: Bafilomycin 
0.01 pM, Lane C: TNF alpha 2ng/ml, Lane D: 5-CDP ImM, Lane E: Benzyl GalNAc 
2nM.
HT-29-MTX cells were grown to 60% confluence in 24 well plates before the addition 
of the inhibitors under test at appropriate concentrations for 48 h. The cells were then 
washed 3 times with PBS and lysed directly with sample buffer. The samples were 
then subjected to slot blot analysis with MAL II lectin, with analysis o f the density of 
bands using Quantity One software (Bio-Rad; Hemel Hempstead, UK).
139
Figure 6.11: Sialic acid expression determined by Mai II lectin binding to treated
HT-29 MTX cells
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Figure 6.11: The density o f MAL II binding after treatment with O-glycosylation 
inhibitors for 48 h as determined by analysis of the density o f bands using Quantity 
One software (Bio-Rad; Hemel Hempstead, UK). Benzyl GalNAc and 5-CDP caused 
the greatest decrease in sialic acid with a mean MALII binding density of 93±5 
(p<0.05).
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The surface expression of sialic acid was assessed using FACS analysis, using 
Maackia amurensis lectin II (MAL II), a MAL-FITC conjugate was used in these 
experiments. MAL II appears to bind only particular carbohydrate structures that 
contain sialic acid and unlike Sambucus nigra (SNA) which seems to prefer structures 
with a2-6 linked sialic acid, MAL II appears to bind sialic acid in an a2-3 linkage. The 
experiment was repeated 3 times and each analysis was of 10,000 gated events, 
representative graphs are shown in Figure 6.13. The control gated mean (±SD) was 
30±2 and only Benzyl GalNAc appears to have an effect on cell surface sialic 
expression, causing a decrease as compared to control cells, with a gated mean of 23±2 
(n=3, p<0.005) [Figure 6.12]. HT-29-MTX cells treated with Bafilomycin had a gated 
mean o f 29±2, TNFa a gated mean o f 30±2 and 5-CDP a gated mean of 30±2 (All 
n=3, and p>0.05).
Figure 6.12: Gated mean value of FACs analysis of MAL II binding
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Figure 6.12: Gated mean values o f HT-29-MTX cells which have been incubated with 
MAL II-FITC prior to FACS analysis. Benzyl GalNAc, p< 0.005 (**). All others not 
significant.
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Figure 6.13: FACS analysis of MAL II binding after inhibitor treatm ent
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Figure 6.13: FACS analysis of HT-29 MTX cells that were treated with the O- 
glycosylation inhibitors for 48 h prior to incubation with MAL II-FITC conjugate. 
Only Benzyl GalNAc causes an increase of surface TF expression compared to control 
cells with a mean gated value of 23 (n=3, p<0.005)[ANOVA], All other treatments had 
no significant effect.
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The data from the FACS analysis implies that benzyl-GalNAc affected cell surface 
glycosylation with an increase in TF expression and a decrease in sialylation with a 48 
h incubation with the inhibitor. It may be possible that a longer incubation period with 
the inhibitors may result in the other agents having an effect on cell surface 
glycosylation.
6.4.5 O-glycosylation inhibitor drugs shown no effect on reducing Hsp70 translocation 
into the nucleus
The effects o f the O-glycosylation inhibitors on the expression of TF and sialic 
acid have then been established and this allows an investigation into the effect of these 
changes in glycosylation on NLS-dependent nuclear protein import by assessing the 
translocation o f Hsp70 into the nucleus upon heat shock. O-glycosylation-inhibiting 
drugs benzyl GalNAc and 5-CDP and also bafilomycin, TNFa were used to treat HT- 
29 MTX cells for 48 h. A percentage of Hsp70 visualised in the cell nucleus compared 
to the cytoplasm was calculated, a representative image for each inhibitor is shown in 
Figures 6.14 and 6.15. For each experiment 10 cells at random were chosen, and the 
experiment was repeated 3 times. Control cells were shown to have a nuclear Hsp70 
fluorescence o f 43 ± 2 % [mean±SD] (n=30). None of the O-glycosylation inhibitors 
induced a significant variance from the control, bafilomycin = 42 ± 2% (n=30), TNFa 
= 42 ± 2 % (n=30), 5-CDP= 40 ± 2% (n=30), benzyl GalNAc = 40 ± 1% (n=30). The 
inter assay coefficient o f variance for the experiments was 8.3% and the intra assay 
coefficient o f variance was 4.1% [Figure 6.16].
HT-29-MTX cells were then heat treated at 42°C for 1 h to measure the 
translocation o f Hsp70 from the cytoplasm into the nucleus. The control cells showed 
an increase in nuclear fluorescence with an average o f 60 ± 2% [mean ± SD] (n=30) 
(p<0.001). The HT29-MTX cells that were treated with inhibitors showed no
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significant variance from control cells, Bafilomycin -  61 ± 1% (n-30), TNFa -  60 ± 
1% (n=30), 5-CDP= 61 ± 2% (n=30), Benzyl GalNAc = 59 ± 1% (n=30). The inter 
assay coefficient o f variance for the experiments was 8.0% and the intra assay COV 
3.0% [Figure 6.16].
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Figure 6.14: Hsp70 nuclear localisation before heat treatment
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Figure 6.14: Representative images of Hsp70 immunohistochemistry captured with 
x40 objective. Hsp70 (green) and nuclear (red) in HT-29-MTX cells, showing 
localisation predominantly in the cytoplasm. The inhibitor treatments showed no 
significant change compared to control cells.
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Figure 6.15: Hsp70 nuclear localisation after heat treatment
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Figure 6.15: Representative images of Hsp70 immunohistochemistry captured x40 
objective. Hsp70 (green) and nuclear (red) in HT-29-MTX cells, showing localisation 
in the nucleus after heat treatment for 1 h at 42°C. The inhibitor treatments showed no 
significant change compared to control cells.
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Figure 6.16: Hsp70 nuclear localisation in HT-29 MTX cells after heat treatment.
70
Figure 6.16: Nuclear fluorescence of control cells was increased upon heat treatment, 
average control" 43 ± 2% compared to average heat treated 60 ± 1.8% (p<0.001). 
None o f the glycosylation inhibitors or TNFa have a significant effect compared to
control. (BG=benzyl-GalNAc).
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6.4.6 siRNA Galtransferase causes a reduction in TF expression and increase in Tn 
expression in HT-29 cells
This further experiment to uncover a possible role for the oncofetal antigen TF 
utilised siRNAs directed to the Galtransferase responsible for the formation of the TF 
antigen and again observed the effect on Hsp70 translocation following heat treatment. 
This experiment first establishes effectiveness o f the siRNA Galtransferase on the 
reduction o f TF antigen expression.
HT-29 cells were transfected with siRNA Galtransferase for 48h in a 96 well 
plate before direct lysis in slot blot lysis buffer and followed by slot blotting. Lectin 
blotting with either PNA for TF expression or VVA for Tn expression was quantified 
using Quantity One software (Bio-Rad; Hemel Hempstead, UK) [Figure 6.17]. The 
experiment was repeated 3 times and on each occasion in triplicate. The control and 
siRNA controls were found to be not statistically different from each other in any 
instance. TF decreased in response to siRNA Galtransferase by 21 ± 3% (p<0.005) 
compared to siRNA control. Tn expression increased in response to siRNA 
Galtransferase by 42 ± 3% (p<0.001) [Figures 6.18-6.20].
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Figure 6.17: TF and Tn expression by HT-29 cells in response to siRNA
Galtransferase transfection
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Figure 6.17: TF and Tn expression by HT-29 cells assessed by PNA and VVA lectin 
blotting respectively. Lane A: control, B: siRNA control, C: siRNA Galtransferase. 
Demonstrates the reduction of PNA binding and increase in VVA binding after 
siRNAGaltransferase incubation.
149
Figure 6.18: Reduction in TF expression in response to siRNA Galtransferase:
quantative analysis
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Figure 6.18: HT-29 cells were transfected with siRNA Galtransferase or siRNA 
control for 48 h in 96 well plates, prior to slotblotting and lectin analysis of TF 
expression with PNA lectin (arbitrary densiometric units). The experiment was 
repeated 3 times, on each occasion 3 separate wells were taken for analysis and for 
each experiment siRNA Galtransferase caused a significant decrease of TF expression, 
(p<0.005) for each experiment, n=3. [ANOVA].
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Figure 6.19: increase in Tn expression binding after SiRNA Galtransferase
treatment: quantative analysis
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Figure 6.19: HT-29 cells were transfected with siRNA Galtransferase or siRNA 
control for 48 h in 96 well plates, prior to slotblotting and lectin analysis of Tn 
expression with VVA lectin (arbitrary densiometric units). The experiment was 
repeated 3 times, on each occasion 3 separate wells were taken for analysis and for 
each experiment siRNA Galtransferase caused a significant increase o f Tn expression, 
(p<0.005) for each experiment, n=3. [ANOVA].
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6.4.7 siRNA Galtransferase transfected cells show no reduction in Hsp70 translocation 
in to the nucleus upon heat treatment compared to controls
The effect of the siRNA Galtransferase upon NLS-dependent nuclear protein 
import was assessed by observing the translocation of Hsp70 into the nucleus upon 
heat shock. HT-29 cells were grown on cover slips and transfected with siRNA control 
or siRNA Galtransferase for 48 h. The localisation of Hsp70 after heat treatment was 
then assessed as an indication o f NLS-dependent nuclear protein import, and the ^  
nuclear fluorescence was calculated. The experiment was repeated 3 times, on each 
occasion 10 cells were selected at random (n=30) [Figure 6.21 and 6.22]. The control 
cells displayed a nuclear fluorescence of 42 ± 1%. The siRNA control transfected 
cells were similar to control cells with a nuclear fluorescence o f 41 ± 1%. The 
siRNA Galtransferase transfected cells also were found not to be different from
controls with a nuclear fluorescence of 40 ± 1%.
The percentage nuclear fluorescence of control cells after heat treatment was 
61 ± 1%, significantly increased compared to non heat treated cells (p<0.005). The 
siRNA control treated cells displayed a similar nuclear fluorescence of 61 ± 1%, 
after heat treatment. Nuclear fluorescence of siRNA Galtransferase heat treated cells 
was also similar at 58 ± 1%. Thus no change in Hsp70 translocation was observed 
after siRNA Galtransferase transfection.
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Figure 6.21: H sp70 localisation after siR N A  G altransferase treatm ent
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Figure 6.21: Hsp70 immunohistochemistry (x40 magnification). Hsp70 (green) and 
nuclear (red) localisation in HT-29-MTX cells after siRNA Galtransferase transfection 
and heat treatment. siRNA Galtransferase, although shown to cause a significant 
reduction in TF expression is shown not to have an effect on NLS-dependent nuclear 
protein import as assessed by nuclear import of Hsp70 in response to heat stress 
[Figure 6.2 IB].
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Figure 6.21B. Nuclear fluorescence of Hsp70 with siRNA Galtransferase
transfection
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Figure 65.21B: HT-29 cells were grown on coverslips prior to Hsp70 
immunohistochemistry. The percentage nuclear fluorescence was calculated. The 
siRNA Galtransferase transfected cells with nuclear fluorescence o f 58 ± 1% after heat 
treatment demonstrated no difference to siRNA control cells after heat treatment with 
a nuclear fluorescence of 61 ± 1 %
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6.5 DISCUSSION
The oncofetal Thomsen-Friedenreich carbohydrate antigen is expressed in 
about 90% of all human carcinomas (Hanisch et al. 1997). There is a great interest in 
the TF antigen as a possible diagnostic marker in cancer detection and also in the 
understanding of the functional consequence of its expression by cellular 
glycoproteins. The demonstration in the previous chapter that a constitutively 
expressed cytoplasmic isoform of Orpl50 expresses TF in its sialylated form and that 
this isoform of Orpl50 is involved in NLS-dependent nuclear protein import, is 
intriguing and led to the investigation into the possible functional importance of TF in 
NLS-dependent nuclear protein import. Hsp70 translocation into the nucleus upon heat 
shock was utilised to determine the effect o f the known O-glycosylation inhibitors and 
of siRNA Galtransferase on NLS-dependent nuclear protein import.
It was clearly demonstrated that bafilomycin, 5-CDP, TNFa and especially 
benzyl-GalNAc significantly increase cellular TF expression, determined by increased 
PNA binding. FACS analysis reveals that benzyl-GalNAc also increased the 
expression o f cell surface TF, whereas the other inhibitors appeared not to have an 
effect. These results are consistent with the current understanding of the actions of 
these inhibitors from the literature and previous experiments in our laboratory. 
Densitometric analysis o f MAL II binding also revealed that 5-CDP and benzyl- 
GalNAc caused a significant reduction of sialic acid content in the HT-29 MTX cells 
with benzyl-GalNAc also showing a cell surface reduction o f sialic acid with FACS 
analysis. 5-CDP and benzyl-GalNAc have both been described previously to inhibit 
sialylation. It was initially expected that the FACS analysis would confirm the lectin 
blotting effects; however after 3  experiments it was apparent that there was a 
difference between the two techniques. FACS analysis upon fixed intact cells is
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dependent upon the cell surface expression of glycans. The lack of effect upon 
glycosylation of the inhibitors by FACs analysis, with the exception o f benzyl- 
GalNAc, compared to the lectin blotting technique could represent the difference 
between the total cellular glycosylation and the cell surface expression of glycans.
The translocation o f Hsp70 into the nucleus after heat shock was unaffected by 
pre-incubation with the inhibitors. This indicates that either the sialyl-TF antigen is not 
involved in NLS-dependent nuclear protein import or that the inhibitors have no effect 
on glycosylation o f the key proteins involved in NLS-dependent nuclear protein 
transport. In order investigate and specifically target the TF antigen, siRNA 
Galtransferase was utilised.
The novel use of siRNA to silence the gene responsible for the Core pi-3 
Galtransferase is reported here. The investigation demonstrated a modest but 
statistically significant decrease in the TF antigen when analysed by PNA binding and 
this coincided with an increase in the Tn antigen. This reduction o f TF however did not 
result in any alteration in the NLS-dependent nuclear import o f Hsp70.
RNA silencing with siRNAs has increasingly been utilised for the specific 
suppression of a gene o f interest, with a successful knockdown of protein expression 
seen at over 90% for the 0-GlcNAc transferase (OGT) in 3T3 LI adipocytes 
(Robinson et al. 2007). Compared to previous utilisation o f siRNA Orpl50, which 
gave sustainable reductions of >60%, the siRNA Galtransferase gave more varied 
results. Attempts to alter variables such as cell number and length of transfection aided 
the consistency o f TF knock-down, but not the overall reduction in TF. In contrast to 
the other studied p-Galactosyltransferase families, which encompass many 
homologous genes, a complete investigation revealed the presence of only 1 Core pi-3 
Galtransferase, responsible for the addition of Gal to GalNAc, which deems it unlikely
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that any further human homologues will be identified (Ju et al. 2002). Therefore, it is 
intriguing that only a modest reduction of TF expression (a mean reduction of 21%) 
was observed with the siRNA Galtransferase transfection, as it would seem that a 
knock down of this key enzyme would cause a more significant reduction in TF with 
no other enzymes known to add galactose to GalNAc. The observed increase of Tn is 
an important positive control that confirms that reduced Gal addition to GalNAc has 
resulted in more unsubstituted GalNAc (Tn). One potential reason for a low knock­
down of TF is the high abundance of Core pi-3 Galtransferase in the cell. It could also 
reflect the efficiency of Core p i-3 Galtransferase, and that only a small proportion of 
the enzyme is required for the addition of Gal to GalNAc. A number of attempts were 
made to immunoprecipitate the Orpl50 protein and analyse the effects of the siRNA 
upon the Orpl50 protein. Unfortunately the antibody was ineffective for this 
procedure.
Overall from these experiments it has been possible to demonstrate that TNFa, 
benzyl-GalNAc, 5-CDP, bafilomycin and siRNA Galtransferase all exert effects on the 
O-glycosylation processes of HT-29 cells with relation to TF expression. These global 
alterations in cellular glycosylation did not correlate with any alterations of NLS- 
dependent nuclear protein import. Further experiments could address more closely the 
role o f the TF antigen on Orpl50 if an antibody was available that would allow 
immunoprécipitation.
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CHAPTER 7
EFFECTS OF BAFILOMYCIN AND ADHESIVE BACTERIA ON GOLGI 
ARRANGEMENT AND 0-GLYCOSYLATION
7.1 HYPOTHESIS
Bacteria may interact with the colon epithelial cells to disrupt the Golgi apparatus and 
affect glycosylation.
AIMS
• To investigate the effect of a supernatant of a Crohn’s disease mucosa-associated 
bacteria on the structure of the Golgi and TF expression in colon epithelial cells.
• Release of the pro-inflammatory cytokine, IL-8 , to be measured as a positive control to 
monitor the response of epithelial cells to bacterial interactions
7.2 INTRODUCTION
7.2.1 Aberrant glycosylation in colonic disease
In colonic disease the increased expression of the TF antigen has been 
demonstrated following its specific cleavage by O-glycanase from mucins extracted 
from colon cancer and ulcerative colitis mucosal samples (Campbell et al. 1995), and 
the Tn antigen in its native and sialylated form (Brockhausen et al. 1998, Karlen et al. 
1998) is seen in ulcerative colitis and in colonic adenomas (Itzkowitz et al. 1992). 
Another common glycosylation change seen in cancer is the more frequent occurrence 
o f highly branched heavily sialylated glycoproteins (Warren et al. 1978). These 
alterations often affect Lewis antigens (Kim et al. 1986) known to be ligands which 
interact with various lectins and antibodies. In normal colonic mucosa type 1 and 2
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chain extensions are formed, in colonic adenocarcinomas there is an increase in type 2  
chains which are the precursor for the increased activities o f a 3 -sialyltransferases seen 
in colorectal cancer, resulting in higher expression o f sialyl-Lewisx (SLex) in particular 
sialyl-dimeric lewisx antigen which is correlated to poor prognosis. Colonic mucins in 
colitis can also be less sulphated (Brockhausen 2003) and colitis mucosal samples 
show lower sulphate incorporation compared to IBD controls when cultured in vitro 
(R aoufetal. 1992).
7.2.1.1 Mechanisms of altered glycosylation
In the normal colonic epithelium a broad range o f O-glycans can be observed. 
One possible mechanism for the occurrence of truncated glycans in colonic disease is 
an alteration of the glycosyltransferase levels in the Golgi apparatus. A reduced level 
of Core 3 p3 -A-acetylglucosamine (GlcNAc) is observed, allowing the GalNAc 
peptide to be acted upon by the Core 1 and 2 enzymes and leading to a higher 
prevalence o f TF antigens. (Brockhausen et al. 2001). It has also been demonstrated 
that there is an elevated level o f the transferase responsible for addition o f sialic acid to 
this structure. Since ST6 GalNAc-II is increased, leading to increased levels of sialyl- 
TF (Schneider et al. 2001). A high mucin type M-enzyme (C2Gnt) activity alongside 
leucocyte-type L-enzyme (CIGnT) converts the TF antigen into the Core 2 structure in 
the normal colonic tissue, however, in tumorigenic cells derived from human adenoma 
cells this C2GnT activity was diminished, but in some other human colon cancer cell 
lines such as HT-29 the activity was still high (Vavasseur et al. 1994, Vavasseur et al. 
1995). Overall, however, it seems that C2GnT is up-regulated relative to CIGnT in 
most colon cancer tissues. This shift in relative activity would result in a decrease of 
Core 4 structures and an overall increase in Core 2 structures, which are the main 
bearers o f SLex. However, a detailed study of the relative expressions o f glycosyl-,
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sialyl- and sulpho-transferases in colon cancer showed that although there are 
differences, these differences related poorly to the changes in the carbohydrate 
expression (Yang et al. 1994). With no straightforward correlation of enzymatic 
alterations and the occurrence o f aberrant glycosylation this therefore, suggests that 
there are other mechanisms involved in disease-related changes in O-glycosylation.
12.1.2 Effect of pH on glycosylation and Golgi structure
The Golgi apparatus is the centre of the secretory pathway and is also 
responsible for the tight regulation o f glycosylation [Figure 7.1]. Proteins on entering 
the cis face will pass through the Golgi encountering glycosyltransferases in a specific 
order in transit to the trans face. How the glycosyltransferases are localised is not fully 
understood, and the localisation of only a few specific glycosyltransferases is known, 
for example, the enzymes that synthesis core 1 and core 2  structures are seen mainly in 
the cis-Golgi (Roth et al. 1994, Rottger et al. 1998). Significantly the 
glycosyltransferases involved have been shown not to be segregated in separate 
compartments, but rather to form overlapping gradients (Rabouille et al. 1995), and 
there must be mechanisms in place to enable this distribution. Certain regions o f 
glycosyltransferases have been shown to be critical for their localisation in the Golgi 
(Colley 1997). It has recently been demonstrated that Golgi-resident 
glycosyltransferases, which are type II integral membrane proteins have a short 
cytoplasmically exposed amino-acid tail, which plays a role in localisation and that 
coat protein complex I (COPI) vesicle mediated retrograde transport is also involved in 
their localisation (Tu et al. 2008). However, these cytoplasmic tails lack the known 
COPI binding motifs and it has been shown by Tu and colleagues that another protein 
involved with protein trafficking, Vps74p, promotes glycosyltransferase incorporation
into COPI binding vesicles, which therefore maintains a steady-state localisation (Tu et
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al. 2008). The identification of these targeting domains has uncovered further 
complexity and it is probable that there exist multiple mechanisms to ensure the correct 
localisation o f glycosyltransferase. The understanding of the retention or positioning of 
glycosyltransferases against the flow of proteins moving through the Golgi requires an 
understanding of the movement of cargo across a Golgi stack. The mechanisms of 
cargo transport through the Golgi are still being investigated, but it is clear that the 
retention o f glycosyltransferases is intimately linked to the organisation of Golgi 
membranes and control of anterograde and retrograde protein transport (Opat et al. 
2001). It has been demonstrated that an alteration in Golgi pH can disrupt the traffic o f 
proteins through the Golgi (Gustafson et al. 2000, Henkel et al. 1998, Wagner et al. 
1986), and cause aberrant glycosylation of proteins resulting in changes that included 
an increase in expression of TF and Tn (Kellokumpu et al. 2002).
The Golgi contents are normally acidic and maintenance of this reduced pH is 
via vacuolar iC-ATPases in the Golgi membrane (Glickman et al. 1983). The 
localisation of the specific glycosyltransferases, essential in the process of mucin type 
O-glycosylation, has been shown to be dependent on Golgi pH (Axelsson et al. 2001). 
In another investigation into the effect o f pH on glycosylation, the pH was measured 
and found to be significantly more alkaline in HT-29 and SW-48 colon cancer cell 
lines compared to control, and only a 0.2pH increase in pH was needed to induce an 
increase in TF antigen expression in cells (Rivinoja et al. 2006). In addition, drug- 
induced alkalinisation of the Golgi by bafilomycin A l or monensin in the goblet cell 
differentiated colonic cell line LS174T caused increased TF expression, as seen in 
colon cancer (Campbell et al. 2001). Such alterations in pH, by pH gradient dissipating 
drugs, disrupt the Golgi structure, as visualised by immuno-staining with Giantin 
(Kellokumpu et al. 2002)[Figure 7.2]. Giantin is a structural protein of about 350-400
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KDa and its localisation, conservation, and physical properties suggest that it may 
participate in forming the intercistemal cross-bridges of the Golgi complex. The 
physical disruption of the Golgi is thought to prevent proteins that are undergoing 
glycosylation in meeting specific glycosyltransferases in the appropriate sequence to 
allow normal O-glycan structures to be formed.
Figure 7.1: The Golgi apparatus
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Figure 7.1: Transit through the Golgi apparatus (adapted from 
http://fig.cox.miami.edu)
How pH dissipation results in the structural disorganisation of the Golgi
apparatus is not clear, but does suggest the possibility that by disrupting the flow
through the Golgi dismpts not only the recycling and positioning of the
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glycosyltransferases thereby affecting normal glycosylation, but also effects the 
structural organisation of the Golgi.
Figure 7.2: Disorganization of the Golgi apparatus in cultured NRK cells treated 
with pH gradient dissipating drugs
Figure 7.2: Anti-Giantin antibody staining. NRK cells were grown on coverslips and 
treated with the above dugs. The Golgi apparatus is fragmented and scattered near the 
nuclei in the drug-treated cells, but not in untreated cells (Kellokumpu et al. 2002).
7.2.2 Bacteria-epithelial interactions as a possible trigger for altered glycosylation
Previous studies from our group (Bodger et al. 2006) have shown that 
unaffected identical twins of EBD patients had increased TF expression on intracellular 
proteins in the colonic epithelium cells, despite the absence of histological 
inflammation. The fact that these changes were not seen in cells deeper in the crypts 
suggested that they are acquired rather than genetically determined. The glycosylation 
changes were found to correlate with immunohistological demonstration of NFkB
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activation in the surface epithelium. In the absence o f histological inflammation it 
seems a probable hypothesis that this NFkB activation may have resulted from 
bacteria-epithelial interaction, perhaps as a result o f a genetically determined defect in 
the mucosal barrier. This has led to the experiments detailed here in which I have 
investigated directly the effect o f bacteria-epithelial interactions on O-glycosylation in 
colon epithelial cells.
12.2 .1  Colonic epithelium
The human intestine is colonised with between 500-1000 different bacterial 
species (Egert et al. 2006). The colonic epithelium is an effective physical barrier, 
protected by mucins and trefoil peptides secreted by goblet cells. The interactions of 
bacteria with the epithelium are complex and involve interactions between the bacterial 
surface determinants and the host epithelium receptors. Pathogens share similar 
mechanisms o f interactions with the host but individual bacteria possess unique 
abilities to exploit the host processes. The epithelial glycocalyx is a layer of 
glycoconjugates expressed at the surface epithelium and these oligosaccharides can 
serve as receptors for microorganisms. The functional importance of altered intestinal 
epithelial glycosylation is still being uncovered but it could lead to the recruitment of 
bacteria to the epithelium.
The innate immune system is crucial in the defence against microbes of the 
gastrointestinal tract. It acts through a number o f receptors present on the intestinal 
epithelial cells and macrophages which recognise microorganisms through unique 
prokaryotic molecular motifs and pattern recognition receptors (PRR), receptors 
include Toll like receptors (TLR) and the intra cellular Nod proteins. Eleven different 
TLR’s have been identified in humans (Harris et al. 2006). These are able to recognise 
a range o f bacterial and viral antigens such as lipopolysaccharide (TLR4), flagellin
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(TLR5) and fatty acids (TLR2). Activation of the TLRs triggers a range of pro- 
inflammatory and anti-inflammatory responses. The location of the receptors appears 
to be important and it is known that the surface expression of TLRs, such as TLR2 and 
TLR4 in the gut epithelium is down-regulated (Akira et al. 2006). Where TLR’s are 
expressed they can be relocated to intracellular compartments such as the Golgi 
apparatus. The TLR4 receptor is internalised and able to fully recognise internalised 
LPS (Homef et al. 2003), the TLR5 receptor which recognises flagellin, is located on 
the basolateral aspect of intestinal epithelial cells (Gewirtz et al. 2006) allowing the 
recognition o f any flagellin that crosses the epithelium. These mechanisms allow the 
host to recognise invading pathogens and also allow an interaction with the commensal 
bacteria.
12.2 .2  Bacteria and inflammation
An aberrant mucosal response to intestinal bacteria is thought to be the trigger 
for the inflammatory bowel diseases (IBD) that consist chiefly o f Crohn’s disease and 
ulcerative colitis. Evidence from animal models of IBD suggests the requirement of 
commensal bacterial in order for inflammation to arise (Hoffmann et al. 2002). In IBD 
there is evidence for quantitative alterations in the mucosa-associated flora and the 
mucus-associated flora with evidence for a novel class o f E.coli that lacks conventional 
pathogenicity genes (Darfeuille-Michaud et al. 1998). Swidsinski and colleagues 
showed that the colonic mucosa of patients with colorectal carcinoma, but not normal 
colonic mucosa has an increase in mucosa-associated E.coli (Swidsinski et al. 1998). 
Work from our laboratory has shown that both the mucosa associated E.coli from CD 
and colon cancer samples can induce the release of pro-inflammatory cytokines and 
that they do not have to adhere to the epithelial membrane to cause an inflammatory 
response (Martin et al. 2004). However, many of these E.coli express
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haemagglutinins, which allow them to adhere to intestinal epithelial cell lines and 
subsequently cause IL- 8  release, mediated by extracellular-regulated kinase (ERK) 
and p38 mitogen-activated protein kinase (MAPK) and inhibited by mesalazine 
(Subramanian et al. 2008). Numerous studies have now identified the presence o f 
adherent and invasive E.coli in Crohn’s disease and ulcerative colitis (Kotlowski et al.
2007) with similar E.coli observed in boxer dogs with granulomatous colitis (Simpson 
et al. 2006). The distribution o f these bacteria in both inflamed and uninflamed mucosa 
suggests they are recruited even without initial inflammation and may be crucial in the 
pathogenesis of IBD. This study investigates the link between bacteria and aberrant 
glycosylation.
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7.3 METHODS
7.3.1 Materials
Recombinant human IL - 8  and TNFa were purchased from Peprotech EC 
(London; UK) and Sigma (Poole; UK) respectively. The mouse anti-human IL- 8  
monoclonal antibody (790A 28G2) and the mouse anti-human IL- 8  monoclonal 
detection antibody (893C 4G2) were both purchased from Biosource (Invitrogen, 
Paisly, UK). Lipopolysaccharide (LPS) from E.coli 0127:B8 and Polymixin B were 
purchased from Sigma (Poole; UK). Human leucocyte elastase was purchased from 
Elastin Products (Owensville, Missouri, USA). The anti-Giantin rabbit monoclonal 
antibody was purchased from Bioquote (York; UK).
7.3.2 Bacterial culture and bacterial supernatant
The E.coli HM427 used in these experiments was previously isolated from 
colonic biopsies from a Crohn’s disease patient (Martin et al. 2004). The common 
laboratory strain, E.coli K12, was used as a control bacteria due to its lack of virulence 
factors. Both were grown individually overnight on nutrient agar from stores kept at - 
20°C. The E.coli were harvested, washed three times with PBS and collected by gentle 
centrifugation at 70g for 1 min (lOOOrpm; MSE microcentaur, Sanyo Gallenkamp 
PLC, UK). The E.coli were then suspended in sterile water at an O.D of 0.125 at 550 
nm equivalent to approximately 7xl0 6 E. coli/vcA, and left for 24 h. A bacteria-ffee 
filtrate was achieved using a 0 . 2  pm pore diameter sterile filter and the resulting filtrate 
confirmed bacteria free by culture on Columbia agar. Fifty pi of the supernatant was 
added to 1ml of the DMEM to treat the HT-29 cells. An aliquot o f the bacterial 
supernatant was treated with human sputum leukocyte elastase (0.25 pM in 0.05
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sodium acetate, pH 5 containing NaCl, for 3 h at 37°C) to remove flagellin. LPS was 
removed by the addition of Polymixin B 10 pg/ml (3 h at 37 °C).
7.3.3 Outer membrane vesicle (OMV) purification from E.coli
OMVs were isolated by filtering the bacteria supernatants though a 0.45 pm 
filter and OMVs were collected by ultracentrifugation at 500,000 g  for 1 h at 4°C 
(100,000 rpm; Beckman TL 100 Ultracentrifuge, Minnesota, USA). OMV pellets were 
resuspended in 10 mM Tris-HCL (pH 8.0)-150 mM NaCl, as described previously by 
Wai (Wai et al. 1995).
7.3.4 Isolation of flagella from HM427
Flagella from the mucosal Crohn’s disease HM427 E. coli isolate was purified 
by the ammonium sulphate precipitation method. Bacteria grown overnight in Luria- 
Bertani broth with constant agitation at 37°C overnight were harvested in 100 ml of 
lOmM phosphate-buffered saline pH 7.4. Flagella were sheared by homogenization for 
2 min followed by centrifugation at 8,000 g for 30 min. The supernatant containing 
sheared flagella was collected and the flagella separated from outer membrane proteins 
and other contaminants by precipitation with 60% ammonium sulphate for 18 h at 4°C. 
After centrifugation at 12,000 g  for 30 min, the flagella-containing pellet was 
resuspended in PBS, and insoluble contaminants were removed by a similar 
centrifugation step. The supernatant was subjected to a second cycle of 20% 
ammonium sulphate precipitation. After dialysis against frequent changes of distilled 
water to remove excess salts, the purity of the preparations was monitored by SDS- 
PAGE and electron microscopy, as described in the methods chapter.
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7.3.5 Treatment of HT-29 MTX cells with bacterial supernatant, LPS and flagella
HT-29 MTX cells are a homogeneous, mainly MUC5AC (normal gastric 
mucin) -secreting population of well-differentiated goblet cells that has been 
obtained by stepwise adaptation o f HT-29 cells to 106or 7 0 5 M methotrexate (MTX) 
(Lesuffleur et al. 1990). HT-29 MTX cells were seeded on to 24-well plates at a 
density o f lxlO5 cells/well and cultured for 48 h at 37°C in a humidified atmosphere o f 
5% C 02, 95% air. Confluent HT-29 MTX cells were then infected, in triplicate, with 
50 pi HM427 or K12 or prepared bacterial supernatant as described earlier for 10 days. 
Recombinant human TNF-a (2 ng/ml) was used as a positive control for IL- 8  release 
compared to saline vehicle alone. In experiments examining the action of purified 
lipopolysaccharide (E.coli 0127:B8, 1 pg/ml) was incubated with HT-29 MTX cells 
for 10 days. Polymixin B (10 pg/ml) was used to block LPS responses. To examine the 
effect o f  flagella, (1 pg/ml) was incubated with HT-29 MTX cells for 10 days, and 
0.25 mM elastase used to block flagellin response.
The medium was collected to quantify IL- 8  release by ELISA. The cells were 
prepared for immunohistochemistry with Giantin antibody to assess Golgi 
fragmentation. The cells were washed 3 times with PBS and fixed for 10 min in freshly 
prepared paraformaldehyde followed by 3 times with PBS washes. The fixed cells 
were then blocked with 300 pi of 5% goat serum (Dako; Glostrup, Denmark) for 1 h at 
room temperature, followed by the addition o f anti Giantin antibody (Bioquote, York) 
1:200 concentration for 2 h. The cells were then washed 2 times with PBS and then the 
FITC conjugated secondary antibody (Dako; Glostrup, Denmark) was added, 
concentration 1:500, for 1 h in the dark. The cells were then washed 3 times with PBS 
and the cover slips mounted on glass slides with a propidium iodide nuclear counter­
stain mounting solution.
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A ninety-six well microtitre plate was coated with 100 pi carbonate- 
bicarbonate buffer (pH 9.6) containing lpg/ml mouse anti-human IL- 8  monoclonal 
antibody (790A 28G2; Biosource, Belgium). Plates were incubated overnight at 4°C. 
Following three washes with PBS (pH 7.4) containing 0.1% v/v Tween 20, antibody- 
coated plates were blocked in buffer containing 1 % w/v bovine serum albumin, for 2  h 
at room temperature. One hundred microliter aliquots of cell-free samples were 
assayed. Recombinant human IL- 8  standards o f known IL- 8  concentration, in cell- 
lysis buffer and cell-free culture medium, were assayed in triplicate [Figure 7.3]. Fifty 
microliters o f 0.4 pg/ml biotinylated mouse anti-human IL- 8  monoclonal detection 
antibody (893C 4G2, Biosource, Belgium) was added to each well and incubated for 2 
h at room temperature. After washing, 100 pi Extravidin-horseradish peroxidase 
conjugate (1:5000) (Sigma, Dorset, UK) was added to each well and the reaction was 
developed with O-phenylenediamine substrate reagent (Sigma, Dorset, UK) and was 
stopped with 4M H2 SO4 . Optical density was measured at 495 nm. The sample 
reading was read against the standard curve using FigSys software (Biosoft, 
Cambridge, UK) and data expressed as ng/ml IL- 8  released. The inter assay coefficient 
of variation for the standards was 1 2 % and the intra-assay coefficient of variation was 
16%.
7.3.6 Enzyme-Linked ImmunoSorbent Assay (ELISA) for interleukin 8 (IL-8)
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Figure 7.3: Representative IL-8 standard curve
Figure 7.3: Recombinant human IL- 8  standards o f known IL- 8  concentration, in cell- 
lysis buffer and cell-free culture medium, were assayed in triplicate, in order to create a 
standard curve to quantify HT-29 cell IL- 8  release.
7.3.7 Quantification of Golgi fragmentation
HT-29 MTX cells were seeded at lx l0 5 on coverslips and cultured for 15 days, 
followed by 10 days incubation with HM427 bacterial supernatant. 
Immunohistochemical staining for Giantin was performed on monolayers of cells 
grown on the coverslips and visualised using confocal microscopy. The experiment 
was performed in triplicate and for each replication 3 randomly selected fields of view 
were selected and a three slice Z stack of images captured by a confocal laser-scanning 
microscope equipped with 488-nm lasers (the acquired images were processed by 
LSM510 software version 3.2 SP2). The Z stack first image was taken from 1pm 
inside from the surface o f the monolayer, and each subsequent image was taken 1 pm 
apart. A ratio o f the number o f Golgi fragments per nucleus through the Z-stack was 
calculated by dividing each image through the Z-stack into quadrants, designated 
A,B,C,D [Figure 7.4]. Each quadrant was then analysed for the number of intact,
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individual green stained Golgi fragments. The number of nuclei was also counted, 
discarding any which touched the outermost borders. The number of Golgi fragments 
and nuclei was averaged for each respective quadrant through the Z stack. This was 
done to allow a representation of the Golgi fragments on different levels through each 
cell. The quadrant averages were then collated to give an overall depiction of the 
number of Golgi fragments per nucleus across a 2 pm ‘slice’ of the HT-29 MTX 
monolayer.
Figure 7.4: Z-stack
7.3.8 Analysis of Adenylate Kinase (AK) release into the medium
The Toxilight bioassay (Lonza, Basel; Switzerland) is a non-destructive 
bioluminescent cytotoxicity assay designed to measure toxicity in mammalian cell 
lines in culture.
To analyse the AK release in to the medium, first all the reagents were warmed 
to room temperature. The AK detection buffer was then reconstituted in assay buffer 
(Lonsa, Basel; Switzerland), 20 pi of the cell medium under analysis was then plated 
out in triplicate in a 96 well luminescence compatible plate to which 100 pi of the AK 
detection buffer was added. The plate was left for 5 min before reading in the 
luminometer. Total lysis of the remaining cells was achieved with a provided lysis 
buffer (Lonsa, Basel; Switzerland) to give a total AK amount in the well.
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7.4 RESULTS
7.4.1 HM427 Bacterial supernatant causes an increase o f TF expression in HT-29 
MTX cells
This experiment investigates the effect of the bacterial supernatant upon 
glycosylation in HT-29 MTX cells, by specifically investigating the expression of TF 
after 1, 5 and 10 days incubation. HT-29 MTX cells were seeded at 1 xlO5 cells per/ml 
in 24 well plates and cultured for 15 days until post confluent as in previous 
experiments. Bacterial supernatant HM427 or K12, an OMV preparation or purified 
flagellin from HM427 was then added to the culture medium as described in the 
methods. The medium and bacterial supernatant was replaced every 24 h and the cells 
removed after 1, 5, or 10 days. Cells were washed 3 times with PBS before direct lysis 
with sample buffer, protein estimations were performed on identical wells to ensure 
equal loading on to the slot blot [Figure 7.5]. TF expression was quantified by 
densitométrie analysis o f the bands after PNA lectin blotting using Quantity One 
software (Bio-Rad; Hemel Hempstead, UK) [Figure 7.6]. The experiment was 
completed 4 times and on each occasion in duplicate. After 24h the mean PNA 
binding density of control HT-29 MTX cells was 1300 ± 200 ADU (arbitrary 
densometric units), this was not altered after any o f the treatments. After 5 days the 
mean PNA binding o f control cells increased to 1600 ±300  ADU, incubation with the 
OMV preparation significantly increased the PNA binding density to 1800 ± 200 ADU 
(p<0.005)[ANOVA], none o f the other treatments increased TF expression. After 10 
days the control cell PNA binding density was 1400 ± 300 ADU, this was increased by 
incubation with the HM427 bacterial supernatant to 2300 ± 200 ADU (p<0.005), by 
the OMV preparation to 2000 ± 100 ADU (p<0.005) and by flagellin to 2000 ± 200
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ADU (p<0.005), indicating that these three treatments after 10 days have increased the 
amount of TF expression of the HT-29 MTX cells.
Figure 7.5: Representative Slot blots of PNA binding after bacterial supernatant
incubation
PNA
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Figure 7.5: HT-29 MTX cells were seeded at 1 xlO5 cells per/ml in 24 well plates and 
cultured for 15 days until post confluent. Bacterial supernatant HM427 or K12, an 
OMV preparation or purified flagellin from HM427 was then added to the culture 
medium, the medium was replaced every 24 h complete with treatments, and the cells 
removed after 1 ,5 , or 1 0  days and subjected to slot blotting.
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Figure 7.6: M ean density of PNA binding after incubation with bacterial 
supernatant HM427 or K12, OMV preparation and flagellin
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Figure 7.6: HT-29 MTX cells were seeded at 1 xlO5 cells per/ml in 24 well plates and 
cultured for 15 days until post confluent. Bacterial supernatant HM427 or K12, an 
OMV preparation or purified flagellin from HM427 was then added to the culture 
medium. After 10 days incubation HM427 bacterial supernatant, OMV and flagellin 
caused a significant increase in TF expression (p<0.005) compared to control. 
(Arbitrary densitometric units, ADU).
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7.4.2 The cellular distribution o f the Golgi apparatus is altered by Bafilomycin
The Golgi apparatus under normal cellular conditions is crescent shaped and 
perinuclear when viewed after immunohistochemical staining for the cis-Golgi 
structural protein, Giantin. Bafilomycin is an ATPase pump inhibitor causing 
alkalisation of the Golgi apparatus and also alterations in glycosylation. This 
investigation observes the Golgi structure after HT-29 MTX cells have been incubated 
with bafilomycin. HT-29 MTX cells were grown to 60% confluence on cover slips and 
then bafilomycin was added to the culture medium for 2 days at 1 OOmM concentration. 
The cells were probed with anti-Giantin antibody, which in the control cells is displays 
a perinuclear crescent like shape. After the incubation with bafilomycin the Golgi 
appears more rounded and condensed [Figure 7.7]. The experiment was repeated on 2 
separate occasions.
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Figure 7.7: Representative immunohistochemistry. Golgi disorganisation shown
by Giantin staining, after 2 day treatment with lOOnm bafilomycin.
2 day Control 2 day treated with lOOnM Bafilomycin
Figure 7.7. Anti-Giantin immunohistochemistry. HT-29 MTX cells were grown to 
60% confluence prior to 48 h incubation with 100 nM bafilomycin. Immuno-stained 
with anti Giantin antibody, cells treated with bafilomycin have altered Golgi structure 
compared to control.
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7.4.3 HT-29 MTX cells show increased MUC5AC expression from after 10 days o f 
seeding
HT-29 MTX is a well differentiated cell line that forms a polarised goblet cell 
monolayer when post confluent; this makes it suitable for experiments involving the 
interaction with bacteria. It has been previously shown that the increased expression of 
MUC5AC accompanies the differentiation into goblet cells. HT-29 MTX cells were 
seeded at l x l0 5 cells/ml and each day the MUC5AC secreted in the medium was 
calculated by immunoslotblotting and densitométrie analysis o f the bands [Figure 7.8 
and 7.9]. The expression o f MUC5AC secreted was seen initially to be extremely low 
with a mean binding less than <0 .0 0 1 , until day 1 0  where expression increased sharply 
to a mean density o f 0.15 (p<0.005) [ANOVA] (n=3). From this experiment HT-29 
MTX cells were then grown for 14 days prior to incubation with bacteria in all 
subsequent work.
Figure 7.8: Representative 0-15 day time course of MUC5AC expression
Figure 7.8: Anti-MUC5AC immunoblot. HT-29 MTX cells cultured for 8  days show 
expression of MUC5AC secreted into the medium, the expression increases until 11 
days before plateau. The secretion o f MUC5AC is a marker of differentiation into 
goblet cells.
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Figure 7.9: Time course of MUC5AC expression
Figure 7.9: MUC5AC excretion in to medium is increased significantly from day 10 
onwards. An increase occurs till day 12 when a plateau is observed. It has been 
previously shown that MUC5AC expression can be correlated with HT-29 MTX cell 
differentiation (Gouyer et al. 2001). The MUC5AC expression was measured in the 
medium and the amount was correlated to protein concentration of the lysed cells. 
MUC5AC protein was measured at a mean density o f 0.09 ADU at day 9 (n=3) a 
significant increase at day 10 of a mean density o f 0.15 ADU (n=3) (p<0.005), this 
significant increase was observed from day 10 onwards, indicating that the HT-29 
MTX cells were differentiated.
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7.4.4 Cellular distribution o f the Golgi in sub confluent HT-29MTX cells is altered by 
5 days incubation with mucosa-associated E.coli HM427 bacterial supernatant
Initial experiments focused on 24 h incubation with the bacterial supernatant on 
a confluent monolayer o f HT-29 MTX cells. This experiment showed no visible 
alteration in the Golgi structure from the control perinuclear crescent shape. HT-29 
MTX cells seeded at lx l0 5cells/ml and cultured for 48 h were then incubated with 
HM427 bacterial supernatant for 5 days, before immunohistochemical staining with 
Giantin [Figure 7.10]; this led to the Golgi having a more fragmented appearance with 
no visual effects on cell health.
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Figure 7.10: HT-29 MTX after 5 days incubation with bacterial supernatant
Day 5
incubation
with
HM427
supernatant
Figure 7.10: Anti-Giantin immunohistochemistry. HT-29 MTX cells were seeded at 
1x10s and cultured for 5 days on coverslips with HM427 bacterial supernatant. The 
green immunofluoresent stain shows Giantin. The control cells have a perinuclear 
crescent shape, compared to after the HM427 supernatant incubation where no 
perinuclear crescent shaped nuclei could be observed leading to a fragmented 
appearance of the Golgi.
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The HT-29 MTX cells become differentiated from day 10 onwards with the 
secretion o f MUC5AC into the cytoplasm. It was not possible to visualise successfully 
the Golgi apparatus o f the cells in a confluent monolayer using conventional immuno- 
microscopy and so confocal microscopy was utilised. The Golgi apparatus has been 
shown to fragment in response to incubation with the HM427 bacterial supernatant in 
the previous experiments. In order to quantify this observed effect, the HT-29 MTX 
cells were again seeded at lx l0 5 on coverslips and cultured for 15 days, followed by 10 
days incubation with HM427 bacterial supernatant. Immunohistochemical staining 
with Giantin was performed on monolayers o f cells grown on the coverslips and 
visualised using confocal microscopy. The effect o f E.coli K12 supernatant was also 
investigated and the effects of the flagellin from HM427 and lipopolysaccharide (LPS) 
were also examined. Bafilomycin was used as a further control, as it has previously 
been shown to cause fragmentation of the Golgi (Kellokumpu et al. 2002) [Figure 7.7].
The experiment was performed in triplicate with each replication having 3 
randomly selected fields o f view were selected and a 3 slice Z stack of images 
captured [Figures 7.12-7.16], each beginning 1pm inside from the surface o f the 
monolayer and with 1 pm space between each image. Each image was then subjected 
to an analysis o f the number of Golgi fragments, as a ratio to the number of nuclei, 
which were counterstained with propidium iodide. The data from each Z stack were 
then collated and an average number of fragments per nucleus was then calculated.
The control HT-29 MTX monolayers have an average (±SD) 2.1 ±0.0 Golgi 
fragments per nucleus after 10 days. A 10 day incubation of the confluent monolayers
7.4.5 C e llu la r  d is tr ib u tio n  o f  the G o lg i in p o s t  confluent, d iffe re n tia te d  H T -2 9 M T X
c e lls  is  a l te r e d  b y  1 0  d a ys  in cu ba tion  w ith  m u c o sa -a s so c ia te d  E .c o li H M 4 2 7  b a c te r ia l
su p ern a ta n t
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with HM42 causes an increase in the average Golgi fragments per nuclei to 4.5 ± 0.6, 
(p<0.01) [ANOVA], [Figure 7.17]. E.coli K12 bacterial supernatant caused a 
significant increase to 4.6 ± 0.8 (p<0.01) Golgi fragments per nucleus. The OMV 
preparation caused a significant increase in the average Golgi fragments per nucleus to
5.3 ± 1.3 (p<0.01), with the OMV free preparation having no significant effect. LPS 
and Flagellin caused no significant effect, bafilomycin after 2 day incubation caused a 
significant increase to 5.0 ± 1.0 (p<0.01) fragments of Golgi per nucleus.
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Figure 7.12: Representative Giantin immunohistochemical images of HT-29 MTX
cells after HM427 supernatant incubation.
Figure 7.12: Anti Giantin immunohistochemical staining (green). HT-29 MTX 
cells were seeded at lxlO5 on coverslips and cultured for 15 days. The post confluent 
monolayers of cells were then incubated with HM427 bacterial supernatant which 
caused a fragmentation of the Golgi. Increasing the number of fragments per nucleus 
from an average of (±SD) 2.7 ± 0.6 to 4.5 ± 0.60.
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Figure 7.13: Representative Giantin immunohistochemical images of HT-29 MTX
cells after K12 supernatant incubation.
Figure 7.13: Anti G iantin immunohistochemical staining (green). HT-29 MTX 
cells were seeded at lxlO5 on coverslips and cultured for 15 days. The post confluent 
monolayers of cells were then incubated with K12 bacterial supernatant. K12 has a 
similar effect to HM427 in causing fragmentation of the Golgi, increasing the number 
of fragments per nucleus from an average of (±SD) 2.7 ± 0.5 to 4.6 ± 0.8 (p<0.01).
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Figure 7.14: Representative Giantin immunohistochemical images of HT-29 MTX
cells after incubation with outer membrane vesicle preparation.
Figure 7.14: Anti Giantin immunohistochemical staining (green). HT-29 MTX 
cells were seeded at lxlO5 on coverslips and cultured for 15 days. The post confluent 
monolayers of cells were then incubated with OMV’s, or a preparation with the 
OMV’s removed. The OMV preparation caused fragmentation of the Golgi increasing 
the number of fragments per nucleus from 2.7 ± 0.5 to 4.3 ±1 .3  (p<0.01), the OMV 
free preparation had no effect.
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Figure 7.15: Representative Giantin immunohistochemical images of HT-29 MTX
cells after incubation with flagellin.
Figure 7.15: Anti G iantin immunohistochemical staining (green). HT-29 MTX 
cells were seeded at lx l0 5 on coverslips and cultured for 15 days. The post confluent 
monolayers of cells were then incubated with flagellin which did not cause increased 
fragmentation of the Golgi.
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Figure 7.16: Representative Giantin immunohistochemical images of HT-29 MTX
cells after incubation with LPS
Figure 7.16: Anti G iantin immunohistochemical staining (green). HT-29 MTX 
cells were seeded at lxlO5 on coverslips and cultured for 15 days. The post confluent 
monolayers of cells were then incubated with LPS which did not cause increased 
fragmentation of the Golgi.
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Figure 7.17: Representative Giantin immunohistochemical images of HT-29 MTX
cells after bafîlomycin treatment
Figure 7.17: Anti Giantin immunohistochemical staining. HT-29 MTX cells were 
seeded at lx  105 on coverslips and cultured for 15 days. The post confluent monolayers 
of cells were then incubated bafilomycin which caused increased fragmentation of the 
Golgi from an average 2.7 ± 0.5 fragments to 5.0 ±1.0  (p<0.01)
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Figure 7.18: Mean number of Golgi fragments per nuclei after incubation with 
bacterial supernatants
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Figure 7.18: HT-29 MTX cells were seeded at 1x10s on coverslips and cultured for 
15 days. The post confluent monolayers of cells were then incubated with treatments 
for a further 10 days. The Golgi was visualised with an anti Giantin antibody using 
confocal microscopy, and the number of Golgi fragments calculated per nucleus as 
described in methods. HM427 and K12 both caused a significant increase in Golgi 
fragments (*) (p<0.05). OMV preparation and Bafilomycin control also caused a 
significant increase in the number of Golgi fragments per nucleus (p<0.01).
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This study assesses the effect of the HM427 bacterial supernatant and other 
treatments on the health o f the HT-29 MTX cells. Adenylate kinase (AK) is a protein 
that is released into the cell culture medium upon cell death. The enzyme 
phosphorylates ADP to ATP which can be quantitatively measured utilizing a 
bioluminescent assay. As the level of cytolysis increases the amount of AK released in 
to the culture medium also increases resulting in a higher emission of light from the 
assay (Lonza, Basel; Switzerland). The release of AK into the culture medium allows 
the kinetic monitoring of AK levels over time. A total lysis control was also employed 
to reveal the total AK in the HT-29 MTX cells.
The HT-29 MTX cells were seeded at lx l0 5 cells/ml and cultured for a further 
15 days. The post confluent monolayers were then incubated with the HM427 bacterial 
supernatant. Further treatments included a bacterial supernatant o f E.coli K12, LPS 
purified from E. coli 0127:B8, flagellin and an outer membrane vesicle preparation 
from HM427 and the O-glycosylation inhibitors bafilomycin, TNF a, benzyl-GalNAc 
and 5-CDP. The treatments were added to the DMEM at the concentrations outlined in 
the methods, which was replaced each 24 h complete with respective treatments and 
the medium collected for the AK bioluminescent assay on day 1, day 5 and day 10. 
The inhibitors were observed at day 1. The experiment was repeated 3 times and on 
each occasion in triplicate. After 1 day incubation the control cells gave an average 
(±SD) 30800 ± 350 toxilight RLU [Figure 7.18], cells that were incubated with 
HM427 bacterial supernatant had an average 34100 ± 200 RLU which was statistically 
significant (p<0.005) [ANOVA]. The K12 bacterial supernatant also caused a 
significant increase in AK release with an average reading o f 34200 ± 200 RLU. The 
OMV preparation gave an average reading of 35800 ± 200 RLU (p<0.005) and the
7 .4 .6  H M 4 2 7  b a c te r ia l su p e rn a ta n t ca u ses  A K  re le a se  in to  m ed iu m
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OMV free preparation reading was not significant. Flagellin caused a significant 
r id in g  o f 35600 ± 200 RLU, the reading for LPS was not significant. Bafilomycin 
gave a larger reading of 54300 ± 3000 RLU (p<0.001) as did TNF alpha 42900 ± 3000 
RLU, 5-CDP 41400 ± 3000 RLU and benzyl GalNAc 36200 ± 4400 RLU. The Total 
AK was greater than 100000 RLU.
After 5 days the control cells had an average reading o f 32000 ± 1300 RLU, 
cells after incubation with HM427 bacterial supernatant gave an average reading of 
39600 ± 500 RLU (p<0.005) [ANOVA]. HM427 and elastase gave a significant 
reading o f 37200 ± 1100 RLU (p<0.005. The K12 bacterial supernatant caused no 
significant increase in the toxilight readings after 5 days incubation. The OMV 
preparation had an average reading of 42100 ± 1300 RLU (p<0.005) and the OMV 
free preparation gave no significant response. Flagellin gave a reading of 37100 ± 600 
RLU (p<0.005) and LPS caused no significant response from control. After 10 Days 
the control cells gave an average reading of 27600 ± 500 RLU, this was increased by 
the incubation with HM427 bacterial supernatant to 34700 ± 1200 RLU (p<0.005). 
K12 bacterial supernatant gave an average reading o f 32700 ± 800 RLU’s (p<0.005). 
The OMV preparation gave a reading of 39300 ± 900 RLU (p<0.005) with the OMV 
free preparation not giving a significant response. Flagellin gave a reading of 39400 
± 1700 RLU (p<0.005) and combined incubation with elastase reduced this response 
to a non significant level o f 29700 ± 1600 RLU. LPS did not give a significant 
response [Figure 7.18].
The data demonstrates that all treatments apart from OMV free and LPS 
cause modest toxicity to the cells with bafilomycin causing the most AK release.
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Figure 7.19: AK released in to medium in 24 h after 1 day bacterial supernatant
incubation
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Figure 7.19: HT-29 MTX cells were seeded at lx l0 5 cells/ml and cultured for 15 days 
until post confluent. The following treatments were then added to the culture medium: 
HM427 bacterial supernatant, bacterial supernatant o f E.coli K12, LPS purified from 
E. coli 0127:B8, flagellin from HM427, an OMV or OMV free preparation and the O- 
glycosylation inhibitors bafilomycin, TNF a, benzyl-GalNAc and 5-CDP. The medium 
was collected after 1 day and the AK content quantified by a bioluminescent assay 
(Lonza, Basel; Switzerland). Total AK release from the cells was achieved with 
toxilight lysis reagent (Lonza, Basel; Switzerland) (*=p<0.01, ***=p<0.001)
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Previous experiments have shown that bacteria and bacterial supernatant can 
elicit IL-8 secretion from HT-29 cells (Subramanian et al. 2008), this IL-8 secretion 
occurs via a MAPK-dependent pathway. IL-8 response was therefore measured here as 
a positive control to indicate the physiological response to the bacterial supernatant.
This experiment observes amount o f IL-8 secreted into the culture medium via 
an ELISA assay, stimulated by HM427 supernatant and K12 supernatant. Two of the 
active components o f the bacterial supernatants are flagellin and LPS, the effects o f 
both are also observed in this experiment. HT-29-MTX cells were seeded at lx l0 5 
cells/ml in 24 well plates and grown for 15 days until post confluent. The HT-29 MTX 
monolayers were then incubated with the HM427 bacterial supernatant, a bacterial 
supernatant o f E.coli K12, LPS purified from E. coli 0127:B8, flagellin from HM427 
and an OMV or OMV free preparation. The culture medium was replaced every 24h 
and collected on day 10 for analysis by ELISA for the amount o f IL-8 secreted into the 
medium. A positive control of TNFa was utilised as a known stimulator of IL-8 
secretion. The experiment was completed 3 times and on each occasion in triplicate.
After 10 days incubation the control cells released an average o f 10 ± 2 ng/ml 
o f IL-8 into the medium, this was increased by HM427 to 27 ± 5 ng/ml (p<0.005). K12 
stimulated an IL-8 concentration in the medium of 16 ± 2 ng/ml (p<0.01). Flagellin 
caused an increase o f IL-8 concentration to 23 ± 3 ng/ml (p<0.005). LPS caused an IL- 
8 concentration of 20 ± 3 ng/ml (p<0.01). TNF a stimulated an IL-8 concentration of 
46 ± 6 ng/ml (p<0.001) [Figure 7.20].
7.4 .7  H M 4 2 7  b a c te r ia l su p ern a ta n t s tim u la te s  IL -8  re le a se  f r o m  H T -2 9  M T X  ce lls
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Figure 7.20: IL-8 release into medium after 10 day incubation with bacterial
supernatant and fractions
Control HM427 K12 OM V OMVFree Flagellin LPS TN Fa
Figure 7.20: HT-29 MTX cells were seeded at lx l0 5 cells/ml and cultured for 15 days 
until post confluent. The following treatments were then added to the culture medium: 
HM427 bacterial supernatant, a bacterial supernatant of E.coli K12, LPS purified from 
E. coli 0127:B8, flagellin from HM427, an OMV or OMV free preparation and TNFa. 
The medium was replaced complete with treatments every after 24 h and the medium 
collected 10 days had the concentration of IL-8 secreted into the medium measured by 
an ELISA.
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7.5 DISCUSSION
Altered glycosylation has long been associated with disease states, and the 
expression o f TF, which is normally concealed by further modifications, has been 
demonstrated in about 90% of all human cancers (Hanisch et al. 1997). The increase 
o f TF expression and Golgi fragmentation shown in these experiments in response to 
bacteria and bacterial components are in keeping with the hypothesis that intestinal 
mucosal glycosylation changes in inflammatory and malignant intestinal disease 
could occur, at least in part, as a result of increased interaction between bacteria and 
the epithelium. The colonic epithelium of inflammatory bowel disease patients, often 
has an increased number of immunocytes (s.g., T lymphocytes, mast cells) as well as 
evidence o f increased release o f cytokines (Collins 2005), histamine, proteases, and 
prostaglandins (Barbara et al. 2004). These mediators could be responsible for 
intestinal dysfunction, as a consequence of a breakdown o f the mucosal barrier, caused 
by a defect in the mucus, the glycocalyx, the tight junctions or a combination o f all 
three. An increased permeability potentially exposes the mucosa to an increased 
challenge o f luminal bacteria and dietary antigens that could promote and maintain 
mucosal immune activation. This seems likely to be part of the explanation for 
glycosylation changes seen in the non-inflamed surface epithelium in unaffected 
identical twins o f IBD patients (Bodger et al. 2006).
From the present study it is not known by what mechanism the bacterial 
supernatant is mediating the effects seen and further experiments are required. The 
effect o f the bacterial supernatant could reflect an interaction between released factors 
such as flagellin, cell wall peptidoglycans and lipopolysaccharide and their relevant 
toll-like receptors on the colonic epithelium. One or more o f these factors may be 
responsible for the fragmentation of the Golgi apparatus and, therefore, a subsequent
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disorganisation in mucin type O-glycosylation leading to the increased expression of 
TF. Such changes in O-glycosylation would also further damage the protective mucus 
and glycocalyx propagating the detrimental effects.
Bacteria adhere to the colonic mucosa through fimbrial or surface proteins 
known as adhesins (Soto et al. 1999), which act as lectins able to recognise the 
glycosyl motifs expressed on the cell surface glycoproteins. The aberrant glycosylation 
changes seen in ulcerative colitis and Crohn’s disease, such as increased TF 
expression, have been demonstrated to be functionally important, allowing interaction 
with dietary lectins such as the peanut lectin (Ryder et al. 1998) and it, therefore, 
seems possible that microbial lectins may interact in a similar manner. There is 
increasing evidence that mucosa-associated bacteria may well be important in the 
pathogenesis o f inflammatory bowel diseases, with increased numbers of E.coli 
reported to be adjacent to the ileal (Darfeuille-Michaud et al. 1998) and colonic 
mucosa (Martin et al. 2004, Swidsinski et al. 2002). These mucosa-associated bacteria 
lack conventional pathogenic genes, but are able to adhere and invade epithelial cell 
lines in vitro. E.coli account for a disproportionally high amount of the mucosa- 
associated bacteria found in inflammatory bowel diseases and colorectal cancers 
(Martin et al. 2004). However the effects seen in these experiments are unlikely to be 
specific to E.coli. Streptococcus bovis is another bacterium that has been associated 
with colon cancer (Tjalsma et al. 2006) and has also been shown to elicit a cytokine 
response in vitro in Caco-2 cells (Biarc et al. 2004).
Further evidence for the involvement of bacteria comes from the study of 
monozygotic twins, with the unaffected twin in the study possessing the same 
glycosylation alterations as the genetically identical twin, who was affected by 
in f la m m a to r y  bowel disease (Bodger et al. 2006). This altered glycosylation was
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predominantly observed in the surface epithelium, whereas genetic changes would be 
expected to originate from the stem cell compartments, affecting the whole crypts. 
Inspection o f the mucosal biopsies revealed no histological inflammation but 
activation o f NFkB at the surface epithelium. This suggests a possible interaction 
between the bacteria and epithelium for inducing these glycosylation changes rather 
than inflammation.
The overall picture from the present series o f experiments reveals that the 
HM427 E.coli along with flagellin and outer membrane vesicles purified from 
HM427 E.coli can cause fragmentation o f the Golgi and significantly increase the 
expression of TF on the HT-29 MTX cells. E.coli K12 supernatant also caused a 
significant increase in Golgi fragmentation, but not a significant increase in TF 
expression. The bacterial supernatants, flagellin and outermembrane vesicles all 
caused some amount of damage to the cells, as shown by adenylate kinase release 
into the medium and all stimulated cytokine interleukin-8 release.
The quantification o f the Golgi fragmentation was complicated as the natural 
structure o f the HT-29 MTX Golgi is slightly fragmented, therefore, any subsequent 
fragmentation is harder to quantify. In addition, the confocal images obtained give a
1-D perspective, which does not allow for the natural variations of shape o f the Golgi 
which could cause the Golgi to appear to be more or less fragmented than in reality. 
To overcome this, 3 images were acquired over 3 pm with a 1pm space between, the 
number of Golgi fragments were then averaged over these 3 images, however, there 
is still the possibility o f error in this calculation. Further to this, the mean number of 
fragments were divided by the number of cells in the image, this was because the 
fragments counted could not be assigned to a particular cell in the image; this could 
be a further source o f error.
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Further experiments must be undertaken to support the results the 
demonstrate the fragmentation o f the Golgi apparatus due to incubation with 
bacterial supernatant possibly by utilising other cell lines with more naturally 
complete Golgi. These experiments would be combined with an investigation into 
the effects o f bacterial supernatant on the Golgi pH in intestinal epithelial cells. It is 
looking increasing likely that bacteria that interact with the colonic epithelium play a 
major role in the pathogenesis of colorectal cancer and inflammatory bowel disease 
and altered glycosylation may be one o f the pathogenic mechanisms involved.
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CHAPTER 8
SUMMARY OF THE MAIN FINDINGS IN THIS THESIS
•  There exist two isoforms of Orpl50. A Constitutive form localised in the 
cytoplasm and a heat stress inducible form is localised in the ER. A possible 
further third isoform is observed after 2-D electrophoresis.
•  Constitutive Orpl50 is bound by ABL/Jacalin indicating the likely presence of 
sialyl-TF.
• Analysis of Jacalin-lectin purified Orpl50 by mass spectrometry did not reveal 
the presence of sialyl-TF but indicated the presence o f 4 high mannose N- 
glycopeptides the most abundant of which were Man5_8GlcNAc2 . One further 
glycopeptide was observed at m/z 7473+ indicating the presence of a single 
HexNAc.
•  Depletion of Orpl50 from FIT-29 cells with siRNA causes reduced NLS- 
dependent nuclear protein import.
•  The intra-cellular localisation o f Ran is unaffected by reduced Orpl 50 protein 
expression induced by siRNA.
• ABL lectin affinity purification of a pure cytoplasmic fraction from colon 
epithelial cells yields several proteins implying the existence of several sialyl- 
TF expressing cytoplasmic proteins.
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• ABL and Jacalin lectin both recognise cytoplasmic Hsp90.
• All of the O-glycosylation inhibitors tested increased TF expression, with 
benzyl-GalNAc having the greatest effect on increasing TF.
• Cell surface and whole cell sialylation was decreased by benzyl-GalNAc and 
5-CDP.
• Inhibitors of O-glycosylation including benzyl-GalNAc and 5-CDP have no 
effect on Hsp70 translocation into the nucleus upon heat treatment.
• SiRNA Galtransferase caused a modest decrease o f TF and more marked 
increase in Tn expression, but this had no effect on Hsp70 nuclear 
translocation in response to heat stress. Therefore, NLS-dependent nuclear 
protein import is probably not dependent on TF or sialyl-TF expression by 
Orpl50 or other cytoplasmic proteins.
• Bafilomycin causes dispersion of the Golgi apparatus.
• 5 to 10 day incubation of confluent monolayers o f HT-29 MTX cells with 
HM427 E.coli supernatant causes Golgi apparatus fragmentation.
• Incubation with an outer membrane vesicle preparation and flagellin from 
HM427 E.coli also causes Golgi apparatus fragmentation.
• Bacterial supernatant HM427, outer membrane vesicles and flagellin cause an 
increase o f TF expression on HT-29 MTX cells.
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CHAPTER 9
GENERAL DISCUSSION AND IMPLICATIONS FOR FUTURE STUDIES
The expression o f sialyl-TF on a constitutive cytoplasmic isoform of oxygen 
regulated protein 150 (Orpl50) is intriguing. Previous work by Yu et al. has 
demonstrated that the ability o f ABL lectin to reversibly inhibit cellular proliferation is 
the result of ABL internalisation. The internal ligand for the lectin was shown to be 
Orpl50 (Yu et al. 2002), thus implying the existence of sialyl-TF on Orpl50. The 
work presented here further demonstrates that it is the cytoplasmic isoform of Orpl50 
that has a role in NLS-dependent nuclear protein transport by observing the 
translocation of Hsp70 into the nucleus upon heat shock. HT-29 colon cancer cells 
treated with siRNA to reduce Orpl50 had a subsequently reduced Hsp70 translocation 
into the nucleus upon heat shock. This discovery adds evidence to support Orpl50 as 
an essential protein in the NLS-dependent nuclear protein import mechanism [Figure 
9.1]. Further evidence for the role of Orpl50 in NLS-dependent nuclear protein import 
was uncovered when Orpl50 was co-immunoprecipitated alongside Ran (Yu et al. 
2002), which is a protein known to be essential in the NLS-dependent nuclear import 
o f proteins. However, the intra-cellular localisation o f Ran appears unaffected by a 
reduction o f Orpl50 by siRNA and this suggests that Orpl50 is not involved in the 
translocation o f Ran into and out of the nucleus.
The discovery o f a constitutive isoform of Orpl50 which expresses sialyl-TF is 
one o f only 2 reports so far of a cytoplasmic protein expressing sialyl-TF, the other 
being alpha-synuclein (Shimura et al. 2001). The demonstration that Orpl50 expresses 
sialyl-TF by lectin analysis, but not by mass spectrometry means further work must be 
continued to confirm this glycosylation. It is possible that O-glycans including sialyl-
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TF might have been degraded during the preparation of Orpl50 for mass spectrometric 
analysis. Another factor which might have affected mass spectrometry analysis is the 
low abundance of Orpl50 isolated for analysis. Unfortunately immunoprécipitation of 
Orpl50, which might have produced better yields was unsuccessful. Lectin affinity 
purification using TF recognising lectins did not yield enough protein to stain with 
coomassie and this hampered analysis. Evidence that Hsp90 also expresses sialyl-TF is 
presented in this thesis and the functional significance of this glycosylation also merits 
further exploration.
Figure 9.1: Hypothetical role of cytoplasmic constitutively expressed O rp l5 0  in 
inhibiting NLS-dependent nuclear protein im port.
ABL reversibly inhibited NLS-dependent nuclear protein import. The internal ligand 
was found to be a cytoplasmically localised isoform of Orpl50 which was shown to be 
associated with Ran. The diagram indicates how Orpl50 might inhibit NLS-dependent 
nuclear protein import by preventing the cycling of Ran GDP from the cytoplasm to 
the nucleus.
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The functional importance of the sialyl-TF present on the cytoplasmic Orpl50 
protein remains unclear. Experiments utilising known O-glycosylation inhibitors 
demonstrated no significant change in NLS-dependent nuclear protein import. A 
limitation o f the approach is that this will affect all cellular O-glycosylation and may 
therefore have other unforeseen effects. Direct demonstration of the effect o f the 
inhibitors on the glycosylation o f Orpl50 was not achieved, as immunoprécipitation of 
the protein was not successful. A further experiment to address the role of sialyl-TF 
was made by using siRNA directed to the Galtransferase responsible for the addition o f 
Gal to GalNAc. This is the first time this technology has been used to reduce the 
expression of this enzyme. The siRNA Galtransferase reduced the TF expression only 
modestly considering that only one transferase is responsible for the addition of Gal to 
GalNAc (Ju et al. 2002). With TF expression reduced Tn expression was observed to 
increase strongly. This observation confirms the down-regulation o f the Galtransferase 
however it is not clear why the expression of the TF antigen was not more strongly 
diminished. Again, nuclear protein import was not affected.
There is a delicate relationship between the human intestine and the 
commensal bacteria and it has been shown that the normal bacterial flora is a 
prerequisite for the development of inflammation and inflammation-related colorectal 
tumours in animal models. Evidence that led to H.pylori becoming classified as a 
group 1 carcinogen in 1994 by the World Health Organization has triggered an interest 
into the association between epithelia-associated bacteria and colorectal cancer. The 
colonic mucosa o f patients with colorectal carcinoma has an increase in mucosa- 
associated E.coli, and these E.coli were also present in non cancerous mucosa distant 
to the tumour (Martin et al. 2004, Swidsinski et al. 1998). In this thesis interaction 
between E.coli HM427 and colon epithelial cells has been shown to cause a significant
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increase in the fragmentation o f the Golgi. Similar fragmentation of the Golgi 
apparatus has previously been shown to be associated with aberrant glycosylation in 
colon cancer (Kellokumpu et al. 2002) and in this study an increase of TF expression 
was also observed. Truncated glycans such as the TF antigen could act as ligands to 
recruit further bacterial and dietary lectins which in turn have been shown to be able to 
exert a range of effects on cells such as the PNA lectin which increases cellular 
proliferation (Ryder et al. 1998). Unchecked mucosal proliferation and decreased 
mucosal apoptosis could increase the likelihood of the onset of cancer.
The incidence o f colorectal cancer is about 28,000 cases per annum in the 
United Kingdom and it is the second most common cause of cancer-related deaths in 
the world (Evans et al. 2002). A diet high in vegetable consumption has long been 
associated with a protective role against colonic disease and cancer and high cereal 
fiber intake was also thought to be protective but lacks convincing evidence (Fuchs et 
al. 1999). There is a strong protective, effect from the consumption of brassicas, 
thought to stem from the isothiocyanates contain within them. Now it has been 
hypothesised that high galactose fiber contained in some vegetables may confer a 
protective effect (Evans et al. 2002). The glycosylation alterations observed in colon 
cancer and pre-cancer states, such as the increased expression the TF antigen, allows 
the epithelium to bind intraluminal galactose-binding lectins that would otherwise pass 
through the intestine. This has been successfully demonstrated with the peanut lectin 
which can cause colonic epithelial proliferation (Ryder et al. 1998). It is conceivable 
that bacteria or bacterial lectins could be acting in the same manner. An understanding 
of bacterial-epithelial interactions could lead to the design of inhibitors that act as a 
blockade to the lectin-carbohydrate interactions and this could have significant 
implication in treatment and prevention of colorectal cancer and inflammatory bowel
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diseases. It could be an important mechanism for the protective effects o f dietary fibre. 
The discovery that bacteria could be directly responsible for the disruption of the Golgi 
adds further to the understanding of the complex relationship between bacteria and the 
host in a disease state.
IMPLICATIONS FOR FUTURE STUDIES
This thesis has raised many interesting questions which require further 
investigation. The discovery of sialyl-TF on Orpl50 should be further confirmed by 
mass spectrometry analysis. In addition, further work to observe the effects of O- 
glycosylation inhibitors in purified Orpl50 may give insight not only into whether the 
expression o f sialyl-TF was o f functional importance, but also the mechanism by 
which it becomes expressed. If the glycosylation of Orpl50 was not altered by either 
the inhibitors or the siRNA Galtransferase, this would hint at the possible presence of 
an additional Galtransferase, possibly with a cytoplasmic localisation. The analysis of 
O-glycosylated Hsp90 could be furthered by immunoprécipitation of the protein and 
further analysis by mass spectrometry to confirm the presence o f sialyl-TF.
The possibility that disease-associated changes in intestinal glycosylation may 
be the result o f bacterial epithelial interactions leading to Golgi fragmentation is 
in t r ig u in g . Further work is needed to elucidate the exact component o f the bacterial 
supernatant responsible and to observe the effects of a range o f bacteria on Golgi 
fragmentation. The fragmentation o f the Golgi apparatus could also be examined in a 
cell line with a more naturally intact Golgi. Histological sections o f inflammatory 
bowel disease affected tissue could be stained for Giantin and the structure of the Golgi 
and TF expression observed. The mechanism by which the bacterial supernatant causes
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the effects also needs to be understood. The secreted factors in the bacterial 
supernatant such as flagellin and LPS are able to activate receptors. It has been shown 
that Toll like receptor 4 is expressed in the Golgi apparatus and LPS can activate 
NFkB when internalised (Homef et al. 2003). It is possible that one o f these factors is 
responsible for the disruption of the Golgi and future experiments may be able to 
elucidate why the Golgi apparatus becomes fragmented. There remains a great deal of 
interesting work to be done to elucidate the causes and consequences of altered O- 
glycosylation in disease states.
The principle conclusions from this study are:
1) Provision o f further evidence that the cytoplasmic constitutive isoform of 
Orpl50 is glycosylated with sialyl-TF and that the Orpl50 protein is involved 
in NLS-dependent nuclear protein import.
2) Identification of another cytoplasmic protein (Hsp90) that expresses sialyl-TF.
3) Identification of Golgi disruption as a possible mechanism by which bacteria 
could cause aberrant glycosylation in colonic epithelial cells.
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APPENDIX 1
Components of cell culture medium and buffers
Dulbecco’s Modified Eagle Medium (DMEM) (IPX)
Inorganic salts: mg/ml
CaCL2.2H20 2640.0
Fe (NO)3. 9H20 1.0
KC1 4000.0
M gS04.7H20 2000.0
NaCl 6000.0
Na2H2P 0 4.H20 1400.0
Other components
D-glucose 4500.0
Hepes 170.0
Amino acids:
L-Alanine 356.0
L-Asparagine 600.0
L-Arginine.HCL 840.0
L-Aspartic acid 530.0
L-Glutamic acid 590.0
Glycine 300.0
L-Histidine HCL.H20 420.0
L-Isoleucine 1050.0
L-Leucine 1050.0
L-Lysine HCL 1460.0
L-Methionine 300.0
L-Phenylalanine 660.0
L-Proline 460.0
L-serine 420.0
L-Threonine 950.0
L-Tryptophan 16.0
L-Tyrosine 72.0
L-Valine 940.0
Vitamins
D-Ca pantothenate 40.0
Choline Chloride 40.0
Folic acid 40.0
i-Inositol 72.0
Nicotinamide 40.0
Pyridoxal HCL 40.0
Riboflavin 4.0
Thiamine HCL 40.0
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Phosphate buffered saline (TBS'): g/ml
CaCl2 1-0
KCL 2.0
KH2PO4  2 0
MgCl2 .6H20  10
NaCL 80.0
Na2H2P 0 4.7H20  21.6
SDS-PAGE buffers:
Running buffer:
25mM Tris
250 mM glycine, pH 8.3 
0.1% SDS
Resolving buffer
1.5 M Tris, H C LtopH  8.8
Stacking buffer
1.0 Tris, N H C LtopH  6.8
SDS gel loading buffer (sample buffer) 
70% Stacking buffer (4X)
20% Glycerol 
10% Mercaptoethanol 
4% SDS
0.01% Bromthymol
Destain buffer for commassie blue staining 
10% Ethanol 
10% Acetic acid
Blocking buffer for lectin/westem blot 
PBS
1% bovine serum albumin 
0.5% Tween-20
Modified RIPA buffer
Tris-HCl: 50 mM, pH 7.4 ,
N P-40:1%
Na-deoxycholate: 0.25%
NaCl: 150 mM 
EDTA: 1 mM 
PMSF: 1 mM
Aprotinin, leupeptin, pepstatin: 1 microgram/ml each 
Na3V04: 1 mM 
NaF: 1 mM
230
2-D electrophoresis buffers
2-D lysis buffer 
8M urea 
2M thio urea 
4% Chaps 
1% DTT
5nM sodium vanadate 
40mM Tris
Equilibration buffer
30% glycerol (v/v)
6M urea 
2% SDS (w/v)
50ml 1.25M Tris-HCL to pH6.8 in distilled H20
Destain
50mM ACN (Acetonitrile)
50mM Ammonium bicarbonate (Ambic)
Rehydration buffer , , _  .
50mM ammonium bicarbonate and trypsin (9pi ambic and lp l trypsin
stock, 100ng/pl)
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APPENDIX 2
Average number of Golgi fragments per nucleus after HM427 supernatant 
incubation
A vera g e  
n u m b e r o f 
N ucle i
A v e ra g e  n u m b e r 
o f G o lg i 
F ra g m e n ts
A vera g e
F ra g m e n ts/a ve ra g e  
n u cle u s per 
q u a d ra n t
O v e ra ll ■
control 1 A 15.33 27.67 1.80 2.12±0.2
B 12.33 25.67 2.08
C 12.00 28.33 2.36
D 14.00 31.67 2.26
control 2 A 12.00 41.00 3.42 2.96+0.3
B 15.67 45.33 2.89
C 14.33 41.33 2.88
D 18.33 49.00 2.67
control 3 A 12.33 45.33 3.68 3.13±0.4
B 9.67 31.67 3.28
C 18.67 53.33 2.86
D 13.67 37.33 2.73
HM427 1 A 8.00 42.33 5.29 5.04±0.6
t - h 9.33 44.33 4.75
c 8.00 46.00 5.75
D 12.33 54.00 4.38
HM427 2 A 7.00 31.67 4.52 4.54Ü.0
B 12.00 51.00 4.25
C 8.33 29.33 3.52
D 8.33 49.00 5.88
HM427 3 A 21.00 81.67 3.89 3.85±0.4
B 20.00 80.00 4.00
C 19.33 63.33 3.28
D 17.67 75.33 4.26
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Average number of Golgi fragments per nucleus after K12 supernatant, LPS and
Flagellin incubation
A ve ra g e  
n u m b e r o f 
N ucle i
A v e ra g e  n u m b e r 
o f G o lg i 
F ra g m e n ts
A v e ra g e
F ra g m e n ts/a v e ra g e  
n u c le u s  per 
q u a d ra n t
O v e ra ll ■  
_
K12 1 A 19.67 66.00 3.36 5.01±1.1
B 13.00 70.67 5.44
C 15.33 90.67 5.91
D 16.00 85.00 5.31
K12 2 A 15.67 54.33 3.47 3.7210.7
B 14.33 62.67 4.37
C 17.00 49.00 2.88
D 16.00 67.00 4.19
K12 3 A 15.00 69.00 4.60 5.1610.4
B 12.33 65.33 5.30
C 12.67 68.33 5.39
D 12.33 66.00 5.35
LPS 1 A 15.00 39.67 2.64 3.1010.4
B 13.67 50.67 3.71
C 14.00 42.67 3.05
D 13.67 41.33 3.02
LPS 2 A 12.33 35.33 2.86 3.5510.6
B 13.00 45.67 3.51
C 10.00 43.00 4.30
D 11.33 40.33 3.56
LPS 3 A 11.67 39.00 3.34 2.5710.7
B 15.00 42.67 2.84
C 18.67 30.67 1.64
D 14.00 34.33 2.45
Flagellin 1 A 10.00 36.33 3.63 2.9911.0
B 14.33 36.00 2.51
C 18.67 52.00 2.79
D 10.33 31.33 3.03
Flagellin 2 A 8.67 40.00 4.62 3.35+2.5
B 4.67 12.00 2.57
G 8.67 27.00 3.12
D 8.33 26.00 3.12
Flagellin 3 A 8.67 30.33 3.50 3.0910.6
B 12.33 39.67 3.22
C 10.67 36.67 3.44
D 12.00 26.67 2.22
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Average number of Golgi fragments per nucleus after OMV and Bafilomycin
incubation
A verage 
n um ber of 
Nuclei
A verage  ! 
n um b er of 
G o lg i
Fragm ents
A ve rage
Fragm ents/average  
nucleu s per 
q uad rant
O verall ■
OMV 1 A 18.00 64.00 3.56 4.1810.5
B 20.67 97.33 4.71
C 21.00 85.00 4.05
D 16.33 71.67 4.39
OMV2 A 11.67 91.33 7.83 6.6512.7
B 25.00 105.33 4.21
C 21.33 98.00 4.59
D 8.33 83.00 9.96
OMV3 A 12.33 55.00 4.46 5.0910.6
B 11.33 64.33 5.68
C 11.00 51.67 4.70
D 8.33 46.00 5.52
OMV Free 1 A 15.00 70.67 4.71 3.9210.6
B 14.67 53.67 3.66
C 18.00 61.67 3.43
D 16.00 62.33 3.90
OMV free2 A 12.00 30.00 2.50 3.3210.8
B 10.67 43.33 4.06
C 10.00 39.67 1 3.97
D 10.67 29.33 2.75
OMV free 3 A 11.33 27.33 2.41 2.5110.3
B 10.67 29.67 2.78
C 12.67 27.67 2.18
D 12.33 32.67 2.65
Bafilomycin 1 A 14.87 75.24 5.06 4.6310.4
B 15.23 70.24 4.61
C 16.78 69.23 4.13
D 15.28 72.17 4.72
Bafilomycin 2 A 20.15 84.21 4.18 4.2810.2
B 20.87 86.14 4.13
C 23.67 100.78 4.26
D 21.59 98.27 4.55
Bafilomycin 3 A 14.25 89.26 6.26 6.1410.3
B 17.54 84.66 4.83
C 12.36 89.75 7.26
D 13.77 85.32 6.20
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